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Zusammenfassung 
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ZUSAMMENFASSUNG 
Bluthochdruck ist der wichtigste Risikofaktor für Mortalität und Morbidität weltweit. Daher 
besitzen Faktoren, die den Blutdruck erhöhen und auf große Teile der Bevölkerung einwirken, 
eine hohe Relevanz bei der Erforschung von kardiovaskulären Erkrankungen. Es gibt erste 
Hinweise darauf, dass Luftverschmutzung ein solcher Faktor ist.  
Der Zusammenhang zwischen Luftverschmutzung und kardiovaskulärer Morbidität und Mor-
talität ist in den letzten zwei Jahrzehnten eingehend untersucht und nachgewiesen worden. 
Einige Studien haben gezeigt, dass eine kurzfristige Erhöhung der Konzentration der Luft-
schadstoffe zu einer akuten Steigerung des Blutdrucks führen kann. Es wird vermutet, dass 
Langzeitexpositionen gegenüber Luftverschmutzung stärkere Auswirkungen auf den Blut-
druck haben könnten. Außerdem könnte chronisch erhöhter Blutdruck als Teil des pathologi-
schen Wirkungspfads verstanden werden, wie Luftverschmutzung zu Herz-Kreislauf Erkran-
kungen und Mortalität führen könnte.  
Bislang ist die Evidenz für den Zusammenhang zwischen langfristiger Belastung gegenüber 
Luftverschmutzung und arteriellem Blutdruck nicht ausreichend. Es ist außerdem nicht klar, 
welche Partikel, Gase und andere Komponenten der Luftverschmutzung für eine Erhöhung 
des Blutdrucks verantwortlich sein könnten. Auch der biologische Wirkungspfad der Luftver-
schmutzung auf den Blutdruck ist noch nicht etabliert beschrieben worden.  
Ziel dieser Studie war es, sowohl die Assoziation zwischen der langfristigen Luftschad-
stoffexposition und dem arteriellen Blutdruck, als auch mögliche zugrundeliegende Wir-
kungspfade, zu untersuchen. Die Forschungsfragen wurden mithilfe zweier methodischer An-
sätze beantwortet: (1) Auswertung von Daten einer großen bevölkerungsbasierten Kohorten-
studie und (2) Messung und statistische Auswertung von Daten aus einem Tierexperiment.  
Für den ersten methodischen Ansatz wurden Daten aus der Heinz Nixdorf Recall Studie, einer 
prospektiven Kohorte im Ruhrgebiet, ausgewertet. Langzeitkonzentrationen verschiedener 
Komponenten der Luftverschmutzung aus urbanem Hintergrund wurden mit einem Dispersi-
ons- und Chemie-Transport Modell geschätzt und den Wohnadressen der Studienteilnehmer 
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zugewiesen. Blutdruckmessungen, Laboruntersuchungen, anthropometrische Messungen so-
wie Befragungen zum Lebensstil, zur Bildung, zu Vorerkrankungen und anderen Risikofakto-
ren wurden von geschulten Mitarbeitern anhand standardisierter Vorgaben durchgeführt und 
erfasst. Außerdem wurden Informationen über Verkehrslärm und der sozio-ökonomische Sta-
tus der Nachbarschaft erhoben. Der Zusammenhang zwischen Langzeitbelastung gegenüber 
Luftschadstoffen mit dem gemessenen Blutdruck und einer Hypertonie wurden mit multiplen 
Regressionsmodellen analysiert, welche für relevante Kovariablen und die Einnahme von 
antihypertensiven Medikationen adjustiert wurden. Multi-Pollutant Modelle (Einbeziehung 
mehrerer Luftverschmutzungskomponenten) wurden berechnet, um die verantwortlichen 
Komponenten für eine Blutdrucksteigerung zu identifizieren. Die Analysen wurden sowohl 
im Querschnitt (Blutdruck, Prävalenz der Hypertonie) als auch im Längsschnitt (Inzidenz 
einer Hypertonie) durchgeführt.  
Die Analysen zeigten eine positive Assoziation zwischen der langfristigen Exposition gegen-
über Feinstaub aus dem städtischen Hintergrund und einer Erhöhung des Blutdrucks. Dieser 
Zusammenhang war unabhängig von Expositionen gegenüber gasförmigen Luftschadstoffen 
(mit der Ausnahme von Ammoniak). Die Assoziation war linear, ohne Schwellenwert. Ver-
kehrslärm, der sozio-ökonomische Status der Nachbarschaft und andere relevante Störfakto-
ren hatten auf diesen Befund keinen Einfluss. Zusätzlich weisen die Ergebnisse auf einen po-
sitiven Zusammenhang von langfristigen Ammoniak-Expositionen am Wohnort und Blut-
druckwerten hin, welcher in weiteren Studien Bestätigung finden sollten. Assoziationen mit 
arterieller Hypertonie wurden nicht beobachtet.  
Im experimentellen Tierversuch wurde die 13-wöchige Exposition gegenüber Dieselabgasen 
und Stickstoffoxiden untersucht. Die Expression von Genen, die auf dem Wirkungspfad zwi-
schen Luftverschmutzung und höheren Blutdruckwerten beteiligt sein können, wurde mithilfe 
quantitativer Echtzeit-Polymerase-Kettenreaktion in Mäuselungen gemessen. Die Exposition 
gegenüber Dieselabgasen und Stickoxide wirkte sich auf die Aktivität von fünf Genen aus: 
CYP1A1, NQO1, iCAM, iNOS und TNF. Die Produkte dieser Gene sind in den Fremdstoff-
metabolismus, in Entzündungsprozesse, oxidativen Stress und Gefäßtonus-Regelung einge-
bunden.  
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Zusammenfassend lässt sich festhalten, dass sich positive Assoziationen zwischen der lang-
fristigen Exposition gegenüber Luftverschmutzung mit erhöhtem Blutdruck in einer bevölke-
rungsbasierten Kohorte zeigten. Erkenntnisse des experimentellen Teils dieser Studie deuten 
drauf hin, dass verkehrsbezogene Luftverschmutzungspartikel zu Entzündungen, oxidativem 
Stress und Gefäßreaktionen führen können, was wiederum den Bluthochdruck beeinflussen 
könnte.  
Blutdruck ist einer der wichtigsten modifizierbaren Risikofaktoren für Morbidität und Morta-
lität weltweit. Die Zahl der Hypertoniker in der Bevölkerung steigt stetig an. Eine relativ ge-
ringe Erhöhung des Blutdrucks aufgrund der Einwirkung von Luftverschmutzung könnte, auf 
Bevölkerungsebene, zu einer wesentlich höheren Belastung der Bevölkerung führen. Die Er-
gebnisse dieser Studie liefern Hinweise dafür, dass weitere Maßnahmen zur Verringerung der 
Luftverschmutzung zu erheblichen gesundheitlichen Vorteilen für die Bevölkerung führen 
könnten. 
Abstract 
6 
ABSTRACT 
High blood pressure is a major determinant for mortality and disability in the developed 
world. Therefore, factors which increase blood pressure and which affect large populations 
have a high priority in cardiovascular health research. One of such factors may be ambient air 
pollution.  
The link between air pollution and cardiovascular morbidity and mortality has been estab-
lished in the last two decades. There are studies showing that short-term elevations in air pol-
lution can lead to increased blood pressure within hours or days. It has been suggested that 
long-term exposure to air pollution would have an even stronger effect on blood pressure. 
Moreover, chronically elevated blood pressure could be a part of the pathophysiologic mech-
anism on how exposure to air pollution can lead to cardiac events and mortality.  
So far, only few studies have investigated the effect of long-term exposure to air pollution on 
blood pressure, with mixed results. Multiple questions remain unanswered yet. Which pollu-
tant (or pollutants) in the air pollution mixture could be responsible for blood pressure eleva-
tion? Is the association of air pollution with blood pressure confounded by the influence of 
concurrent residential exposures, such as road traffic noise and neighborhood deprivation? 
Finally, it is not clear through which biologic pathways air pollution could chronically in-
crease blood pressure and lead to hypertension. It is likely that inflammation and oxidative 
stress, triggered by inhaled pollutants, play a central role in this process. Oxidative damage, 
autonomic nervous system imbalance, and vascular endothelial dysfunction could be some of 
the mechanisms involved in chronic blood pressure elevation following long-term air pollu-
tion exposure.  
The aim of this study was to investigate the effect of long-term air pollution and its specific 
components on blood pressure and hypertension and to investigate possible underlying patho-
physiologic mechanisms. In the research part of this study, I applied two methodologies: (1) 
observational, including statistical analyses of the data from a prospective cohort study, and 
(2) experimental, using a controlled-exposure animal study.  
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I conducted the observational part of this study using a population-based cohort, the Heinz 
Nixdorf Recall Study in the highly urbanized Ruhr area of Germany. Long-term concentra-
tions of urban background air pollution (particulate and gaseous pollutants) at participants’ 
residences were modeled with dispersion and chemistry transport model. Related residential 
exposures (road traffic noise, area-level socio-economic status) were also assessed. Blood 
pressure was measured at baseline and after five years of follow-up with a standardized pro-
cedure. Information on cardiovascular risk factors, co-morbidities, lifestyle and socio-
economic factors was collected. Cross-sectional and longitudinal multiple regression analyses 
were performed, taking into account relevant confounders, and the intake of blood pressure 
lowering medication. I also employed multi-pollutant models to identify the responsible com-
pounds.  
I found a positive association of long-term exposure to fine particulate matter with blood 
pressure. This association was independent of gaseous pollutants (except ammonia), traffic 
noise, other co-exposures, and relevant confounders. The association of air pollution with 
blood pressure was linear and without a threshold. I also found a positive association of long-
term ammonia exposure at residence with blood pressure, which should be confirmed in fur-
ther studies. I observed no associations with prevalent or incident hypertension.  
In the experimental part of this study, I measured and compared gene expression in mice 
lungs after controlled 13-week exposure to diesel engine exhaust and nitrogen oxides. I found 
changes in the activity of the following genes: CYP1A1, NQO1, iCAM, iNOS, and TNFα. 
These genes are involved in xenobiotic metabolism, inflammation, oxidative stress and vascu-
lar tone regulation.  
In summary, I found a positive association of long-term exposure to air pollution with elevat-
ed blood pressure in a population-based cohort. This association is likely attributable to fine 
particulate matter and independent from co-exposure to most gases in the air pollution mix-
ture, to road traffic noise, to residential deprivation, or from relevant confounders. My find-
ings from the experimental part of this study provide supportive evidence that traffic-related 
air pollution can induce inflammation, oxidative stress and vascular reactions, which might 
favor hypertension in the long run. 
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1. THEORETICAL BACKGROUND 
1.1. Introduction 
High blood pressure (BP) is a leading risk factor for global mortality and disability, account-
ing for at least 15% of all health loss in adults aged 50 and older and for more than 9 million 
deaths in 2010 worldwide (Ezzati et al. 2002; Lim et al. 2013; Lipfert et al. 2003). The risk 
for cardiovascular diseases (CVDs), such as heart failure, infarction, and stroke, doubles with 
every increase in either systolic BP (SBP) of 20 mmHg or diastolic BP (DBP) of 10 mmHg, 
even within a normal BP range (Carretero and Oparil 2000; Lewington et al. 2002). The asso-
ciation of BP with mortality is not linear, with a rapid increase in risk at values close to hyper-
tension: 140 mmHg SBP and 90 mmHg diastolic DBP (Lipfert et al. 2003). The risk of devel-
oping hypertension for the population aged 55 and older is 90%, and the lifetime probability 
of receiving the BP lowering medication (BPLM) is 60% (Vasan 2002).  
Even small absolute decreases in BP lead to a substantial reduction of CVD risk in the popula-
tion (Cook et al. 1995; Erlinger et al. 2003). A reduction in SBP by 2 mmHg reduces stroke 
mortality by 5%, coronary heart disease (CHD) mortality by 4%, and total mortality by 3% 
(Whelton et al. 2002). A reduction in DBP by 2 mmHg has been linked to 6% decrease in the 
risk of CHD and 15% reduction in the risk of stroke and transient ischemic attack (Cook et al. 
1995). Hence, even factors with relatively small impacts on BP, but affecting large propor-
tions of the population, should have a high priority in cardiovascular health research.  
Ambient particulate matter (PM) air pollution is one of such factors. It is a major risk factor 
for global mortality (Lim et al. 2013) and cardiovascular disease. According to estimation 
from the World Health Organization (WHO), urban outdoor air is responsible for 5% of all 
cardiopulmonary deaths worldwide (WHO 2014). In an updated Scientific Statement from the 
American Heart Association published in 2010, the authors concluded that exposure to fine 
outdoor PM can trigger CVD-related events and mortality within hours or weeks (Brook et al. 
2010).  This effect was even stronger with the long-term exposure (Brook et al. 2010).  
Chronically elevated BP may be one of the underlying mechanisms of PM-induced cardiovas-
cular morbidity and mortality (Brook 2007). Short-term increases in PM air pollution lead to 
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acute increases in arterial BP (Brook 2007; Brook et al. 2009; Chuang et al. 2010; Delfino et 
al. 2010; Dvonch et al. 2009; Mordukhovich et al. 2009; Zanobetti et al. 2004). It has been 
suggested that long-term exposure to outdoor PM can lead to a chronically elevated BP and 
possibly to hypertension (Brook et al. 2010). Indeed, like other cardiovascular outcomes, BP 
is more strongly associated with longer-term average air pollution than with short-term expo-
sure to air pollution (Auchincloss et al. 2008). The associations between long-term air pollu-
tion with elevated BP and the elevated prevalence or incidence of hypertension have been 
reported in a few recent studies from Canada, China, Taiwan, and the USA (Chen et al. 2013; 
Chuang et al. 2011; Coogan et al. 2012; Dong et al. 2013; Johnson and Parker 2009; Schwartz 
et al. 2012). However, these studies differ with regard to the methodologies and the defini-
tions of exposures and outcomes. The results are, in part, not consistent. For example, in one 
study long-term exposure to nitrogen dioxide, a marker of traffic-related air pollution, was 
associated with lower BP and a decreased prevalence of hypertension (Sørensen et al. 2011). 
Therefore, more research on the long-term effects of different pollutants on BP and hyperten-
sion is needed. 
Mostly cross-sectional or repeated measures data have been used in studies of the association 
of air pollution with arterial BP. The cross-sectional analysis with BP as outcome may be 
complicated by participants’ concurrent intake of BPLM, which amounts to 41.0–77.9% of 
the adult population in Europe and North America (Wolf-Maier et al. 2003). If the BP-
lowering effect of medication is not properly accounted for, it may compromise the analysis 
with BP (Tobin et al. 2005).  
Few biologic mechanisms have been suggested for the effect of air pollution on BP (Brook 
2007). The inhalation of particles and their deposition in the lungs can cause local oxidative 
stress. First, the particles can stimulate lung autonomic receptors (either directly or through 
oxidative stress and inflammation) and can lead to systemic vagal withdrawal and autonomic 
imbalance, resulting in acute peripheral artery constriction (Brook 2007). Second, local oxida-
tive stress may extend to systemic oxidative stress, together with elevated levels of circulating 
and vascular cytokines, which can instigate vascular endothelial dysfunction and lead to vaso-
constriction (Brook 2007). The third hypothesized pathway is the translocation of nanoparti-
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cles and soluble compounds to the systemic circulation, which can alter blood rheology and 
can result in oxidative stress in vascular tissue (Brook 2007). The imbalance of the autonomic 
nervous system (ANS) may be primarily responsible for acute BP elevation following air pol-
lution, as shown by Brook et al. (2009). However, more research is needed on the exact 
mechanisms of air pollution-induced BP elevation.  
1.2. Air pollution – the exposure of interest 
1.2.1. Definition and characteristics 
Atmospheric air pollution can be defined as the presence in the atmosphere of gases or partic-
ulate matter, which are not normal air constituents and can harm living organisms and the 
environment (Yu 2005). Air pollution consists of organic, inorganic, gaseous, particulate, and 
liquid compounds. There are natural components of air pollution, such as sea salt, dust, sand, 
pollen and spores. The major anthropogenic constituents of air pollution are combustion 
products: smoke, fumes, soot, and others (Dockery 2009). Traffic and industry emit particu-
late mixtures that transform further in the atmosphere. Interactions between different compo-
nents can change the toxicity of the mixture. For example, sodium chloride (NaCl), frequent 
air pollution component, does not pose any hazard to health per se (Mills et al. 2009). How-
ever, it can form toxic compounds through synergy with other pollutants. For example, Last et 
al. demonstrated a synergistic interaction of NaCl with NO2, which could potentially form a 
toxic compound, nitrosyl chloride, NOCl (Last and Warren 1987; Last et al. 1994). A syner-
gistic effect of PM10 and NO2 in emergency cardiac hospitalizations in Hong Kong has been 
recently reported by Yu et al. (2013). Air pollutants can be divided into two groups by their 
physical characteristics: particles, or PM, and gaseous pollutants, such as ozone, nitrogen ox-
ides, and others.  
PM is composed of solid and liquid aerosols that are dispersed in the air (Pope and Dockery 
2006). PM is frequently used as an exposure in observational and experimental studies on air 
pollution effects, and the most consistent adverse health effects have been reported for this 
component of air pollution (Araujo and Nel 2009). The number of particles and their size, 
surface area, and chemical composition contribute to the toxicity of the air pollution mixture 
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(Mills et al. 2009).  
Sources of air pollution in Germany 
According to the German Federal Environment Agency (2013), energy production, such as 
the burning of fuels (industrial and private) and traffic (combustion, tire and brake wear), was 
a major source of PM2.5 (70%), sulfur dioxide (81%), nitrogen oxides (84%), and carbon 
monoxide (77%). Industry (such as steel production) was the second major emitter of PM2.5 
(15%), PM10 (31%), sulfur dioxide (19%), and carbon monoxide (23%). The use of solvents 
and other products contributed mostly to volatile organic compounds (VOCs) emissions 
(68%) but also to PM2.5 (9%) and PM10 (5%). Agriculture was a major source of atmospheric 
ammonia (94%), mostly emitted through the use of fertilizers.  
1.2.2. Classification of PM  
Classification by size 
Particle size is an important parameter, as it influences particle behavior in the atmosphere 
and within the human respiratory tract. PM is classified according to the aerodynamic diame-
ter, defined as the diameter of a spherical particle with a density of 1000 kg/m3 and the same 
settling velocity as an irregular particle. By definition, the aerodynamic diameter of 50% of 
the particles in the defined fraction should be less than or equal to the selected cut point 
(Chow 1995). The sizes of particles range from 0.5 mm to 10-7mm (Yu 2005). In relation to 
health effects, the inhalable particles (also called ―thoracic fraction‖) with diameters ≤ 10 µm 
are investigated. Thoracic fraction includes coarse, fine, and ultrafine PM. 
Coarse PM consists of particles > 2.5 and ≤ 100 µm in diameter (Kelly and Fussell 2012). 
Size of coarse PM is comparable to some cells in the human body, e.g., red blood cells (Brook 
2008). Particles with aerodynamic diameters ≤ 10 µm (PM10) can be deposited in the naso-
pharynx, and smaller particles (PM10-2.5) may be inhaled to the lungs (Kelly and Fussell 
2012).  PM10 is defined by the European Commission in Directive 2008/50/EC as “particulate 
matter which passes through a size-selective inlet as defined in the reference method for the 
sampling and measurement of PM10, EN 12341, with a 50% efficiency cut-off at 10-µm aero-
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dynamic diameter‖ (Directive 2008/50/EC). Sources of coarse PM include: black smoke, soil, 
agricultural and road dust, soil, crustal materials from roads, tire wear emissions, construction 
debris, farming, mining operations, volcano eruptions, sea salt, pollen, mold, spores, other 
plant parts, and secondary particles (Araujo and Nel 2009; Kelly and Fussell 2012; Pope and 
Dockery 2006). The lifetime of coarse PM is hours to days (Brook 2008). Coarse PM can 
disperse over large areas (10 to 100 km) and contributes to most of the total PM mass (Brook 
2008). 
Fine particles have aerodynamic diameters > 0.1 and ≤ 2.5 µm, which is comparable to sizes 
of bacteria or viruses (Brook 2008). Together with ultrafine particles (UFPs) they are classi-
fied as PM2.5. The European Commission defines PM2.5 as “particulate matter which passes 
through a size-selective inlet as defined in the reference method for the sampling and meas-
urement of PM2.5, EN 14907, with a 50% efficiency cut-off at 2.5-µm aerodynamic diameter” 
(Directive 2008/50/EC). Fine particles consist of soot, organic compounds, endotoxin, sul-
fates, nitrates, metals, etc. (Brook 2008). Main sources of PM2.5 include: combustion (fuel 
combustion and tailpipe and brake emissions from mobile sources, power plants, residential 
wood and coal burning, wildfires), industrial processes (smelters, cement plants, steel and 
paper mills), and secondary gas-to-particle conversion (Araujo and Nel 2009; Pope and 
Dockery 2006). PM2.5 includes UFPs in the nucleation and Aitken modes, along with accumu-
lation mode particles (0.1–1 μm; Araujo and Nel 2009). Fine particles have longer lifetimes 
than UFPs (up to weeks) and are distributed over large areas, forming the background air pol-
lution (Brook 2008). Fine particles can reach alveoli and terminal bronchioles after inhalation 
(Dockery 2009; Kelly and Fussell 2012). Many adverse health effects, both acute and chronic, 
have been attributed to the fine particle fraction (European Environment Agency 2012). PM2.5 
can be distributed regionally (up to 1000 km; Brook 2008). Fine and ultrafine particles are 
major contributors to the number of particles and the surface area of PM, but not to its total 
mass. 
UFPs have aerodynamic diameters ≤ 0.1 µm (PM0.1), which is comparable to the size of mol-
ecules or smaller viruses (Brook 2008). UFPs are by far the most numerous particles in the 
PM mixture. They contribute mostly to surface area but not to the mass of PM (Kelly and 
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Fussell 2012). UFPs are very unstable, and they quickly (within minutes to hours) coagulate 
or condense into larger particles (Brook 2008). The major components of this fraction include 
sulfates, nitrates, elemental carbon, organic carbon, UFPs aggregates, endotoxin, and metals 
(Kelly and Fussell 2012). The major emission sources are combustion processes, such as au-
tomobile emissions (Araujo and Nel 2009; Pope and Dockery 2006). UFPs can also occur 
through the nucleation of gas-phase species to condensed-phase species in the newly emerg-
ing particles that did not grow (aerodynamic diameter < 0.01 μm, classified as nucleation 
mode) or through the coagulation of recently formed particles (0.01–0.1 μm, Aitken mode; 
Araujo and Nel 2009). Lifetime of UFPs is minutes to hours (Brook 2008). UFPs are mostly 
distributed within a 100-m distance from their source (Brook 2008); their concentration de-
creases exponentially with increasing distance from the road to approximately 300 m, where 
they cannot be further distinguished from background particles (Zhu et al. 2002). Combustion 
nanoparticles can carry on their surfaces many substances that can trigger adverse reactions in 
organisms: oxidized transition metals, polycyclic aromatic hydrocarbons, soluble organic 
compounds, and others. (Mills et al. 2009). The small size of the ultrafine particles allows 
them to penetrate the air-blood barrier in the lungs (Kelly and Fussell 2012; Mills et al. 2009). 
Primary and secondary particles 
Airborne particles are classified as primary, originating directly from various sources, and 
secondary, forming from the interactions of primary air pollutants (Dockery 2009). Primary 
PM includes larger particles, usually 1 to 20 µm in diameter (Yu 2005). The primary particles 
are emitted directly to the atmosphere by physical and chemical processes, such as combus-
tion, erosion (Kelly and Fussell 2012). The secondary particles, such as sulfates (SO4
2-) and 
nitrates (NO3
-), are smaller than the primary particles.  They are generated through chemical 
reactions in the atmosphere, e.g., the reactions of inorganic and organic gases with atmospher-
ic oxygen, water vapor, free radicals, and reactive species (Araujo and Nel 2009). The prima-
ry particles contribute a minor amount to the total mass of PM, but can be more hazardous, 
than the secondary particles, because they act as condensation nuclei for the secondary aero-
sol mass and may carry various toxic trace species (Yu 2005). 
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1.2.3. Chemical composition of PM  
The composition of PM depends on the source from which the particles originate. For exam-
ple, sea salt aerosols consist mainly of sodium chloride, NaCl, but also include magnesium, 
sulfate, calcium, potassium, and some organic compounds (Perrino 2010). Sea salt is one of 
the dominant contributors to atmospheric aerosols worldwide: the yearly sea salt flux from the 
ocean to the atmosphere is estimated to be 3.3×1012 kg per year (Intergovernmental Panel on 
Climate Change 2007). The crustal matter originating from the Earth’s crust consists of min-
eral oxides (Perrino 2010). 
Organic matter is another major constituent of PM. It consists of various organic chemical 
compounds, primary (such as VOCs) and secondary (occurring through the oxidation of 
VOCs). VOCs can be of natural origin, e.g., isoprene, terpenoids, esters produced by plants, 
and anthropogenic, e.g., n-butane, ethylene, benzene from the motor vehicle exhaust (Blake 
and Blake 2003; Guenther 2003). Elemental carbon, also called black carbon, is another im-
portant compound of PM. Together, organic matter and elemental carbon form the carbona-
ceous fraction of PM. 
Sulfates and nitrates are important compounds of PM (Kelly and Fussel 2012). Sulfates  
(SO4
2-) are created through the oxidation of sulfur dioxide (SO2). Similarly to sulfates, nitrates 
(NO3
-) are formed through the oxidation of nitrogen dioxide (NO2). Ammonium nitrate 
(NH4NO3) and bisulfate ( (NH4)2SO4) are common secondary particles and are formed from 
atmospheric ammonia, sulfate and nitrate (Perrino 2010). If ammonia is not present in the 
atmosphere, the following acids are formed instead: sulfuric acid (H2SO4) as liquid aerosol 
droplets, and nitric acid (HNO3) as gas (Perrino 2010). 
The relative contributions of different components to the total PM mass in Europe were inves-
tigated by Putaud et al. (2004). Approximately 70% of the total mass of the PM mixture was 
identified. The rest was assumed to be either water vapor or non-estimated matter. Organic 
matter was a major contributor to the annual average PM2.5 and PM10 in the near-city and ur-
ban background (mass contribution 20% to PM10 and 22% to PM2.5) and near the road (22% 
and 29%, respectively; Putaud et al. 2004). Sulfate was the second largest part of urban and 
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traffic PM and a major contributor to the masses of PM10 and PM2.5 from the natural and rural 
background (Putaud et al. 2004). Nitrate was correlated with instances of high PM concentra-
tions; the authors related this observation to specific meteorological conditions, such as cold 
periods, when atmospheric NH4NO3 was very stable (Putaud et al. 2004). The contribution of 
black carbon was relatively small in the urban background and rural sites and was higher near 
the road (Putaud et al. 2004). 
Metals are an important part of the PM mixture: although not largely contributing to total 
mass or size, they define the chemical reactivity and toxicity of the mixture. The following 
transition metals were detected in PM2.5 and UFP: iron (Fe), lead (Pb), mercury (Hg), cadmi-
um (Cd), silver (Ag), nickel (Ni), vanadium (V), chromium (Cr), manganese (Mn), and cop-
per (Cu; Lodovici and Bigagli 2011; Yu 2005). Transition metals can originate from the 
earth’s crust, combustion sources, waste water discharges, and other sources (Lodovici and 
Bigagli 2011). Zink (Zn) is found in traffic-related PM, originating from waste oil (Lodovici 
and Bigagli 2011). Cu and Fe are components of brake wear; in addition, Fe is a soot suppres-
sant emitted as UFP (Lodovici and Bigagli 2011). Particulate iron oxide (Fe3O4) can also be 
produced during combustion of coal which contains iron sulfide (FeS2; Yu 2005): 
3𝐹𝑒𝑆2 + 8𝑂2 → 𝐹𝑒3𝑂4 + 6𝑆𝑂2       [1] 
Lead halide particles can be produced during combustion of leaded gasoline, in a reaction of 
tetraethyl lead (Pb(C2H5)4) with molecular oxygen and halogenated scavengers (dichlorethane 
and dibromoethane; Yu 2005): 
𝑃𝑏(𝐶2𝐻5)4 + 𝑂2 + 𝑕𝑎𝑙𝑜𝑔𝑒𝑛𝑎𝑡𝑒𝑑 𝑠𝑐𝑎𝑣𝑒𝑛𝑔𝑒𝑟𝑠 → 𝐶𝑂2 + 𝐻2𝑂 + 𝑃𝑏𝐶𝑙2 + 𝑃𝑏𝐵𝑟𝐶𝑙2 
+ 𝑃𝑏𝐵𝑟2    [2] 
Quass et al. (2004) analyzed the chemical composition of PM1–PM10 from an urban back-
ground measurement station. They found that larger particles (PM10) contained higher propor-
tions of metal oxides (including aluminum and iron oxides), of calcium, potassium, magnesi-
um, sodium and chloride. Smaller particles (PM2.5 and PM1) contained more ammonia, sul-
fates, nitrates, organic matter, and elemental carbon (Figure 1). 
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Figure 1. Chemical composition of PM10, PM2.5, and PM1 from an urban background station 
in Germany.  
Legend: Adapted from Quass et al. 2004, Figure 3. Mass concentration (%) of the respective 
components of PM1, PM2.5, and PM10 are presented. 
1.2.4. Ozone 
Ozone (O3) is an important outdoor pollutant. As a secondary pollutant, it is formed in the 
troposphere through a complex series of reactions. These reactions involve nitrogen oxides 
(NOx), VOCs, and the presence of sunlight (Brunekreef and Holgate 2002; Melkonyan and 
Wagner 2013). Brönnimann and Neu (1997) distinguish the following two types of chemical 
processes affecting ozone concentrations: (i) the photostatic equilibrium and (ii) the substitu-
tion of O3 with peroxyl radicals. The photostationary equilibrium consists of three reactions: 
NO2 + hυ
1(λ <  200 nm) → NO + O∗      [3] 
O∗ + O3 → O3         [4] 
NO + O3 → NO2 + O2        [5] 
1hv – radiation energy with a frequency v at the wavelength λ < 400 nm (also < 420 nm); h – 
the Planck constant (Melkonyan and Kuttler 2012). 
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NO, emitted from traffic, is introduced to the equilibrium. Decrease in the concentration of 
NO leads to increases in the ozone concentration. Simultaneously, NO, originating from the 
traffic, scavenges O3, which explains the lower concentrations of ozone observed in a city 
center compared to the suburbs (Brönnimann and Neu 1997; Brunekreef and Holgate 2002). 
The substitution of O3 with a peroxyl radical occurs as follows: 
NO + RO2
1 → NO2 + RO         [6] 
NO + HO2 → NO2 + HO
∗²        [7] 
1R is an organic part; RO2 is peroxide radical. ²Hydroxyl radical. 
This process replaces reaction [5] in the photostationary equilibrium and decreases O3 de-
struction, which results in a higher O3 concentration. Peroxyl radicals are products of hydro-
carbons (such as VOCs) and carbon monoxide in reactions with hydroxyl radicals (Brön-
nimann and Neu 1997).  
Temperature and radiation influence chemical activity. The concentration of hydroxyl radicals 
increases in the sunlight (Melkonyan and Kuttler 2012). Decreasing the VOC emissions di-
minished the O3 concentrations (Brönnimann and Neu 1997). On hot, sunny days, the synthe-
sis of O3 dominates over destruction, leading to elevated ozone levels. In contrast, the destruc-
tion of O3 occurs more readily on cold, cloudy days (Brönnimann and Neu 1997). The reac-
tive biogenic VOCs (isoprene, monoterpenes, etc.) are emitted in significant quantities on the 
hot days, resulting in increased amounts of ozone above green areas in the summer (Melkon-
yan and Kuttler 2012).  
The measurement of atmospheric O3 is conducted using continuous and discontinuous (such 
as passive sampler) methods (WHO 1999). The following methods to sample O3 are common-
ly used: laminar flow, turbulent flow and sampling without a manifold (WHO 1999). The au-
tomated measurements most frequently employed to measure O3 include chemiluminescence, 
ultraviolet photometry and differential optical absorption system spectrometry (WHO 1999). 
The reference method to measure O3 in the European Union (EU) is continuous measurement 
by ultraviolet photometry according to the standard EN 14625:2005 (Directive 2008/50/EC). 
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1.2.5. Nitrogen oxides 
The most common atmospheric nitrogen oxides are nitrogen monoxide (NO) and nitrogen 
dioxide (NO2). Nitrogen oxides are produced from the reaction of nitrogen (N2) and oxygen 
(O2) gases during combustion, especially at high temperatures (Yu 2005): 
𝑁2 + 𝑂2 →
1 2𝑁𝑂         [8] 
2𝑁𝑂 + 𝑂2 → 2𝑁𝑂2         [9] 
1Reaction temperature 1210 °C (Yu 2005). 
The primary sources of NO2 include road transportation and power generation (Kelly and 
Fussell 2012). In the presence of oxidants (e.g., O3) NO is transformed to NO2, which is why 
the nitrogen oxides are usually referred to cumulatively as NOx. The major sources of anthro-
pogenic emissions of NOx are transportation, power generation, and fossil fuel burning for 
heating (Brunekreef and Holgate 2002; Lodovici and Bigagli 2011). NOx can also occur natu-
rally during thunderstorms. NOx contributes to the formation of tropospheric O3 and fine PM. 
The reaction of NOx with VOCs forms photochemical smog. The most substantial formation 
of photochemical smog occurs in summer. The major components of photochemical smog are 
ozone, nitrogen oxides, peroxyacetyl nitrate, radical oxygen forms, and various organic com-
pounds (Yu et al. 2005). Nitrogen oxides are the precursors of nitric acid, which, when dis-
solved in atmospheric vapor, forms a component of acid rain.  
The most commonly used methods to measure nitrogen oxides are passive and active sam-
pling, automatic analysis and remote sensing (WHO 1999). In the EU, according to the stand-
ard EN14211:2005 (Directive 2008/50/EC), the reference method for the measurement of 
NOx is chemiluminescence. 
1.2.6. Sulfur dioxide 
Sulfur dioxide (SO2) is an important gaseous constituent of air pollution and constitutes a ma-
jor part (95%) of anthropogenic emissions of sulfur (S) in the atmosphere (Yu 2005). SO2 
mainly originates from power generation and industrial processes including combustion of 
sulfur-containing fuels, such as coal or oil, petroleum refining, and nonferrous smelting 
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(Kelly and Fussell 2012; Yu 2005). In addition, domestic heating and diesel engines can also 
emit SO2 (WHO 1999). Natural sources of SO2 include volcanic eruptions and geothermal 
springs (WHO 1999). Concentrations of atmospheric SO2 have been reduced substantially in 
the USA, Western Europe, and Japan in the past decades, whereas in other countries, such as 
China and South Korea, emissions are increasing (Environmental Protection Agency 2013; 
WHO Air Quality Guidelines for Europe 2000; Lu et al. 2000). SO2 emissions worldwide 
have been largely reduced through flue-gas desulfurization, a technology to bind emitted SO2 
at power plants (Lu et al. 2000). Technologies that allow the removal of sulfur from fuels pri-
or to combustion, such as the Claus and Stretford processes, are also used to reduce atmos-
pheric SO2 emissions. Similar to NOx, SO2 is a precursor for acid rain (forming sulfuric acid) 
and secondary particle formation. SO2 is hazardous to both human health and the environment 
(European Environment Agency 2012; Lu et al. 2000). SO2 is the most important precursor to 
PM2.5 (European Environment Agency 2012). 
The reference measurement method of SO2 in the EU is automated measurement by ultravio-
let fluorescence, as described in EN 14212:2005 (Directive 2008/50/EC). Other commonly 
used methods include active and passive sampling with spectrophotometry, chromatography, 
acidimetry, and others (WHO 1999).  
NO2 and SO2 are the main sources of atmospheric acidity (Kumar et al. 2004). They can be 
oxidized by O3, hydrogen peroxide (H2O2), or hydroxyl radical to sulfuric and nitric acids, 
respectively. The two acids can be further neutralized by atmospheric ammonia, forming am-
monium bisulfate and ammonium nitrate and then remaining in the aerosol phase. Alternative-
ly, sulfuric and nitric acids could be deposited on the Earth’s surface (Kumar et al. 2004). NO2 
can also react with VOCs in direct sunlight, resulting in the production of ground-level O3 
(WHO 2003). 
1.2.7. Ammonia 
Anthropogenic ammonia (NH3) is emitted during agricultural activities, animal feedlot opera-
tions, the decomposition of organic matter, and biomass burning, and, to a lesser extent, from 
industry, traffic, and volatilization from soils and oceans (Behera et al. 2013; Krupa 2003). 
Theoretical Background 
20 
NH3 is deposited within the first 4–5 km from its source (Krupa 2003) and is an important 
precursor of secondary particles in the atmosphere (Perrino 2010). Atmospheric NH3 reacts 
with acids, such as sulfuric (H2SO4), nitric (HNO3), nitrous (HNO2), and hydrochloric (HCl) 
acids, and with oxides, e.g., SO2. The emerging ammonium salts, such as ammonium nitrate 
(NH4NO3) or ammonium bisulfate ((NH4)2SO4), form secondary particles, mostly in the PM2.5 
fraction (WBK and Associates Inc. 2004). Approximately 1% of total atmospheric ammonia is 
involved in the formation of NO (WBK and Associates Inc. 2004). It is estimated that the 
global emissions of NH3 may increase due to increasing anthropogenic activity (Sutton et al. 
2013). 
1.2.8. Carbon monoxide 
Carbon monoxide (CO) is present in small amounts in the atmosphere. CO is a product of (i) 
incomplete combustion of carbon-containing fuels, occurring when the supply of oxygen is 
not sufficient for complete oxidation, (ii) reactions between carbon dioxide (CO2) and carbon-
containing compounds at high temperature, and (iii) CO2 dissociation at high temperature 
(European Environment Agency 2012; Yu 2005). The anthropogenic sources of CO include 
internal combustion engines, man-made fires and fuel combustion, and the natural source of 
CO is volcanic activity (WHO Air Quality Guidelines for Europe 2000). CO is involved in 
photochemical smog formation (Yu 2005). CO reacts with hydroxyl radicals and contributes 
to the synthesis of tropospheric O3. CO is highly toxic because it reduces oxygen delivery to 
the body’s organs and tissues (European Environment Agency 2012). The introduction of cat-
alytic converters in road vehicles has reduced formerly significant amounts of CO at traffic 
sites (European Environment Agency 2012). 
The most common routine measurement method of CO in the atmosphere is non-dispersive 
infrared spectrometry, an automated continuous method (WHO 1999). This method allows for 
the measurement of CO concentrations within the range of 0.5–115 mg/m³.  
1.2.9. Measurement of air pollution 
Commonly used measurement systems of suspended PM are high-, medium- and low-volume 
samplers (defined by the volume of air sampled per unit time; UNEP/WHO 1994). Every 
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sampler should conform to the CEN standard EN 12341 (WHO 1999). The samplers collect 
PM on a filter using high- or low-volume flow (WHO 1999). High- and medium-volume 
samplers can be equipped with PM10 inlets to allow fraction determination (UNEP/WHO 
1994). The filter with collected particles can be analyzed using physical and chemical meth-
ods, the most important of which are the estimation of total sample mass, the characterization 
of PM size distribution, and the chemical analysis of particle fractions (UNEP/WHO 1994). 
The estimation of mass (gravimetry) is achieved using microbalance techniques, tapered ele-
ment oscillating microbalance techniques, and radiometry (pseudogravimetry; UNEP/WHO 
1994). Reflectometry (blackness of filter) is a measure of the total graphitic carbon content in 
the aerosol; thanks to technical simplicity and low cost, this method is widely used 
(UNEP/WHO 1994). Nephelometry (the light scattering capacity of the aerosol) is used as a 
measure of PM2.5 (UNEP/WHO 1994). Chemical characterization of the PM allows for ion 
groups, metals and other functional entities in bulk specimens to be determined (UNEP/WHO 
1994). Additionally, physical methods allow for the elementary molecular or crystalline com-
positions of the particles to be determined (UNEP/WHO 1994). The reference method EN 
12341:1999 is used in the EU for the sampling and measurement of PM10; for PM2.5, EN 
14907:2005 is used (Directive 2008/50/EC). 
The methods to sample gases and vapors can be divided in two groups: (i) sampling in the 
original atmospheric state, without measuring concentrations and (ii) sampling of the atmos-
phere with an assessment of the concentrations of gases and vapors.  
1.2.10. Current regulatory standards 
In the EU, the standards for ambient air quality are set by Council Directive 2008/50/EC, 
which became active on 11 June 2008. This directive sets the maximum limits for 1-hour and 
24-hour average SO2 at 350 µg/m³ and 125 µg/m³, respectively. The 1-hour and 1-year limits 
for NO2 are 200 µg/m³ and 40 µg/m³. The daily maximum for CO is set to 10 µg/m³. Daily 
PM10 has a limit of 50 µg/m³, which is not to be exceeded more than 35 times a calendar year, 
and a yearly limit of 40 µg/m³ (European Commission Air Quality Standards). The target val-
ue for PM2.5 is 25 µg/m³ for the yearly average, which became active 1 January 2010; it will 
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be set as the limit beginning 1 January 2015. The additional objectives of Directive 
2008/50/EC target the population exposure for PM2.5. They include an average exposure indi-
cator, a 3-year running annual mean concentration of PM2.5 representing the urban back-
ground exposure. The EU member states are obligated to reach an average exposure indicator 
limit of 20 µg/m³ by 2015 (years 2013–2015). In addition, the exposure reduction target has 
been set; depending on its average exposure indicator value in 2010, each country is to reach 
a percentage reduction (0, 10, 15, or 20%) and to implement all measures to reach an AEI 
limit of 18 µg/m³ (European Commission Air Quality Standards). 
According to the current WHO Air Quality Guidelines (2005), the recommended 24-hour 
mean for PM2.5 is 25 µg/m³, and the recommended annual mean is 10 µg/m³; for PM10, these 
values are 50 and 20 µg/m³, respectively. It is estimated that reductions of PM concentrations 
to these levels will reduce air pollution-related mortality by 15% (WHO Air Quality Guide-
lines). In addition, three interim targets have been set for PM2.5 and PM10, suggested as help-
ful milestones in the process of reducing the exposure over time. For example, for annual 
mean concentrations of PM2.5, the recommended interim targets were 35, 25 and 15 µg/m³. 
According to the report of the European Environment agency (2012), up to 30% of EU’s ur-
ban population was exposed to PM2.5 concentrations above the EU reference values in 2008–
2010. In the same period, the vast majority (90–95%) of the EU population lived above the 
PM2.5 threshold recommended by the WHO (European Environment Agency 2012). 
Two countries outside the EU have already set limits for PM2.5: USA, at 12 µg/m³ for the an-
nual concentration (Environmental Protection Agency 2012), and Japan, at 15 µg/m³ (Minis-
try of the Environment 2009). 
1.3. Arterial BP – the outcome of interest 
1.3.1. The definition of BP 
The cardiovascular system can be schematized as consisting of a pump (heart), a series of 
distributing and collecting tubes (arteries and veins), and a system of thin vessels that facili-
tate the rapid exchange between the tissues and circulation (Pappano and Wier 2013). Arterial 
BP, or simply BP, is one of the principal vital signs. It is defined as the lateral pressure exerted 
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by a column of blood upon the walls of blood vessels (Pal and Pal 2005). During a single 
heartbeat, BP changes from the maximum, SBP, to the minimum, DBP (Pappano and Wier 
2013). Pulse pressure (PP) is defined as the difference between the SBP and the DBP. SBP 
depends mainly on the cardiac output and increases when cardiac output increases (Pal and 
Pal 2005). DBP depends on the peripheral resistance (Pal and Pal 2005). BP can be calculated 
using the following formula (Steffel and Lüscher 2011): 
BP =  Cardiac output × Resistance      [10] 
Cardiac output is defined as the total blood flow out of the left ventricle, usually per one mi-
nute (Pappano and Wier 2013). It is the product of stroke volume with heart rate. Stroke vol-
ume is the amount of blood pumped out from the ventricle with a heartbeat. Cardiac output is 
the blood flow perfusing all of the tissues of the body. It can change, adapting to the metabolic 
demands of the body: e.g., during severe exercise, it can increase four to five-fold (Pappano 
and Wier 2013). The following factors control cardiac output: heart rate, myocardial contrac-
tility, preload, and afterload (Pappano and Wier 2013). Cardiac output also depends on the 
vascular resistance (Pappano and Wier 2013). 
Total peripheral resistance is the resistance of the peripheral vasculature to the blood flow 
(Pappano and Wier 2013). It increases during vasoconstriction and decreases during vasodila-
tion. The main factors influencing the peripheral resistance are the tone of the small arterioles 
(also known as the resistance arterioles, diameters 100–450 μm), the tone of the pre-capillary 
arterioles (4–100 μm in diameter), and the blood viscosity. The regulatory factors influencing 
peripheral resistance include platelet-derived factors (such as serotonin), which dilate the ves-
sel. Endothelium-derived NO, released following cholinergic stimulation, also works as a 
vasodilator (Pappano and Wier 2013). If the endothelium is damaged (e.g., removed), blood 
vessel dilation does not occur after these stimuli (Pappano and Wier 2013).  
The factors controlling arterial BP may be divided in two large groups: ―physical‖, such as 
arterial blood volume and the elastic characteristics of the system, and ―physiological‖, such 
as cardiac output and peripheral resistance (Pappano and Wier 2013).  
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1.3.2. General mechanism of BP regulation 
BP is regulated as follows: (i) sensors estimate the pressure and transfer a signal to an evalua-
tor; (ii) evaluators translate the coded signal from the sensors, compare the BP with a set point 
(a value desirable under current conditions) and trigger, if needed, the compensatory mecha-
nisms; and (iii) according to the signal from the evaluators, the effector mechanism can 
change the heart rate, the cardiac output or the total peripheral vascular resistance to stabilize 
the BP (Ackermann 2004). BP regulation can produce acute or long-term changes in pressure. 
The short-term responses are mainly produced by baroreceptors (the non-encapsulated nerve 
endings located in the arterial wall of the carotid sinus and the aortic arch) and by the stretch 
sensors in the cardiac atria (Ackermann 2004). The signal is conveyed to the midbrain (neu-
rons in the nucleus tractus solitarius) and can trigger (i) the increased production of angioten-
sin II, which increases sodium and water retention in the kidneys, thereby increasing the 
blood volume; (ii) cardiac parasympathetic outflow, which results in lower heart rate, and, 
correspondingly, lower cardiac output and BP; and (iii) sympathetic nervous outflow, with the 
release of adrenalin, renin and noradrenaline, activating α- and β-adrenoreceptors in the cell 
membranes of the target tissues, resulting in increases in heart rate, cardiac contractility and 
vascular resistance – all of which can lead to a raise in BP (Ackermann 2004).  
1.3.3. Regulation of BP through the control of blood flow 
BP keeps blood flow at the level required for its metabolic activity, which is why maintaining 
a stable BP level is crucially important (Ackermann 2004; Sears and Casadei 2002). Control 
of blood flow and regulation of BP can be seen as two different aspects of the common pro-
cess, each one affecting and being affected by the other. The auto-regulation of blood flow 
involves two processes: (i) metabolic, regulating the coupling between blood flow and tissue, 
and (ii) myogenic, modulating the blood vessel response to BP change (Sears and Casadei 
2002). The metabolic response to BP change is affected by the concentrations of vasodilator 
metabolites and oxygen (Sears and Casadei 2002). Dilation of an arteriole can increase perfu-
sion and oxygen supply. It has been suggested that the lack of oxygen also has a vasodilatory 
effect through a diminished adenosine triphosphate to adenosine diphosphate ratio and the 
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opening of Kadenosine triphosphate channels, relaxing the smooth muscle (Sears and Casadei 2002). 
In addition, a vasodilatory effect was suggested for adenosine in coronary muscle and potas-
sium in skeletal muscle (Sears and Casadei 2002). The myogenic response is a cascade of 
reactions in the vascular smooth muscle cells, occurring in response to changes in pressure 
(Sears and Casadei 2002). It has been suggested that stretching in the arteriolar wall leads to 
constriction of vessels: it activates calcium channels in the vascular muscle cells and that se-
cond messengers, such as arachidonic acid (an inhibitor of KCa channels), act as local vaso-
constrictors (Sears and Casadei 2002). 
1.3.4. Heart rate, stroke volume and peripheral resistance 
BP regulation involves thee parameters: heart rate, stroke volume, and total peripheral vascu-
lar resistance (Ackermann 2004). Heart rate is set and controlled by cardiac pacemaker cells 
(located in the right atrium) which create the impulse (Ackermann 2004). The sympathetic 
nervous activity increases the heart rate, whereas the parasympathetic activity decreases it 
(Ackermann 2004). Stroke volume depends on cardiac performance: preload, afterload, heart 
rate and contractility. In a healthy heart, an increase in preload is associated with a higher ven-
tricular performance, and the increase in afterload is associated with a higher ventricular con-
tractility (Ackermann 2004). Short-term changes in the ventricular contractility occur due to 
neurohumoral factors, whereas long-term changes depend on the morphological changes in 
the contractile proteins actin and myosin (Ackermann 2004). Total peripheral vascular re-
sistance is regulated mainly through changing the luminal arteriolar diameter (Ackermann 
2004). The arteriolar diameter is determined by the degree of constriction or relaxation of 
smooth muscle cells located in the medial layer of the arteriole. This diameter results from the 
action of vasodilators or vasoconstrictors. Most of the factors that act as vasodilators (widen-
ing the arteriolar diameter) are byproducts of tissue metabolism, whereas vasoconstriction 
(narrowing of the arteriole) is achieved through sympathetic nervous activity and the actions 
of chemical compounds such as adrenaline, angiotensin II, or vasopressin (Ackermann 2004). 
Vasoconstriction, which is mediated sympathetically, controls peripheral vascular resistance, 
except for parts of vessels where vasodilatory products are produced by the tissue (Acker-
mann 2004). 
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1.3.5. Endocrine and paracrine regulation of BP 
Endocrine regulation 
The long-term control of BP involves the kidney and angiotensin II (Ackermann 2004). The 
kidney is the most important organ controlling blood volume and pressure (Sears and Casadei 
2002). Kidneys regulate BP through two mechanisms: the modulation of sodium (and there-
fore liquid) balance and the production of vasoactive substances. These substances include 
angiotensin II, prostaglandin and NO, the endothelium-derived relaxation factor (Takenaka et 
al. 2004). 
The endocrine regulation mechanisms include adrenal glands, renin-angiotensin system, and 
vasopressin release. The adrenal medulla of the adrenal gland produces two hormones influ-
encing BP: adrenaline and noradrenaline. These hormones are produced in response to sym-
pathetic stimulation, cause vasoconstriction and increased cardiac output (Sears and Casadei 
2002). The receptors involved in vasoconstriction response are: (i) α1A receptors in the vascu-
lar smooth muscle cells and (ii) α2C receptors in the arteries and veins. The β1 and β2 adrener-
gic receptors, also located in the vasculature, mediate vasodilation (Sears and Casadei 2002). 
The renin-angiotensin system is an important BP regulation system that involves the kidneys 
and controls the cardiac output by modulating urinary salt and water excretion (Suzuki and 
Saruta 2004). If BP is falling, a decrease in renal perfusion pressure, or sympathetic nervous 
activity, or prostacyclin production affects the activity of juxtaglomerular cells in the kidneys. 
This triggers the secretion of renin into circulation (Sears and Casadei 2002). Renin cleaves 
angiotensinogen to angiotensin I, and angiotensin-converting enzyme (ACE) subsequently 
cleaves it to angiotensin II; ACE catalyzes the breakdown of the vasodilator bradykinin to 
inactive peptides (Sears and Casadei 2002). Angiotensin II mediates vasoconstriction and so-
dium and liquid retention (through the release of aldosterone from the adrenal cortex), in-
creasing blood volume and elevating BP (Fujita 2001; Sears and Casadei 2002). Angiotensin 
II also stimulates smooth muscle proliferation (Sears and Casadei 2002). In addition to the 
kidney renin-angiotensin system, there are local systems within the vasculature (Ching and 
Beevers 1991). A local renin system may be activated by local vascular damage, independent 
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of the systemic BP (Ching and Beevers 1991). Angiotensin also plays a role in vascular re-
modeling through the stimulation of angiotensin type 2 receptors (Sears and Casadei 2002).  
Vasopressin, or antidiuretic hormone, acts to retain water in the body and to constrict blood 
vessels. It is secreted in nervous fibers of the supraoptic and paraventricular nuclei of the hy-
pothalamus in response to reductions in plasma volume (activated by baroreceptors; a > 10% 
reduction in blood volume activates the secretion) and increases in plasma osmolality (osmo-
receptors in the hypothalamus) and in response to cholecystokinin, a substance secreted by the 
small intestine (Ashton 2007). Angiotensin II activates and atrial natriuretic peptide inhibits 
vasopressin secretion (Ashton 2007). 
Paracrine regulation 
The auto-regulation of BP (paracrine regulation) produces immediate responses to local 
changes and alters the perfusion of tissues in the area. Different effector mechanisms operate 
at the different sites of the vascular system (Storkebaum and Carmeliet 2011). The release of 
endothelial NO, a decreased supply of O2, decreased pH, an increased supply of CO2, in-
creased temperature, and histamine release (local inflammation) have local vasodilatory ef-
fects (Storkebaum and Carmeliet 2011). Prostaglandins and ETs released by damaged endo-
thelial cells are local vasoconstrictors (Silldorff et al. 1995). 
1.3.6. The neural regulation of blood pressure 
The neural regulation of BP results in acute adjustments to systemic changes and body-wide 
responses, controlled by the medulla oblongata (Schmidt et al. 2011). Neural regulation of BP 
responds to baroreceptors and chemoreceptors. Baroreceptors are located in the high- and 
low-pressure receptor zones in the left and right carotid sinuses, in the aortic arch, and in ar-
teries (Sears and Casadei 2002). The baroreceptors detect changes in arterial pressure and 
send signals to a region in the medulla part of the brainstem (the rostral ventrolateral medul-
la). The rostral ventrolateral medulla adjusts the arterial pressure by altering heart rate (force 
and speed of contractions) and systemic vascular resistance. Baroreceptors in the low-pressure 
receptor zones are located in pulmonary veins, the venae cavae, the atria, and the kidneys (re-
nal baroreceptors; Ashton 2007). They regulate BP by affecting the secretion of vasopressin, 
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renin and aldosterone, which results in increases in blood volume and cardiac output and, as a 
result, increased BP (Ashton 2007). Chemoreceptors are located in the aorta and carotid arter-
ies (Ashton 2007). They react to changes in the concentrations of O2, CO2, and pH (Ashton 
2007).  
1.3.7. The role of vascular endothelium 
The vascular endothelium plays a major role in maintaining local homeostasis through its sen-
sory and effector capacity (Wilson and Lerman 2001). The vasoregulatory role of the endothe-
lium is achieved through the emission of relaxing or constricting factors. NO, the endotheli-
um-derived relaxing factor, is synthesized by endothelial nitric oxide synthase enzyme 
(eNOS) as a response to shear stress (Sears and Casadei 2002). NO diffuses from the inner 
vascular layer (endothelium) to the medial layer (smooth muscle cells) and triggers vasodila-
tion through a decrease in Ca2+ release and activation of K channels; this process involves the 
enzymes guanylate cyclase and protein kinase G (Ching and Beevers 1991; Sears and Casadei 
2002). NO has a half-life of a few seconds and acts rapidly (Wilson and Lerman 2001). The 
circulating agents, such as bradykinin, adenosine, serotonin, histamine, acetylcholine, may 
also activate NO synthesis (Sears and Casadei 2002; Wilson and Lerman 2001). In addition to 
NO, the vascular endothelium can produce other vasodilatory substances, such as prostacyclin 
(Sears and Casadei 2002). In response to angiotensin, vasopressin, thrombin, and adrenaline, 
endothelial cells can release ET-1, a vasoconstrictor (Ching and Beevers 1991; Sears and 
Casadei 2002).  
Endothelium plays the role of an anti-inflammatory barrier: it prevents infiltration of the cir-
culating inflammatory cells under normal conditions (Wilson and Lerman 2001). Endotheli-
um-derived NO has an additional, ―antiatherogenic‖, function: it interacts with adhesion mol-
ecules, such as vascular cell adhesion molecule-1 (VCAM-1), intercellular cell adhesion mol-
ecule-1 (ICAM-1) and endothelial leukocyte adhesion molecule-1, also known as e-selectin, 
to prevent the endothelial adhesion of leukocytes and their further migration to the arterial 
wall; in addition, NO inhibits platelet aggregation (Wilson and Lerman 2001). The same anti-
atherogenic role was observed for the other endothelium-derived relaxing factor, prostacyclin 
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(Sears and Casadei 2002). Endothelium-derived vasoconstrictor ET-1 is a proatherogenic fac-
tor (Wilson and Lerman 2001). 
The imbalance between NO and endothelin may be associated with CVD (Sears and Casadei 
2002). Endothelial dysfunction is characterized by abnormal endothelium-dependent relaxa-
tion, impaired vasoreactivity, decreased NO bioavailability, and increased expression of adhe-
sion molecules and transendothelial migration of circulating monocytes (Wilson and Lerman 
2001). Endothelial dysfunction is associated with early stages of atherosclerosis and may play 
an important role in atherogenesis (Wilson and Lerman 2001). However, the results of a re-
cent analysis in the Multi-Ethnic Study of Atherosclerosis suggest that impaired endothelial 
function is not an independent predictor of hypertension incidence and may not play a sub-
stantial role in hypertension development (Shimbo et al. 2010). 
There are two other nitric oxide synthase enzymes, which produce NO in mammals: inducible 
(iNOS) and neuronal (nNOS). INOS plays an important role in the immune defense (because 
of the free radical properties of NO). ENOS and nNOS are constitutively expressed calcium-
dependent isoforms (Lee and Yen 2008). INOS is either not expressed or expressed at a min-
imal level under normal, non-pathological conditions (Lee and Yen 2008). INOS expression is 
induced in vascular cells by proinflammatory cytokines (Lee and Yen 2008). NO plays a dual 
role: on the one hand, the constitutive production of NO is a mechanism to protect the cells of 
the vascular endothelium, on the other hand, disproportionate (i.e., too much or too little) NO 
production in pathological conditions can result in cytotoxic effects (Lee and Yen 2008). In 
addition to NO production, iNOS simultaneously catalyzes the production of peroxynitrite, a 
potent oxidant that can trigger oxidative damage of the vascular endothelium and can mediate 
protein nitration, guanidine nitration, and deoxyribonucleic acid (DNA) single-strand break-
age, processes that are toxic and mutagenic (Lee and Yen 2008). It has been suggested that the 
increase of iNOS expression results from vascular injury (Lee and Yen 2008). 
1.3.8. The interplay of CO and NO in BP regulation 
NO and CO are important gas transmitters involved in the compensatory regulation of blood 
pressure during the genesis of hypertension (Lee and Yen 2008). Under pathological stress 
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conditions, NO is produced by iNOS (Lee and Yen 2008). CO is produced by heme oxygen-
ase (HO), an enzyme catalyzing the oxidative degradation of heme to biliverdin, CO and iron 
(Lee and Yen 2008). There are three isoforms of this enzyme: HO-1, HO-2, and HO-3 (Lee 
and Yen 2008). Isoforms 2 and 3 are active constitutively, whereas isoform 1, similar to iNOS, 
is normally not active (Lee and Yen 2008). HO-1 expression is induced by oxidative stress, 
cytokines, NO, and other stimuli (Lee and Yen 2008). HO-1 is expressed in the endothelial 
and foam cells of atherosclerotic lesions (Lee and Yen 2008).  
Though CO was originally considered a toxic metabolic waste product, its cytoprotective 
function was discovered recently (Lee and Yen 2008). CO can act as a vasodilator similarly to 
NO (Lee and Yen 2008). Depending on the experimental conditions, CO can act as a vasocon-
strictor or vasodilator (Lamon et al. 2009). The vasoconstricting function of CO is activated 
by the oxidative stress response (Lamon et al. 2009). Alternatively, it has been suggested that 
CO promotes vasoconstriction by inhibiting the formation of NO, the endothelium-derived 
relaxation factor (Johnson and Johnson 2003). It has been suggested that NO and CO dynami-
cally affect each other and that under certain pathological conditions, such as oxidative stress, 
iNOS and HO-1 cooperate and compensate for each other (Lee and Yen 2008).  
1.3.9. Individual factors affecting BP 
Among the factors influencing the average BP level, are age, sex, race, family history, socio-
economic status, early life experiences, body mass index (BMI), nutrition (in particular, sodi-
um, potassium, calcium and magnesium intake, fish oil intake, licorice, tyramine-containing 
foods, coffee consumption, alcohol intake), physical activity, and environmental factors 
(Chobanian et al. 2003; Drøyvold et al. 2005; Geleijnse et al. 2005; Steffel and Lüscher 2011; 
Whelton 1994).  
BP at birth is measured at approximately 70 mmHg SBP to 50 mmHg DBP (Whelton 1994). 
SBP rises gradually over childhood, adolescence, and adulthood, reaching approximately 140 
mmHg by 70-80 years of age (Whelton 1994). The estimated annual increase of SBP in adults 
is approximately 0.9 mmHg (Wills et al. 2012). DBP also increases over a substantial period 
of life, although the rate of increase is smaller than that for SBP (Whelton 1994). After the age 
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of 50, the average DBP stops increasing or even declines due to the growing rigidness of the 
arteries (Whelton 1994).  
The prescription drugs that affect BP levels include cortisone and other steroids, estrogens, 
non-steroidal anti-inflammatory drugs, phenylpropanolamines, cyclosporine and tacrolimus, 
erythropoietin, sibutramine, antidepressants (especially venlafaxine), clozapine, and others 
(Chobanian et al. 2003). Environmental chemicals, such as lead, mercury, heavy metals, and 
lithium salts, are also associated with arterial hypertension (Chobanian et al. 2003). 
During the measurement, the BP reading may be influenced by many factors. For example, 
using different recording devices in one study produces a systematic difference in measure-
ment. In the analysis comparing a random-zero sphygmomanometer (RZS) with an automated 
oscillometric measurement device (AOD), the differences (AOD-RZS) constituted 3.9 mmHg 
for SBP and 2.6 mmHg for DBP (Stang et al. 2006). The measurement procedure can influ-
ence BP levels, particularly, the resting time before the measurement, the consumption of 
food or beverages before the measurement, rigorous exercise, smoking, the use of medication, 
appropriateness of cuff size for measurement, body position, and the arm with which the 
measurement is performed (Kuulasmaa et al. 1998). Therefore, it is important to use a stand-
ardized measurement procedure. 
1.3.10. Arterial hypertension 
Hypertension can be defined as a condition when the vasodilatory response is inefficient or 
when the arteries are injured in the inflammatory process and are therefore less compliant and 
constricted (Lee and Yen 2008). The clinical definition of hypertension given in the Seventh 
Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment 
of High Blood Pressure (JNC7) is SBP ≥ 140 mmHg or DBP ≥ 90 mmHg, or medication with 
antihypertensive agents (Chobanian et al. 2003). Hypertension can be further divided to stage 
1, characterized with SBP 140–159 mmHg or DBP 90–99 mmHg, and stage 2, with SBP ≥ 
160 mmHg or DBP ≥ 100 mmHg (Chobanian et al. 2003). Normal blood pressure is defined 
as SBP ≤ 120 mmHg and DBP ≤ 80 mmHg. Higher BP values indicating prehypertension are 
defined as SBP 120–139 mmHg or DBP 80–89 mmHg. Prehypertension is independently as-
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sociated with cardiovascular risk (Chobanian et al. 2003; Erbel et al. 2012).  
Essential (primary) hypertension is arterial hypertension without an underlying primary dis-
ease; it constitutes 90–95% of all hypertension cases (Carretero and Oparil 2000; Steffel and 
Lüscher 2011). Secondary hypertension occurs as a symptom of another primary disease, such 
as kidney disease, endocrine disruptions, obstructive sleep disturbance, and others (Steffel and 
Lüscher 2011). 
Three hemodynamic subtypes of essential hypertension are defined: isolated systolic hyper-
tension (DBP is normal), isolated diastolic hypertension (SBP is normal), or combined hyper-
tension (both SBP and DBP are high; Victor and Kaplan 2008). Isolated diastolic hypertension 
is more frequent in men than in women; it is also attributed to middle-age weight gain (Victor 
and Kaplan 2008). If not treated, isolated hypertension can progress to combined hypertension 
(Victor and Kaplan 2008).  
The global burden of hypertension is rather high. In 2002, up to 20% of the population in the 
developed countries had high BP, and it was estimated that at least 500 million people world-
wide had or would eventually have hypertension (Mulvany 2002). Hypertension was deemed 
the major risk factor for global mortality in the Global Burden of Disease Study 2010 (Lim et 
al. 2013). 
1.3.11. Pathogenesis of hypertension 
The pathogenesis of hypertension, despite the large volume of research and attention given to 
this topic, is not yet completely understood (Hayashi 2001; Mulvany 2002). Hypertension is 
associated with endothelial dysfunction, altered vascular contractility, and arterial remodeling 
(Paravicini and Touyz 2006). The underlying pathology of arterial hypertension involves ele-
vated systemic vascular resistance, increased cardiac output, or both (Steffel and Lüscher 
2011). The early stages of hypertension are characterized by increased cardiac output, likely 
due to left ventricular hyperactivity (Ching and Beevers 1991). In advanced hypertension, the 
cardiac output is normal, whereas the systemic vascular resistance is increased (Ching and 
Beevers 1991). In response to increased cardiac output in hypertension, the peripheral arteries 
contract, thereby increasing the systemic vascular resistance and further increasing the BP 
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(Ching and Beevers 1991). The regulation of BP is a complex process, and an increase in the 
BP value arises from an imbalance between the vasoconstrictive (such as angiotensin II, endo-
thelin, thromboxane) and vasodilatory (NO, prostacyclin) substances (Steffel and Lüscher 
2011). At the cellular level, hypertension is associated with changes in vascular muscle cell 
growth, apoptosis, cell migration, inflammation, and fibrosis (Paravicini and Touyz 2006). 
It has been suggested that the kidney plays a role in hypertension development (Hayashi 
2001). For example, sodium retention, a result of inadequate renal sodium excretion, is a well-
known determinant of hypertension (Hayashi 2001). It has been suggested that salt sensitivity 
plays a role in hypertension development (Hayashi 2001). The kidney is also responsible for 
the production of various vasoactive substances, such as the renin-angiotensin system, prosta-
glandins, and NO (Hayashi 2001).  
It has been suggested that the endothelial damage occurring in hypertension increases free 
radical production and thus destroys endothelium-derived NO; this process can be reversed by 
antioxidants such as superoxide dismutase, which scavenges free radicals (Ching and Beevers 
1991). In addition, a damaged endothelium produces lower amounts of endothelium-derived 
NO compared to a healthy endothelium (Ching and Beevers 1991). Tissue damage related to 
reactive oxygen species (ROS) activity potentiates vasoconstriction by destroying endotheli-
um-derived NO (Ching and Beevers 1991).  
1.3.12. Small artery remodeling 
The wall of a small artery consists of three layers: (i) the intima, the inner layer, which con-
sists of longitudinally arranged endothelial cells; (ii) the media, the middle layer, which con-
sists of circumferentially aligned smooth cells; and (iii) the adventitia, the outer layer, which 
consists of connective tissue and sympathetic nerves (Mulvany 2002). In hypertensive indi-
viduals, the structure of a small artery is altered: the lumen is reduced, and the ratio of media 
to lumen is increased (Mulvany 2002). This process is called remodeling. It has been suggest-
ed that the small artery diameter decreases and causes thickening of the arterial wall, ensuring 
that the wall tension remains normal (Mulvany 2002).  
The only parameter that is consistently above normal values in hypertensive individuals is the 
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peripheral vascular resistance; most of the other factors, such as sympathetic activity and 
plasma renin activity, remain within normal range (Mulvany 2002). Increased peripheral vas-
cular resistance results in higher BP, according to formula [10]. It has been suggested that 
vascular remodeling is the largest contributor to the increased peripheral resistance, possibly 
through narrowing of the resistance arterioles (Mulvany 2002). Narrowed arteriole diameter 
was a predictor of hypertension development in a rat model (Mulvany 2002). 
The following factors could initiate remodeling: the activation of alpha receptors of the ANS 
by adrenaline; triggering noradrenaline release, which causes vasoconstriction; and circulating 
vasoconstriction hormones, such as angiotensin, vasopressin, prostaglandins, and serotonin 
(Ching and Beevers 1991). The cellular mechanisms of vascular remodeling are not yet com-
pletely understood. It has been shown that the phosphorylation of extracellular signal-
regulated kinases 1 and 2, the expression of the proto-oncogenes c-fos and c-myc, and the 
activities of the platelet-derived growth factor beta receptor and matrix metalloproteinases 2 
and 9 are involved in remodeling (Mulvany 2002). BPLM intake can somewhat reverse vas-
cular remodeling by increasing the lumen diameter, but this process is impaired and does not 
suffice to fully normalize the small artery structure (Heagerty et al. 2010). 
1.3.13. Medication against high blood pressure 
The control of BP, especially of SBP, achieved either with lifestyle modification or medica-
tion, reduces total mortality, cardiovascular mortality, stroke and heart failure (Chobanian et 
al. 2003). The first step in BP control is lifestyle modification. If the aimed BP value is not 
achieved, then medication is prescribed (Chobanian et al. 2003). According to the Anatomical 
Therapeutic Chemical Classification System of the WHO Collaborating Centre for Drug Sta-
tistics Methodology, BPLM includes the following classes of drugs or any combination of 
them: diuretics, β-blockers, ACE inhibitors, angiotensin-receptor antagonists, calcium-
channel blockers, α-blockers, centrally active antihypertensive drugs, and hydralazine. In the 
initial treatment phase, thiazide-type diuretics are used, sometimes in combination with other 
classes of drugs (e.g., an angiotensin converting enzyme inhibitor). A drug from another class 
can be chosen if the initial drug is tolerated. Most often, hypertension is treated with two or 
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more drugs, especially if the initial BP values are very high (Chobanian et al. 2003). 
BP values can diminish substantially after effective therapy with BPLM. Clinical trials have 
reported reductions in SBP of approximately 5.4–8.4 mmHg and in DBP of 2.3–4.2 mmHg in 
response to medication (Turnbull 2003). In diabetic patients, antihypertensive treatment with 
nebivolol yielded an approximately 20 mmHg decrease in SBP (Schmidt et al. 2007). Similar 
results were reported for combination therapy in other studies (Everett et al. 2008; Mourad et 
al. 2007). 
1.4. Association of air pollution with CVD 
1.4.1. Air pollution and cardiovascular mortality and events 
Positive associations of short-term elevations in PM10, PM2.5, UFP, elemental and organic 
carbon with cardiovascular mortality were identified in several studies, as reviewed by 
Rückerl et al. (2011). As estimated in a few time-series U.S. studies, an increase in the 24-
hour mean PM2.5 by 10 µg/m³ is associated with an increase in the relative risk for daily car-
diovascular mortality by 0.4–1.0% (Brook et al. 2010). Brook et al. (2010) also noted that the 
risk is not equally distributed in the population: the susceptible groups, such as the elderly and 
subjects with coronary artery or structural heart disease, may be at higher risk of cardiovascu-
lar mortality due to PM. In Europe, the analysis of two large population-based studies showed 
a positive association with cardiovascular mortality: assuming the association was linear, a 10 
µg/m³ increase in PM10 was associated with a 0.7% increase in cardiovascular mortality (Sa-
moli et al. 2004). In a later re-analysis with North American and European studies together, 
Samoli et al. (2008) found that results for short-term mortality were quite similar. 
Similar to acute effects, the long-term exposure to PM was also associated with cardiovascu-
lar deaths (Brook et al. 2010; Brunekreef et al. 2009; Miller and Siscovick 2007; Pope et al. 
2004). For example, in the study with approximately 500,000 adults from the USA, a 10 
µg/m³ increase in PM10 was associated with a 6% elevation in cardiopulmonary mortality risk 
(Brook et al. 2010). Additionally, reduced exposures to air pollution are associated with lower 
mortality (Laden et al. 2006). In a Dutch cohort, an increase in the yearly mean PM2.5 by 10 
µg/m³ was related to a 4% higher risk or cardiovascular mortality (Brunekreef et al. 2009). In 
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a recent meta-analysis of studies from the USA, Canada, China, Japan, Germany, the Nether-
lands, Switzerland, Italy, and New Zealand, an increase in the long-term PM2.5 by 10 µg/m³ 
was associated with an increase in cardiovascular mortality by 11% (Hoek et al. 2013).  
Short-term elevations in PM concentrations have shown associations with CVD events, such 
as the triggering of an acute myocardial infarction, heart failure and ischemic stroke hospitali-
zation, and discharge of implanted automatic cardioverter defibrillators (Araujo and Nel 
2009). Short- and long-term exposure to PM is associated with hospital admissions for is-
chemic heart disease, heart failure, cerebrovascular disease, cardiac arrhythmias and arrest 
(Brook et al. 2010; Domínguez-Rodríguez et al. 2011) In a meta-analysis of 35 studies on air 
pollution and heart failure, daily increases in CO, SO2, NO2, PM2.5, PM10 were positively as-
sociated with heart failure hospitalization or death (Shah et al. 2013). In a recent meta-
analysis of 11 European cohorts, long-term exposure to traffic-related air pollution was asso-
ciated with an elevated risk of new coronary events, even at air pollution levels below the 
current European limits (Cesaroni et al. 2014). 
1.4.2. Air pollution and atherosclerosis 
The association of different air pollutants with cardiovascular events may share a common 
underlying pathology – atherosclerosis. This disorder is characterized by atherogenesis (the 
development of atheromatous plaques) and, in more advanced stages, smooth muscle cell pro-
liferation, fibrous cap formation, necrotic cores, calcification, rupture, hemorrhage and 
thrombosis (Araujo and Nel 2009). Atherogenesis is a lifelong process (Künzli et al. 2011). 
The early central features of the artery wall pathology are oxidative stress, followed by sys-
temic and vascular inflammation, endothelial dysfunction, and lipid deposition in the arterial 
wall (Künzli et al. 2011). These pathologic changes result in reduced vascular reactivity, arte-
rial stiffening, thickening of the arterial wall, arterial stenosis, and plaque formation (Künzli 
et al. 2011). The atheromatic plaque formation (lipid deposition and oxidation in the artery 
wall) is regarded as an intermediate between risk factor exposure and clinical events (Erbel et 
al. 2010). Coronary plaque rupture leads to acute coronary manifestations, such as myocardial 
infarction; carotid plaque rupture causes cerebral stroke and vascular dementia (Künzli et al. 
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2011).  
According to a lifetime model of atherosclerosis development, progression of atherosclerosis 
can be divided into 3 phases: normal, preclinical and clinical disease manifestation (Künzli et 
al. 2011). Acute clinical events may manifest at approximately 40 years of age or later, de-
pending on the degree of individual risk (Künzli et al. 2011). The degree of atherosclerosis at 
any age reflects a combination of genetic predisposition and cumulative exposure to internal 
and external factors that have either protective or deteriorating effects on vascular health 
(Künzli et al. 2011).  
An external factor possibly affecting vascular health is outdoor air pollution. It has been sug-
gested that air pollution plays roles in pulmonary and systemic inflammation, cardiac auto-
nomic function impairment, and accelerated atherosclerosis (Mills et al. 2009; Pope et al. 
2004). Some studies indicated associations between air pollution and systemic inflammation 
and endothelial dysfunction (Brook et al. 2010; Hertel et al. 2010; Hoffmann et al. 2009; 
Krishnan et al. 2012). Exposure to air pollution induced vascular inflammation and oxidative 
stress and promoted atherosclerotic plaque expansion or rupture (Brook et al. 2010; Mills et 
al. 2009). Künzli et al. (2004, 2010) have identified a cross-sectional and a prospective asso-
ciation of air pollution with subclinical atherosclerosis, measured as carotid intima-media 
thickness. The studies with a population-based German cohort showed that living close to a 
major road and being exposed to elevated concentrations of PM2.5 were positively associated 
with the markers of subclinical atherosclerosis (Bauer et al. 2010; Hoffmann et al. 2007). A 
positive, though much weaker, association of long-term PM with intima-media thickness was 
also identified in an American population-based cohort (Diez Roux et al. 2008). Two hypothe-
ses of the association of air pollution with atherosclerosis have been suggested by Künzli et 
al. (2011): (i) long-term exposure to outdoor air pollution causes atherogenesis, therefore, 
exposed individuals would have a faster progression of vascular pathologies and would reach 
the clinical manifestations of atherosclerosis at earlier ages than non-exposed individuals; and 
(ii) short-term exposure to air pollution can trigger cardiovascular events in susceptible indi-
viduals (i.e., those with pre-existing subclinical atherosclerosis). Considering the longitudinal 
nature of atherogenesis, the chronic effect of air pollution on atherosclerosis, described by 
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hypothesis (i), is relevant at any age. The acute effect on cardiovascular events, described by 
hypothesis (ii), is more relevant at an older age, when atherogenesis reaches the pre-clinical 
stage. 
1.4.3. Association of air pollution with BP and hypertension 
The causal association between air pollution and atherosclerosis and cardiovascular events 
may involve elevated BP and hypertension (Brook et al. 2009). In a few recent studies, a posi-
tive association between short-term increases in PM air pollution and acute elevations in arte-
rial BP has been reported (Brook et al. 2010, 2011; Chuang et al. 2010; Delfino et al. 2010; 
Dvonch et al. 2009; Hoffmann et al. 2012; Mordukhovich et al. 2009; Zanobetti et al. 2004). 
The association was reported in both the general population (Auchincloss et al. 2008; Brook 
et al. 2011) and among more susceptible individuals, such as diabetics (Hoffmann et al. 2012), 
the elderly (Mordukhovich et al. 2009; Wilker et al. 2010), and subjects with chronic obstruc-
tive pulmonary disease (Linn et al. 1999). In a Dutch cohort of pregnant women, the residen-
tial outdoor PM10 concentration was associated with increases in BP in the second and third 
trimesters (van den Hooven et al. 2011). Some studies report inverse associations of short-
term air pollution exposure with BP. For example, ambient PM10 concentration was associated 
with higher BP in the first trimester of pregnancy and lower BP in the later trimesters in a 
French cohort; higher NO2 concentrations were associated with decreased BP throughout the 
entire pregnancy period (Hampel et al. 2011). In a Taiwanese cohort, short-term exposure to 
various air pollutants was negatively associated with SBP and positively associated with DBP 
(Chen et al. 2012). 
Based on the evidence from short-term studies with air pollution and BP, a positive associa-
tion between long-term exposure to air pollution and elevated BP, independent from and pos-
sibly also stronger than short-term fluctuations, has been proposed (Rückerl et al. 2011). 
Stronger associations with long-term than with short-term exposure levels have already been 
shown for other health outcomes (Brook et al. 2010; Diez Roux et al. 2006). There is also 
some supporting evidence for a long-term association with BP. For example, Auchincloss et 
al. (2008) reported that the association of longer-term averages (30- or 60-day means) of 
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PM2.5 with BP was stronger than the results observed for daily or weekly averages.  
Thus far, the evidence for long-term effects is rather scarce. In two American studies with 
selected populations (elderly men and black women, respectively), traffic-related air pollution 
was linked to higher BP or hypertension (Coogan et al. 2012; Schwartz et al. 2012). Long-
term exposures to PM and gaseous air pollutants were associated with high BP and hyperten-
sion in two large Asian cohorts (Chuang et al. 2011; Dong et al. 2013). Long-term PM con-
centrations were positively related to self-reported hypertension among white American adults 
(Johnson and Parker 2009). In a large cohort of non-hypertensive adults from Canada, long-
term exposure to PM2.5 was positively associated with incident physician-diagnosed hyperten-
sion (Chen et al. 2013). One study reported a negative long-term association of air pollution 
with BP: in a large population-based Danish cohort of older adults, long-term exposure to 
nitrogen oxides, indicators of traffic-related air pollution, was associated with decreased BP 
and a lower prevalence of self-reported hypertension (Sørensen et al. 2012). 
1.5. Pathophysiology of the adverse cardiovascular effects of air pollution 
Oxidative stress, a condition involving chronically elevated levels of ROS, plays a central role 
in the development of adverse effects of air pollution on the cardiovascular system (Brook et 
al. 2010; Paravicini and Touyz 2006). Three general pathways have been suggested based on 
the current evidence: (i) pulmonary inflammation and oxidative stress, (ii) ANS imbalance 
and (iii) direct translocation of PM constituents to the systemic blood flow (Brook et al. 
2010).  
1.5.1. Initiation of pulmonary inflammation and oxidative stress 
Inhalation of particles into the lung can trigger a localized inflammatory response in the lung 
(Mills et al. 2009). Exposure to PM has been correlated with the concentrations of redox-
active compounds and macrophage damage in bronchial epithelium (Lodovici and Bigagli 
2011). Transition metals, such as Fe, Pb, Ni, V, Cr, Mn, Cu, can be adsorbed on the surfaces 
of fine and ultrafine particles and can generate ROS (e.g., as hydroxyl radical) with Fenton’s 
reaction (Lodovici and Bigagli 2011): 
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Fe2+ + H2O2 + H
+ → Fe3+ + 𝐻𝑂∗+H2O      [11] 
For example, when polycyclic aromatic hydrocarbons (PAH) are metabolized with cyto-
chrome P450, redox-active quinones are formed, which can trigger ROS production (Lodovici 
and Bigagli 2011). PM can inhibit the oxidative stress responses; activate the proinflammato-
ry genes, such as tumor necrosis factor alpha (TNFα); and stimulate the production of proin-
flammatory cytokines and chemokines (Lodovici and Bigagli 2011). Diesel exhaust particles 
can cause lipid peroxidation and ROS production (Lodovici and Bigagli 2011). Gaseous pol-
lutants, such as ozone and nitrogen oxides, can induce oxidative stress and inflammation. For 
example, O3 induces oxidative stress through the formation of ozonide O3
– and hydrogen per-
oxide (Lodovici and Bigagli 2011).  
1.5.2. Transformation from local to systemic inflammation and oxidative stress 
The cytokines, activated immune cells, and platelets, which are synthesized or released due to 
pulmonary inflammation and oxidative stress, can reach the systemic circulation. The plasma 
levels of cytokines, such as interleukin (IL) 1β, IL-6, and granulocyte-macrophage colony-
stimulating factor, are elevated after exposure to PM (Mills et al. 2009). PM is associated with 
the increased release of neutrophils and monocytes into the systemic circulation (Mills et al. 
2009). Finally, the acute-phase proteins and coagulation markers, such as C-reactive protein 
(CRP), ICAM-1, VCAM-1, fibrinogen, and platelets are associated with short- and long-term 
exposure to PM and gaseous pollutants, such as NO2 and CO, in the general population (Bind 
et al. 2012; Delfino et al. 2008; Hennig 2014; Hertel et al. 2010; Lucking et al. 2008; Pek-
kanen et al. 2000).  
1.5.3. Inflammation, oxidative stress and arterial BP  
There are many links from the immune system and inflammatory processes CVD, and to hy-
pertension in particular. For example, the Toll-like receptors, which are part of the innate im-
mune system and can ―sense‖ pathogens, toxins and other substances, play a role in CVD. 
These receptors can be activated by oxidized lipoproteins, are involved in atherosclerosis de-
velopment, and can send inflammatory response signals that can affect the cardiovascular 
system (e.g., ROS, reactive nitrogen species [RNS], etc.; Harrison et al. 2011).  
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Oxidative stress is an imbalance between ROS formation and antioxidant defense mecha-
nisms (Touyz and Schiffrin). If ROS production in the cell predominates the antioxidant de-
fense reactions, cellular oxidative stress may develop, triggering signaling pathways as a re-
sult of redox disequilibrium that result in the activation of cytokine and adhesion molecule 
expression (Araujo and Nel 2009). It has been suggested that oxidative stress mediates the 
adverse cardiovascular effects of air pollution with PM (Araujo and Nel 2009).  
The vasculature is a rich source of ROS and RNS. Under normal conditions, these molecules 
function to maintain vascular integrity, which is achieved through the regulation of smooth 
cell contraction, relaxation, and growth (Touyz and Schiffrin). Common endogenous ROS 
include superoxide anion *O2
–, hydrogen peroxide H2O2, hydroxyl radical HO
*, and hypo-
chlorous acid HOCl; common RNS include NO and peroxynitrite (ONOO–; Touyz and 
Schiffrin). Under pathological conditions, the same compounds act detrimentally: they may 
trigger endothelial dysfunction, smooth muscle cell apoptosis, inflammation, and other vascu-
lar damage (Touyz and Schiffrin).  
Though the clear cause-and-effect relationships are not yet completely understood, it is known 
that oxidative stress occurs in hypertension (Khullar et al. 2003). Patients with hypertension 
have elevated concentrations of oxidative stress byproducts and demonstrate decreased activi-
ty levels of endogenous antioxidant enzymes in whole blood and mononuclear cells compared 
to healthy individuals (Redón et al. 2003). Oxidative stress in hypertension can promote vas-
cular smooth muscle cell proliferation and hypertrophy and collagen deposition; can stimulate 
the expression of proinflammatory molecules, such as adhesion molecules and chemotactic 
proteins; and can mediate the oxidation of lipids and cell migration(Touyz and Schiffrin). All 
of these processes contribute to arterial remodeling and hypertension development (Touyz and 
Schiffrin). 
Oxidative stress and hypertension are closely related. On the one hand, the production of ROS 
and other markers of oxidative stress is increased during hypertension; on the other hand, the 
deactivation of free radicals with antioxidants improves vascular function and leads to re-
duced BP (Touyz and Schiffrin). Furthermore, animal models that are unable to produce ROS 
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tend to have lower BPs compared to controls (Touyz and Schiffrin). ROS have multiple ef-
fects on the organism that are relevant to hypertension; they promote sympathetic outflow in 
the central nervous system, and they trigger blood vessel constriction and sodium and volume 
retention in the kidneys (Harrison et al. 2011). In addition to this prohypertensive action, ROS 
activate the inflammatory response, which might also be relevant for hypertension. Harrison 
et al. (2011), analyzing the findings of their and other researchers’ studies, hypothesize that 
hypertensive stimuli, such as angiotensin II, may activate T-cells and, in turn, the entry of 
other inflammatory cells into the vasculature; these events lead to the release of cytokines 
causing vasoconstriction, sodium retention, and other effects that further increase BP and lead 
to more severe hypertension. 
Paravicini and Touyz (2006) delineate the three most relevant sources of ROS in vascular pa-
thology: xanthine oxidase, eNOS and nicotinamide adenine dinucleotide phosphate 
(NAD(P)H) oxidase. Of them, NAD(P)H oxidase is the main ROS source (Paravicini and 
Touyz 2006). The NAD(P)H oxidase enzyme is a multi-component, NADPH-dependent en-
zyme that has been characterized in three types of vascular wall cells. The enzyme generates 
superoxide anion in the presence of molecular oxygen (Yu et al. 2008). NAD(P)H oxidase 
plays a significant role in atherosclerosis progression, and its inhibition can slow down ad-
verse cardiovascular processes (Yu et al. 2008). The increased activity of vascular NAD(P)H 
oxidase is associated with hypertension pathology (Touyz and Schiffrin). NAD(P)H oxidase is 
activated by vasoactive hormones (such as angiotensin II), growth factors and mechanical 
stimuli (Paravicini and Touyz 2006). Therefore, angiotensin II may be one of the factors link-
ing hypertension with oxidative stress (Khullar et al. 2003). Its effects are mediated by ROS, 
which are produced with the help of NAD(P)H oxidase (Paravicini and Touyz 2006). The 
antioxidant defense enzymes, such as superoxide dismutase, play an important role in in-
flammation-mediated BP regulation (Gongora et al. 2006; Lob et al. 2010). 
1.5.4. The role of endothelial dysfunction 
An important function of the endothelium is to maintain vascular homeostasis (Widlansky et 
al. 2003). This function is achieved via the interactions of the endothelium with the cells in 
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the vessel wall and lumen (Widlansky et al. 2003). Endothelial dysfunction is characterized 
by the impaired vasomotion and vascular tone, the pro-thrombotic and pro-inflammatory 
state, and proliferation in the arterial wall (Widlansky et al. 2003). Vascular oxidative stress 
decreases the bioavailability of NO, a potent vasodilator; together with an inflammatory re-
sponse, this effect may promote endothelial dysfunction (Touyz and Schiffrin). Inflammation 
mediates oxidative stress in CVD and leads to vascular injury and endothelial dysfunction 
(Lin et al. 2013). Oxidative stress and endothelial dysfunction are often observed in hyperten-
sive subjects, and these conditions have been suggested to play causal roles in hypertension 
development (Lin et al. 2013). Endothelial dysfunction is also considered an early step in ath-
erosclerosis development (Sitia et al. 2010). It has been hypothesized that vascular damage 
due to oxidative stress is a link from hypertension to atherosclerosis (Alexander 1995).  
The inflammatory response induced by air pollution exposure can impair the function of the 
vascular endothelium. For example, in a cohort study with 704 elderly American men, short-
term exposure to traffic-related pollutants (PM2.5, NO2, CO) was associated with vascular cell 
adhesion molecules related to both inflammation and vascular function (Bind et al. 2012). 
Vascular tone regulation was affected by short-term exposure to diesel exhaust in a panel 
study with healthy volunteers (Mills et al. 2005). In an animal model of PM10 exposure, anti-
inflammatory drugs reduced atherosclerosis and improved endothelial function, protecting 
against the adverse effects of PM10 (Miyata et al. 2013). Anti-inflammatory and antioxidant 
medications (such as statins) have beneficial effects on endothelial progenitor cells and there-
fore protect against endothelial injury and aging (Tousoulis et al. 2008).  
1.5.5. Air pollution, ANS imbalance and hypertension 
Short-term exposure to PM can affect the autonomic control of the heart rate, resulting mostly 
in decreased heart rate variability (Brook et al. 2009, 2010; Chuang et al. 2007; Elder et al. 
2007). Air pollution can activate the sympathetic nervous system and trigger parasympathetic 
withdrawal, resulting in an acute increase in BP (Brook et al. 2010; Miller et al. 2012). It is 
hypothesized that deposited particles could alter central nervous system activity either directly 
or by interacting with lung receptors and by altering ANS reflex arcs (Brook et al. 2004). 
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Sympathetic nervous system activation is the most probable mechanism of BP elevation short-
ly after exposure; it has been suggested that decreased heart rate variability leads to elevated 
DBP (Brook et al. 2009). PM inhalation increases baroreceptor reflex sensitivity, which corre-
sponds to the upregulation of vagal reflexes (Shannahan et al. 2012). Additionally, it was sug-
gested that the contradictory results of animal experimental studies, where PM increased BP 
in some studies and decreased in others, were due to the stimulation of either the sympathetic 
or the parasympathetic nervous system (Shannahan et al. 2012).  
Typically, in the state of ANS imbalance, the sympathetic nervous system is hyperactivated 
whereas the parasympathetic nervous system is hypoactive (Thayer et al. 2010). This auto-
nomic imbalance is related to a number of pathologic cardiovascular conditions (Thayer et al. 
2010). In particular, vagal tone is lower in persons with hypertension, and it has been suggest-
ed that decreased heart rate variability may precede hypertension (Thayer et al. 2010). In a 
recent case-control study, the ANS imbalance contributed to prehypertension status and cardi-
ovascular risks caused by insulin resistance, dyslipidemia, inflammation, and oxidative stress 
in diabetic subjects (Pal et al. 2013). 
1.5.6. Translocation of particles into the circulation 
It has been suggested that ultrafine and nanoparticles could rapidly translocate to the circula-
tion (Mills et al. 2009). This translocation has been demonstrated in some recent animal stud-
ies (Mills et al. 2009; Shannahan et al. 2012). Moreover, the capacity of UFPs to translocate 
to secondary organs, such as the liver, the kidney, and the heart, was demonstrated (Shan-
nahan et al. 2012). Both particle size and charge play roles in the translocation (Shannahan et 
al. 2012). It is also possible that particles do not cross the lung-blood barrier directly, but are 
ingested and transported by alveolar macrophages (Mills et al. 2009).  
Translocated UFPs or soluble compounds can induce arrhythmias, reduce myocyte contractili-
ty, and reduce the coronary blood flow (Lodovici and Bigagli 2011). UFP exposure stimulates 
the expression of genes related to inflammation and coagulation, and diesel exhaust may trig-
ger inflammation and oxidative stress (Mills et al. 2009; Shannahan et al. 2012). Translocated 
particles affect vascular reactivity, inhibiting vascular NO production and stimulating vaso-
Theoretical Background 
45 
constriction through oxidative stress (Shannahan et al. 2012). Apart from the particles’ effects, 
additional toxicity was attributed to transition metals and organic components from UFPs, 
which could also translocate through the lung-blood barrier and had cardiotoxic effects 
(Shannahan et al. 2012). The process of translocation can be compared to the accumulation of 
LDL particles (which are approximately the size of a nanoparticle) in the arterial wall, which 
constitutes the pathophysiology of atherosclerosis (Mills et al. 2009).  
1.6. Methodological challenges in the investigation of air pollution associations with BP 
and hypertension 
1.6.1. The responsible components 
Many constituents of air pollution are correlated. Therefore, the adverse health effects, ob-
served with specific components of the mixture, may actually reflect the toxicity of other 
components correlated with them. For example, NO2 is an indicator of traffic-related air pol-
lution but also contributes to the generation of O3 and oxidant pollutants and is a precursor of 
nitrates in PM (WHO 2003). It is necessary to disentangle the effects of individual com-
pounds, which can be achieved with multipollutant models, such as models including both 
particulate and gaseous components. The results with multipollutant models may differ sub-
stantially from single-pollutant models. For example, though it is generally considered that 
the PM component of air pollution contributes to elevated BP, Coogan et al. found that NOx 
but not PM2.5 was associated with the incidence of hypertension and diabetes mellitus in a 
two-pollutant model to which both these exposures were included (Coogan et al. 2012). 
1.6.2. Related exposures at the residence 
In studies of air pollution effects, it is important to take into account other residential expo-
sures that may confound the results. One of such exposures is road traffic noise. Daytime 
noise at a level of 65 dB is harmful for health (Babisch 2008). It is assumed that the adverse 
effects of noise occur through the stress response system (Babisch 2008). Road traffic noise 
was associated with the risk of myocardial infarction in a dose-response manner (Babisch 
2008). The association of road traffic noise with BP and hypertension has been extensively 
studied. Laboratory studies demonstrated that acute noise exposure affects the sympathetic 
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ANS and endocrine system, triggering a number of nonspecific physiological responses, in-
cluding altered heart rate variability, vasoconstriction and elevated BP, stress hormones, and 
others. (Babisch and Kamp 2009). Although it is likely that road traffic noise does not con-
found the results with air pollution and cardiovascular outcomes, as shown in recent studies 
(Beelen et al. 2009; Viehmann et al. 2010), it is important to investigate the role of road traffic 
noise in the effects observed with air pollutants.  
Residential characteristics, such as neighborhood-level income, population density, and other 
socio-economic factors, are associated with CVD (Diez Roux 2003; Dragano et al. 2009b; 
Gerber et al. 2011). Similarly to road traffic noise, residential deprivation may confound the 
association with air pollution and needs to be taken into account. 
1.6.3. Correction for BPLM intake in BP analysis 
The lifetime risk of developing hypertension for normotensive individuals aged 55–65 is more 
than 90% (Chobanian et al. 2003). Therefore, a substantial proportion of the general popula-
tion is on BPLM. In medicated subjects, the measured value will be greatly influenced by 
medication and will not reflect the actual (―underlying‖) value. This disparity could lead to 
bias in an analysis with BP as the outcome (Tobin et al. 2005). 
Thus far, there is no universally used strategy to correct for BPLM intake in the analyses with 
BP. Many researchers still use the ―naïve‖ methods of adjustment, which are not recommend-
ed because they can yield biased results (McClelland et al. 2008; Tobin et al. 2005). ―Naïve‖ 
adjustment strategies include (i) ignoring the problem, (ii) adjusting for BPLM intake with an 
indicator variable, (iii) excluding medicated participants from the analysis (McClelland et al. 
2008), or (iv) adjusting for baseline BP, which all lead to biased results in genetic association 
studies (McArdle and Whitcomb 2009). The only conditions under which the model ignoring 
treatment will provide an unbiased estimate of the actual effect are if (i) no participants are 
taking any medications and if (ii) the medication has no effect (McClelland et al. 2008). These 
adjustments can barely be fulfilled in a real-life cohort, which is why it is very important to 
use more sophisticated techniques to correct for medication intake. 
In a study by Tobin et al. (2005), various techniques to correct for BPLM were estimated us-
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ing simulated and real data. Among the recommended methods that had already been used in 
a few other studies were fixed addition (adding a fixed increment to measured BP values in 
medicated individuals; Newton-Cheh et al. 2009; Timpson et al. 2009); censored normal re-
gression (censoring BP values in medicated individuals with the assumption that the distribu-
tion of BP in medicated and non-medicated subpopulations does not differ); and a semi-
parametric method to substitute BP values in medicated individuals, based on averaging the 
ordered residuals (Tobin et al. 2008). These and other methods of correction for BPLM imply 
some assumptions for the dataset and should be carefully considered before the analysis strat-
egy is chosen. 
1.7. Summary: rationale for this project 
The long-term effects of air pollution on BP are not completely understood. In 2010, high BP 
was deemed one of three major risk factors for mortality worldwide (Lim et al. 2013). It is 
hypothesized that long-term exposure to air pollution could raise BP chronically and lead to 
hypertension (Brook 2007), but the evidence is scarce and not conclusive.  
The components of the air pollution mixture that are responsible for the positive association 
with BP should be identified. Thus far, the most consistent association with CVD has been 
reported for PM2.5. However, it is possible that other components, such as nitrogen oxides or 
carbon monoxide, can affect cardiovascular health. Due to the correlations of individual mix-
ture components, the results with one exposure may actually reflect the toxic effects of the 
other component. It is also possible that PM interacts with gaseous pollutants, which may 
alter the composition and toxicity of the mixture (WHO 2003). 
Detailed information is needed regarding the exact mechanistic pathways through which air 
pollution can lead to hypertension. It is hypothesized that air pollution could elevate BP 
through oxidative stress and inflammation, ANS imbalance, and vascular dysfunction (Brook 
et al. 2010). Experimental animal studies or controlled-exposure human studies are scarce and 
do not provide conclusive information.  
It is important to disentangle air pollution effects from other related exposures. Exposure to 
traffic particles co-occurs with exposure to road traffic noise. Traffic noise acts through stress-
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response mechanisms, which may overlap with those involved in particle effects or may inter-
act with them (Babisch 2008). Additionally, air pollution may correlate with the neighbor-
hood-level deprivation. The effects of air pollution may thus reflect the differences in health 
caused by numerous factors related to socio-economic status.  
The choice of an appropriate strategy to correct for the effect of BPLM is important. Out-
come-affecting medication is an acknowledged constraint in analyses (Tobin et al. 2005). The 
literature offers recommendations regarding methods to correct for this effect.  
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2. STUDY AIMS AND HYPOTHESES 
Aim of the study 
The aim of this study is to investigate the effect of long-term air pollution and its specific 
components on BP and hypertension in humans and to investigate possible pathophysiologic 
mechanisms in an animal model. PM2.5 is the primary exposure of interest in this study. In 
addition, coarse (PMcoarse, PM10) and ultrafine (PM1, particle number (PN)) particles will be 
analyzed as exposures. Common gases of the air pollution mixture will be investigated as co-
exposures.  
Specific objectives 
1. Study the long-term association of PM2.5, PM10, PN, PM1, nitrogen oxides (NO2, NO), 
SO2, CO, NH3, and O3 with arterial BP and hypertension in a population-based cohort.  
a. Perform cross-sectional and longitudinal analysis, controlling for the relevant con-
founders. 
b. Study the robustness of the results using different covariate specifications. 
c. Test the independence of results with PM from co-exposure to the gasous com-
pounds, using multipollutant models and other methods. 
d. Test the independence of results for PM from other residential exposures: i.e., road 
traffic noise and neighborhood characteristics.  
e.  Identify the susceptible population groups using effect modification analysis. 
f. Select and apply different strategies to correct for BPLM intake in the analysis of 
the effect of air pollution on BP.  
2. Investigate the expression profiles of genes related to air pollution and hypertension in 
murine lung tissue after experimental exposure to diesel exhaust. 
a. Prepare the biologic materials. 
b. Measure the expression levels of selected genes involved in inflammation, oxida-
tive stress, and vascular response and compare them to housekeeping genes. 
c. Investigate quantitative data on gene expression in exposed animals compared to 
non-exposed controls. 
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3. Integrate the results, discuss them and make conclusions.  
Hypotheses 
1. Long-term residential exposure to fine PM is linearly associated with an increase in arteri-
al BP and risk of hypertension in the general population. This association is independent 
from the following factors: short-term air pollution fluctuations, co-exposure to common 
gases in the air pollution mixture, road traffic noise, neighborhood social factors, and per-
sonal risk factors. 
2. Traffic-related air pollution can affect the expression of genes related to elevated BP and 
hypertension in an animal model setting.
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3. MATERIALS AND METHODS 
3.1.  Observational part 
3.1.1. Study population 
I used data from the prospective ongoing Heinz Nixdorf Recall (Risk Factors, Evaluation of 
Coronary Calcium and Lifestyle; HNR) study. The HNR study aims to evaluate the prognostic 
value of noninvasive visualization and quantification of atherosclerosis (e.g., electron-beam 
computed tomography for the prediction of cardiac events), in a population-based cohort, and 
investigate whether electron-beam computed tomography, as a novel method of risk assess-
ment, provides independent information in addition to the traditional analysis of risk factors 
(Erbel et al. 2012; Schmermund et al. 2002). Parallel to the main aim of the study, a large 
amount of individual data, such as health characteristics, biomarkers, socio-economic indica-
tors, genetic polymorphisms, environmental exposures, residential context factors, etc., is 
being collected and used in various investigations. The study population was randomly select-
ed from the mandatory registries of three adjacent cities: Bochum, Essen, and Mülheim an der 
Ruhr. These three cities are located in the densely populated Ruhr area, with a tight traffic and 
industrial network. Study participants were aged 45 to 75 years at baseline. If a participant 
had overt CHD, defined as diagnosed myocardial infarction or revascularization of coronary 
arteries, including balloon dilatation and coronary bypass surgery, he (or she) was excluded 
from the primary HNR analysis as a prevalent case, but not from the HNR cohort or the anal-
ysis cohort, included in the current study. 
Baseline examination 
In total, 4,814 participants were invited to the university hospital of Essen to undergo the first 
(baseline) physical examination and medical history assessment. The first baseline examina-
tion of a participant was performed on December 11, 2000 and the last on August 13, 2003. 
All participants signed informed consent forms. Examinations in the cohort were conducted in 
accordance to the recommendations for research on human subjects, adopted by the 18th 
World Medical Assembly, Declaration of Helsinki (World Medical Association 1964) and 
later revisions, and were approved by the ethics committee at the University of Essen, Ger-
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many (Schmermund et al. 2002). An external review board evaluated the study. Study person-
nel underwent certification (the German Institute for Standardization, Euronorm ISO 
9001:2000), and regular quality checks.  
During the baseline visit, the following measurements were performed: anthropometric meas-
urements, laboratory blood tests (blood sugar, lipids, inflammatory factors and others), BP 
measurement, resting and exercise electrocardiograms, ankle-brachial index measurement, 
coronary calcification assessment with non-contrast-enhanced electron-beam computed to-
mography, and carotid artery intima-media thickness measurement with B-mode sonography 
(Bauer et al. 2010; Schmermund et al. 2002). Information on current medication, lifestyle 
(diet, physical activity, smoking, and alcohol consumption), and individual socio-economic 
status (SES, defined as education, economic activity, household income) was collected in a 
computer-assisted personal interview. Except for electron-beam computed tomography results 
and experimental findings (novel risk factors, genetic polymorphisms), the results were re-
ported to a participant and, upon each participant’s agreement, to his primary physician 
(Schmermund et al. 2002). 
Follow-up period and second examination 
During the follow-up period, self-report questionnaires were sent to participants annually by 
post. In these questionnaires, the study end points were assessed. The primary endpoints in-
cluded nonfatal myocardial infarction and cardiac death. The secondary endpoints included 
all-cause mortality, cerebrovascular events, coronary revascularization, angiographically de-
fined incident peripheral vascular disease, hospitalization for cardiac disease, and initiation of 
medical therapy for cardiac disease (Schmermund et al. 2002). Endpoints were affirmed by 
the endpoint committee, including cardiologists and at least one epidemiologist. Some addi-
tional information, e.g., lifestyle, nutrition, traffic noise annoyance, etc., was also gathered in 
annual questionnaires. Five years after the baseline interview, the participants were re-invited 
to a follow-up assessment of their medical history, physical and health risk factor status, blood 
tests, blood pressure measurement, non-contrast electron-beam computed tomography imag-
ing, and electrocardiograms (Lehmann et al. 2014). Follow-up assessment was completed for 
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4,359 participants. Loss to follow-up constituted 9.5% of the study population, which was 
lower than the estimation of 15% (Schmermund et al. 2002). The first follow-up investigation 
was performed on May 15, 2006, and the last one on September 18, 2008. 
Participants included in the current analysis 
In the analysis with baseline data I included all participants with no missing information on: 
(i) exposure (modeled air pollution concentrations); (ii) outcome (measured BP and BPLM 
intake); and (iii) residential co-exposures and covariates in the main model. In total 4,584 
participants, comprising 95.2% of the baseline sample, were included to the current analysis 
with baseline data (Figure 2).  
 
Figure 2. Baseline and follow-up examination in the HNR study and the inclusion of partici-
pants in this analysis. 
Legend: BL = baseline examination, FU = follow-up examination. 
Out of 4,359 participants who filled out the follow-up questionnaires, arterial BP was meas-
ured in 4,157 participants. I excluded 685 participants who changed their residences during 
follow-up (to avoid exposure misclassification) and 220 with missing information on expo-
Baseline 
examination
N= 4,814
4,809 with air pollution value
4,799 with systolic BP
4,800 with diastolic BP
4,798 with information on BPLM use
3,986 with air pollution value
4,145 with systolic BP
4,145 with diastolic BP
4,157 with information on BPLM use
3,472 did not change address during
follow-up
Current analysis
(FU)
N=3,240
230 excluded due to missing
exposure, outcome, or covariates
685 excluded due change in address
214 excluded due to missing BP 
value
220 excluded due to missing
exposure or covariates
Total excluded N=1,119
Current analysis
(BL)
N=4,584
Follow-up
questionnaires and
examination
N= 4,359
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sures or covariates. The remaining sample of 3,240 participants was included in the analysis 
of the follow-up data. 
3.1.2. Exposure assessment 
Air pollution 
The European Air pollution Dispersion Chemistry and Transport Model (EURAD-CTM) was 
employed to assess individual air pollution exposure at the home addresses of the HNR partic-
ipants (Ebel et al. 2007; Memmesheimer et al. 2004). The EURAD-CTM is a validated, time-
dependent, three-dimensional model. With the help of this model, the daily mass concentra-
tions of PM1, PM2.5, PM10, PN, NO2, NO, SO2, O3, CO, and NH3 were modeled for the study 
area (approximately 600 km²) with a resolution of 1 km², as shown in Figure 3. This resolu-
tion is the smallest for the anthropogenic emissions, such as industrial sources, household 
heating, traffic, agriculture, etc., provided by the North Rhine-Westphalia State Agency for 
Nature, Environment and Consumer Protection. The EURAD-CTM “simulates the physical, 
chemical and dynamical processes that control emission, production, transport and chemical 
transformation and deposition of atmospheric trace species” (Rhenish Institute for Environ-
mental Research); it is based on the fundamental physical principles of conservation of mass, 
momentum and energy (Hennig et al. 2014). The model combines the fluid dynamic equations 
with information on chemical and physical transformations that air pollution constituents un-
dergo in the atmosphere (Hennig et al. 2014). The upper vertical boundary of the model is 16 
km; the lowest layer is approximately 40 m high (Hennig et al. 2014). The EURAD-CTM 
uses the sequential nesting method, starting from the large Europe-wide scale and narrowing 
down to the Ruhr area (in total, there were 4 nests with grid sizes of 125 km, 25 km, 5 km, 
and 1 km), which allowed to include the long-range transport and formation of secondary par-
ticles in the atmosphere (Hennig et al. 2014; Memmesheimer et al. 2004).  
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Figure 3. Modeled yearly concentrations of urban background PM2.5 in the study area.  
Legend: A = year2001, B = year 2002, C = year 2003. Source: I. Vanberg, unpublished (per-
sonal communication). 
A
B
C
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With the help of the EURAD-CTM model, the mean daily concentration of each respective 
pollutant was modeled in 1 km2 grid cells. The primary output concentrations were then cali-
brated with measured PM10 concentrations from 6 routine monitoring sites throughout the 
study area, taking into account the nature of the monitoring station (traffic, industrial site, 
urban background, regional background). Data from measurement stations were supplied by 
the North Rhine-Westphalia State Agency for Nature, Environment and Consumer Protection. 
The calibrated values were assigned to the participants’ addresses using the geographic infor-
mation system (ArcView 9.2, ESRI, Redlands, CA, USA). I calculated the mean of the 365 
daily PM values prior to the participant’s examination date to assess the individual long-term 
residential exposure. To discriminate the spatial contrast in exposure from the temporal con-
trast, I calculated a long-term grid-specific mean concentration as the average of the baseline 
period (2000–2003) and the follow-up period (2006–2008) for each grid cell 1×1 km. The 
long-term grid-specific mean concentration was assigned to each participant’s residence.  
Short-term air pollution and meteorology 
Short-term exposure was included as a covariate in the analysis. I calculated the respective 
short-term mean (the choice of averaging time was based on model fit), subtracting the yearly 
mean to avoid over-adjustment. In addition to air pollutant concentrations, the EURAD-CTM 
model predicts meteorological parameters (Hennig et al. 2014). I used mean of lags 0–6 with 
all PM metrics, PN, NOx, SO2, and CO, mean lags 0–1 with NH3, and mean of lags 0–2 with 
O3. Daily mean temperature (t°), precipitation, and wind speed were assigned to each partici-
pant’s address, similarly to air pollution. Two-day mean temperature and East-West wind were 
selected as the short-term meteorology variables based on the best model fit and were includ-
ed as covariates in some adjustment models.  
Traffic indicators 
Distance from participant’s residence to the nearest major road was estimated using digital-
ized maps (ArcView 9.2, ESRI, Redlands, CA, USA) and daily traffic counts provided by the 
North Rhine–Westphalia State Agency for Nature, Environment and Consumer Protection. A 
major road was defined as a road section in the upper quartile of the daily traffic count (> 
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22,980 vehicles per day for general traffic, > 756 vehicles per day for heavy-duty traffic and > 
4,341 for diesel traffic). I categorized distance to major road as follows: ≤ 50 m, 51-100 m, 
101-200 m, and > 200 m (reference category). When entered as a covariate in the analysis 
with air pollution or road traffic noise as main exposures, linear distance to road in upper 
quartile of diesel vehicle density was used as a covariate, based on the better model fit. 
Road traffic noise 
Long-term road noise was modeled according to the Directive 2002/49/EC of the European 
Parliament and of the Council as weighted 24-hour mean (Lden) and night-time mean (Lnight). 
The following formula was used: 
𝐿𝑑𝑒𝑛  =  10𝑙𝑔
1
24
(12 × 10
𝐿𝑑𝑎𝑦
10 + 4 × 10
𝐿𝑒𝑣𝑒𝑛𝑖𝑛𝑔+5
10 + 8 × 10
𝐿𝑛𝑖𝑔𝑕𝑡+10
10 )  [12] 
where Lday was the A-weighted long-term average sound level, as defined in ISO 1996-2: 
1987, determined over all of the day periods of the year; Levening was the A-weighted long-
term average sound level, as defined in ISO 1996-2: 1987, determined over all of the evening 
periods of the year; and Lnight was the A-weighted long-term average sound level, as defined 
in ISO 1996-2: 1987, determined over all of the night periods of a year (Directive 
2002/49/EC). The small-scale topography of the area, dimensions of buildings, noise barriers, 
street axis, vehicle type-specific traffic density, speed limit, and type of street surface were 
included in the noise model (Directive 2002/49/EC). The calculation method VBUS/RLS-90 
(VBUS 2006; RLS 90) and the software CadnaA (DataKustik GmbH 2014) were used for the 
noise modeling at façade points. The highest façade point noise level within a buffer of 10 m 
from the residence was used as the individual noise level. The reference level was set to 45 
dB for Lden and to 40 dB for Lnight. I additionally categorized continuous values of road traffic 
noise in 5-dB categories. Merging of the continuous noise variable into 5-dB categories was 
performed to correct for pseudo-precision – a very precise modeling of noise combined with 
no information on actual exposure (i.e., location of bedroom, ventilation patterns, etc.). This 
definition (continuous noise variable in 5-dB categories) was used when road traffic noise was 
entered as a covariate in the analysis with air pollution or traffic indicators as main exposure. 
According to a better model fit, Lnight was used as a covariate in these analyses. Tram noise, 
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obtained from isophone maps, was included to the analyses as well. It was defined with 5-dB 
categories, ranging from ≤5 to >65 dB. In the analysis with noise as a main exposure, I addi-
tionally included noise as categorical variable to account for a possible threshold of a biologi-
cal effect. 
Neighborhood-level socio-economic status 
Table 1. The neighborhood-level social characteristics obtained for the HNR study area and 
their definitions.  
Variable Definition 
Population density Npopulation
1
/AreaNeighb.(km
2
) 
Percentage of elderly residents (Naged ≥ 65/Npopulation)×100 
Unemployment rate Nunemployed/(NEconomicly active)×100 
Social welfare rate (Nreceiving welfare benefits/Npopulation)×100 
Residential turnover ((Nmoved in + Nmoved out)/Npopulation)×100 
Source: Jöckel et al 2010. 
1Number of residents in the neighborhood. 
The study area was divided into 106 neighborhoods, each corresponding to a statistical unit 
with a median size of 11,263 inhabitants (interquartile range 7,875–16,022) (Dragano et al. 
2009a). The socio-economic characteristics for each neighborhood in the study area were re-
trieved from the city departments in charge of statistics and monitoring in Essen, Bochum, 
and Mülheim an der Ruhr (Jöckel et al. 2010). The neighborhood-level data were assigned to 
the HNR participants by address linkage (Jöckel et al. 2010; Dragano et al. 2009a). The fol-
lowing data were retrieved: population density, age structure, unemployment rate, social wel-
fare rate, and residential turnover (Table 1).  
3.1.3. Assessment of study outcomes 
Blood pressure measurement 
BP measurements at baseline and follow-up were conducted according to the WHO monitor-
ing trends and determinants in cardiovascular disease (MONICA) measurement protocol 
(Hense et al. 1995). BP was recorded using the AOD (Omron HEM-705CP; OMRON Corpo-
ration, Hoofddorp, the Netherlands), and the RZS (Mark II; Hawksley, Lancing, United King-
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dom; Stang et al. 2006). The rationale of using two BP recording devices on one subject was 
to investigate differences between obtained values, to compare the values, and to develop a 
conversion algorithm that could be used in other studies in which comparisons between popu-
lations or population groups are limited because of the different devices used (Stang et al. 
2006). AOD is currently used in the vast majority of epidemiologic studies with BP (Stang et 
al. 2006). In the current study, the values obtained with an AOD were used (unless the AOD 
values were missing; see details below). The AOD displayed BP values to the nearest 1 
mmHg, and the RZS displayed the values to the nearest 2 mmHg (Stang et al. 2006). The 
measurement devices were regularly calibrated by the Bureau of Standards, the Board of 
Weights and Measures (Stang et al. 2006).  
According to the standards of the WHO MONICA BP recording protocol, study personnel 
conducting BP measurements were certified and regularly trained in measuring BP (Hense et 
al. 1995; Stang et al. 2006). Arm circumference was measured before BP recording, and the 
appropriate cuff size was chosen according to the protocol (Stang et al. 2006). The HNR par-
ticipants were asked not to drink coffee or any other beverages containing caffeine before the 
measurement. BP measurements were performed on the right arm, in a seated position with at 
least 5 minutes of rest before measurement and with a 3-minute interval between the BP read-
ings. To ensure that these standards were followed, the BP measurement was conducted in the 
middle of the computer-assisted personal interview; the participants were asked at least 53 
questions before their BP was measured (Stang et al. 2006). 
At baseline, participants were randomly assigned to the order of measurement devices, de-
pending on whether their personal identification number was odd or even (Stang et al. 2006). 
At baseline, BP was measured with both devices in all participants, whereas at follow-up, BP 
was measured with AOD in all participants and RZS in a subsample (n = 885, 21% of the fol-
low-up sample). At follow-up, for those 885 participants whose BPs were measured with both 
devices, the order of devices was opposite to baseline. On average, the intervals between the 
two devices were 22 minutes at baseline (Stang et al. 2006) and 23.5 minutes at follow-up. BP 
was measured three times with both types of measurement device. Due to the time constraints 
and personnel shortage, a reduced program of BP recordings (two measurements with AOD 
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and one with RZS) was applied for approximately 13% of the study participants at baseline 
(Stang et al. 2006). At the follow-up measurement, the reduced program was not applied. 
During the measurement, some information related to BP value and measurement conditions 
was recorded: room temperature, participant’s intake of coffee and other beverages before the 
measurement, whether a participant was diagnosed with hypertension and whether he or she 
received antihypertensive treatment.  
A standard quality assurance protocol was applied to check the BP values for plausibility at 
baseline (Author: A. Stang, personal communication). Briefly, the following parameters were 
checked: 
 The availability of each measurement (1st, 2nd, 3rd) of SBP and DBP with both recording 
devices;  
 With RZS measurements only: the availability of the correction factor; 
 Whether the correct sleeve size was used during measurement; 
 Temperature in the measurement room (allowed range: 18–28 °C); 
 Whether the order of devices was the same as assigned to the participant; 
 Plausibility of the measured BP values and their variability within one participant. 
The final SBP and DBP values at baseline and follow-up (―best-off‖ BP) were calculated as 
shown at Figure 4. BP was calculated as the mean of the 2nd and 3rd measurement values with 
AOD. The 1st measurement was generally disregarded, as it was assumed to be higher than 
the consequent measurements (Stang et al. 2006; Pickering et al. 2005). 
A strategy to diminish the number of missing values was used (Author: A. Stang, personal 
communication). If the readings 2 and 3 with AOD were missing, the first available of the 
following options was selected: (i) mean of the readings 1&3 or 1&2 with AOD; (ii) the sin-
gle available BP with AOD; (iii) mean of readings 2&3 with RZS; (iv) mean of the readings 
1&3 or 1&2 with RZS; (v) the single available BP with RZS; or (vi) the BP value from the 
pre-stress phase of the ergometric stress testing. PP was calculated as the difference (SBP mi-
nus DBP) of the final BP values. 
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Figure 4. The “best off” BP value calculation strategy.  
Legend: R = reading; BL = baseline measurement; FU = follow-up measurement.
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Assessment of BPLM intake 
Current BPLM intake was assessed at the baseline visit in a physician-conducted interview. Par-
ticipants were additionally asked to bring to the examination all packages of medication, which 
they had been taking during the past 7 days. The list of drugs included as BPLM was defined by 
HNR study cardiologists using the WHO Anatomical Therapeutic Chemical Classification Sys-
tem; in 294 participants (6% of the total HNR sample) missing information on ATC codes was 
replaced with self-reported intake of BPLM, recorded during BP measurement or ergometric 
stress testing was used instead. 
Table 2. Blood pressure-lowering medications in the HNR study.  
Class ATC codes included 
Diuretics 
Thiazides: C03EA14, C03BA04, C03BA03, C03AA03, C03BA11, 
C03BA08, C03BA02, C03BA10.  
Loop diuretics: C03CA02, C03CX01, C03CA01, C03CA03, 
C03CA04. 
Beta-blocking agents 
Selective: C07AB04, C07AB03, C07AB05, C07AB07, C07AB08, 
C07AB02, C07AB12, C07AB13.  
Non-selective: C07AA01, C07AA19, C07AA30, C07AA15, 
C07AA14, C07AA18, C07AA12, C07AA02, C07AA23, C07AA03, 
C07AA05.  
Alpha and beta blocking agents: C07AG02. 
ACE inhibitors 
C09AA07, C09AA01, C09AA08, C09AA02, C09AA09, C09AA03, 
C09AA13, C09AA04, C09AA06, C09AA05, C09AA11, C09AA10.  
Angiotensin II antagonists C09CA06, C09CA02, C09CA04, C09CA01, C09CA07, C09CA03. 
Selective calcium channel 
blockers 
Dihydropyridine derivatives: C08CA01, C08CA02, C08CA03, 
C08CA09, C08CA13, C08CA04, C08CA05, C08CA10, C08CA07, 
C08CA08.  
Benzothiazepine derivatives: C08DB01.  
Phenylalkylamine derivatives: C08DA02, C08DA01. 
Alpha-adrenoreceptor 
antagonists 
C02CA07, C02CA04, C02CA01, C02CA08. 
Anti-sympathetic nervous 
system agents 
C02AC01, C02CC07, C02AC02, C02AB01, C02AC05. 
Arteriolar vasodilators C04AX37, C02DB01, C02DC01. 
Other BP-lowering agents C03BX03. 
Combination drugs 
Diuretics and potassium-sparing agents: C03EA01, C03EA06, 
C03EA12, C03EA14, C03EA15, C03EA21, C03EA41, C03EB01, 
C03EB02, C03EB21. Beta blocking agents and diuretics: C07BA01, 
Materials and Methods 
63 
Class ATC codes included 
C07BA02, C07BA05, C07BA12, C07BA14, C07BA18, C07BB02, 
C07BB03, C07BB04, C07BB07, C07BG02, C07CA02, C07CA03, 
C07CA05, C07CA23, C07CB02, C07CB03, C07CB04, C07CB08, 
C07DA05, C07DB01.  
Loop diuretics and ACE inhibitors: C09BA01, C09BA02, C09BA03, 
C09BA04, C09BA05, C09BA06, C09BA07, C09BA08, C09BA09, 
C09BA13.  
Thiazides and angiotensin II antagonists: C09DA01, C09DA03, 
C09DA04, C09DA06, C09DA07. ACE inhibitors and calcium 
channel blockers: C09BB05, C09BB10.  
Calcium channel blockers and diuretics: C08GA01, C08GA02.  
Definition of hypertension 
Prevalent hypertension was defined as SBP ≥ 140 mmHg or DBP ≥ 90 mmHg or as the current 
use of BPLM (Chobanian et al. 2003). In the analysis of incident hypertension, the prevalent cas-
es (hypertensive at baseline) were excluded. 
Self-reported hypertension and BPLM intake 
At baseline and follow-up examinations (during a computer-assisted interview), the HNR partici-
pants were asked whether they had physician-diagnosed hypertension and, if yes, whether they 
were treated for high BP with medications. These variables were used as additional outcomes: 
self-reported physician diagnosed hypertension and self-reported BPLM intake. 
3.1.4. Individual-level covariates 
Age, sex, lifestyle, and co-morbidities 
Age at the examination date was calculated as the difference in years with the date of birth. Life-
style was represented with smoking, alcohol consumption, and physical activity. BMI was calcu-
lated as weight divided by squared height in meters. I assessed current and previous smoking, the 
lifetime cumulative exposure in pack-years, and any environmental tobacco smoke (ETS) expo-
sure (at home, at work, at other places). Amount of alcohol intake was given as a number of 
drinks per week (one drink defined as 0.25 L beer, 0.1 L wine, or 0.02 L spirits) and was catego-
rized as 0, 1–3, 4–6, and > 6 drinks per week. I categorized each participant’s sport and physical 
activity as self-reported times of physical exercise per week: < 1, 1, 2–3, and > 3 times/week. 
CVD, representing chronic disease or markers of deprived health, was included as CHD (self-
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reported history of myocardial infarction or coronary intervention) and type 2 diabetes mellitus 
(T2DM; prior physician diagnosis of T2DM or use of antidiabetic drugs or random blood glucose 
≥ 11.1 mmol/L or fasting blood glucose ≥ 7 mmol/L).  
Individual socio-economic status 
Individual level SES was assessed as years of formal education (United Nations Educational, 
Scientific, and Cultural Organization 1997) and was categorized as low (≤ 10 years), medium 
(11–17 years), and high educational level (≥ 18 years). Economic activity was categorized as em-
ployed, retired, unemployed, or economically inactive. 
Other covariates 
As surrogates for the study surface area characteristics (influencing the distribution, accumulation 
and transport of the pollutants), I used indicator variables for city (Mülheim, Essen, Bochum) and 
geographic area (North, Center, South). To account for temporal variations in exposure and out-
come, I calculated the time trend variable as the count of days starting from the first examination 
date at baseline or follow-up, correspondingly, to the examination date of each participant.  
3.1.5. Statistical analysis 
Causal graphs to define the adjustment sets 
The adjustment sets were identified using causal graphs (Glymour and Greenland 2008). The 
most likely causal relations between variables were based on prior biological and epidemiological 
knowledge and derived adjustment sets (Figure 5). The minimal sufficient sets were obtained 
using DAGitty 2.0 (Textor et al. 2011). Two minimal sufficient adjustment sets were identified to 
estimate the direct (causal) effect of air pollution on BP. They included the following concepts: (i) 
short-term air pollution, age, sex, lifestyle, CVD, and road traffic noise; and (ii) short-term air 
pollution, age, sex, BPLM intake, lifestyle, and road traffic noise. The adjustment set (i) was se-
lected as the main model because the relationship between air pollution BPLM intake and the 
resulting BP was investigated separately (see the subsection ―Correction for BPLM intake‖). 
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Figure 5. Hypothesized associations between air pollution, individual and neighborhood-level 
risk factors, and arterial BP.  
Legend: question mark (?) = the study question; weather = short-term meteorology; surface = 
study area characteristics. 
Selection of variables for the statistical model 
I checked how many missing values each of the variables, suggested for the main or extended 
adjustment sets, had and selected the variables with fewer missing values. For example, intima-
media thickness, which is a measure of the progression of atherosclerosis, had 1,000 missing val-
ues and was therefore omitted from the analysis. I checked all of the variables for the plausibility 
of values. Pack-years of smoking at baseline had one extremely high value (400 pack-years, 
which was twice as high as the second highest value). After consulting with data managers and 
the HNR study team, I assigned this participant the second highest value (204 pack-years), which 
resulted in the improved model fit. If more than one variable was available for controlling for 
possible confounding, for example, different blood lipids as a surrogate for the nutrition compo-
nent of lifestyle, the decision on the variable was made in the model checks step. 
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Statistical analysis  
Statistical analyses were performed using the following software: SAS version 9.2 (SAS Institute 
Inc., Cary, NC, USA), STATA version 12.0 (StataCorp, College Station, TX, 12 USA; 
www.stata.com) and R version 2.13.1 (R Core Team 2013). 
Univariate analyses of data, such as descriptive statistics, correlations, cross-tables and subgroup 
comparisons were performed prior to the regression analysis. The distribution of longitudinal 
variables was checked for normality. The parametric statistical procedures (e.g., Pearson’s corre-
lation coefficient calculation and the T-test in two groups) were employed regardless of the vari-
ables’ distribution based on the central limit theorem, because the number of participants in the 
analysis was substantial. 
Exposure was entered as a linear term in all analyses based on the reported linearity of the associ-
ation with cardiovascular mortality (Brook et al. 2010). Regression estimates were presented per 
interquartile range (IQR) of respective pollutant concentration. In addition, the dose-response 
relationship of exposure with outcome was tested using categorical exposure (by quartiles) and 
penalized splines (Hastie and Tibishirani 2007).  
Outcomes were not transformed for the analysis. BP was analyzed with a linear regression model, 
and BPLM and hypertension with a logistic regression. To correct for the BPLM intake in a sen-
sitivity analysis, I also used a right-censored regression (see the section ―Correction for BPLM 
intake‖). In the analysis with the incidence of hypertension as an outcome, a Poisson regression 
with robust variance estimation was used. 
I conducted cross-sectional and longitudinal analysis. For the cross-sectional analysis, exposure 
and outcome values from the same time period were used (baseline or follow-up, respectively). 
Longitudinal analysis was conducted in few different ways: (i) the association of baseline air pol-
lution concentrations with BP, the incidence of hypertension, and BPLM intake at follow-up; (ii) 
the association of baseline air pollution concentration with change in BP from baseline to follow-
up, the incidence of hypertension, and BPLM intake at follow-up; and (iii) the association of 
change in air pollution from baseline to follow-up with change in BP from baseline to follow-up, 
the incidence of hypertension, and BPLM intake at follow-up. The longitudinal analysis with 
change in BP as the outcome was conducted in a subsample of participants not taking BPLM. 
The non-linearity of covariate-outcome relationships was investigated using squared terms cen-
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tered on the mean. Non-linearity was tested for the following covariates: age, BMI, lipid ratio 
(LDL/HDL), HDL, triglycerides, and time trend. Of them, a significant non-linear relationship 
was observed for age, but only with DBP; this observation is consistent with the evidence that 
DBP increases only until a certain age, after which, with the progression of arterial stiffness, DBP 
starts to decrease (Chobanian et al. 2003; Whelton 1994). Non-linear terms were also significant 
for BMI, triglycerides (only with DBP), and time trend. The variables which showed a deviation 
from a linear relation with BP were included to the main adjustment model as polynomials and 
linear terms, centered on the mean. 
Regression model checks 
I checked the following assumptions of the linear regression model: collinearity of predictor vari-
ables, distribution of residuals, and presence of influential observations. These checks were per-
formed with the main adjustment set, but without the exposure in the model (the ―empty‖ model). 
The collinearity of predictor variables was checked using correlations. Variables with Pearson’s 
correlation coefficients > 0.7 were not included in the model simultaneously. For example, of the 
two highly correlated meteorological variables humidity and temperature, only humidity was left 
in the model. In addition, I considered the variance inflation factor (VIF) as another measure of 
collinearity: a variable with VIF > 10 was excluded from the analysis. The distribution of residu-
als was close to normal, although the Kolmogorov-Smirnov test revealed a deviation from nor-
mality. I checked the leverage of individual observations plotting the leverage against the squared 
residual plot. One observation had a substantially high leverage. This participant was deleted 
from the analysis, which resulted in a better model fit. Using the main adjustment set with SBP, 
DBP and PP as outcomes, I computed the plot of residuals versus fitted values, and found no evi-
dence that the model was making unusually large or small predictions. 
The main adjustment model 
The main adjustment set with SBP, PP, hypertension and BPLM as outcomes included time trend 
(linear and squared terms, centered on mean), short-term exposure (mean of lags 0–1 with NH3, 
mean of lags 0–2 with O3, and mean of lags 0–6 with all PM metrics, PN, NOx, SO2, and CO; for 
all short-term exposures, yearly mean was subtracted), Lnight traffic (linear, in 5-dB categories), 
Lden tram (linear, in 5-dB categories), distance to major road (upper quartile of diesel vehicle den-
sity), age, sex, BMI (linear and squared terms, centered on the mean), waist-hip ratio (WHR), 
blood lipids (lipid ratio, HDL, triglycerides), smoking status, ETS, physical activity (in catego-
Materials and Methods 
68 
ries), education (in categories), and economic activity (in categories). The main adjustment set 
with DBP as the outcome additionally included linear and squared terms for age and the concen-
tration of blood triglycerides. 
The following covariates in the main model were significant predictors of SBP: sex, age, BMI, 
current smoking, alcohol consumption > 6 drinks/week, sport < 1 time/month, educational status, 
road traffic noise, and the city of residence (the model estimates with all outcomes are presented 
in Tables 38–42 in the Appendix). 
Subjects excluded from the analysis at baseline 
I preformed complete case analysis, excluding participants with missing values. At baseline, 230 
subjects were excluded due to missing values (Appendix Table 43). There were slightly more 
men, smokers, subjects with CHD, participants with lower educational levels, those practicing no 
sport, and retired people; the distributions of exposure, outcome and the remaining personal char-
acteristics were quite similar to the main analysis subset. At follow-up, 685 participants were not 
included because they changed their addresses during the follow-up period. This group was not 
compared to the main group. The examination of personal characteristics of the 232 subjects ex-
cluded from the follow-up sample (those who did not change their addresses) due to missing val-
ues did not reveal any substantial differences to the follow-up analysis subset with regard to ex-
posure, though some characteristics differed slightly (Appendix Table 44); the excluded subjects 
had lower BP values, higher rates of medication use and hypertension, more women, more sub-
jects with CHD, fewer smokers, more exposure to CHD, lower educational levels and no sport 
activity. 
Sensitivity analyses  
In addition to the analysis with the main outcomes (BP, hypertension based on BP and BPLM 
intake, and BPLM intake), I conducted a sensitivity analysis with self-reported hypertension and 
BPLM intake as outcomes.  
In the extended adjustment sets, those variables that were not included in the main model but 
were nevertheless important predictors of BP were added, including (i) short-term meteorology 
(humidity and wind speed), (ii) alcohol and pack-years of smoking (available for a subset of 
4,368 participants), (iii) co-morbidities (CHD, T2DM), (iv) city of residence and geographic area 
(North, Center, South), and (v) area-level SES (in the mixed-effects regression model). In the 
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additional analysis, I deleted 3 influential observations (with high residual/leverage). 
I investigated the spatial component of exposure definition. The individual 365-day mean reflects 
both spatial and temporal differences in the study area during the baseline period: for example, 
two participants living on the same street, but coming for baseline measurements of BP on differ-
ent dates would be assigned different 365-day mean concentrations of residential air pollution. 
Therefore, in a sensitivity analysis, the grid-specific mean of the baseline period (2000–2003) 
representing only spatial differences was used as a main exposure. I did not adjust for time trend 
in this model because the grid-specific mean had only spatial variation. 
I calculated the two-exposure models combining particulate and gaseous components: in one 
model, both of the exposures were entered as independent predictors, in the other interactions 
with high levels of one of the pollutants were tested. For the interaction analysis, the pollutant 
was dichotomized at the 75th percentile, and analyses with product terms Exposure1×Exposure2 
(dichotomous) were conducted.  
Analysis of effect modification. 
I tested for effect modification of results with BP as the outcome using the product term expo-
sure×effect modifier. The Z-test was used to assess the significance of effect modification. The 
following factors were tested: sex, age ≥ 60 years, BMI ≥ 30 kg/m², CHD, T2DM, current smok-
ing, passive smoking, acute inflammation (CRP > 3 µg/L), high alcohol consumption, no sport 
activity, low education level, T2DM, CHD, city of residence, meteorological season (winter vs. 
other), road traffic noise ≥ 65 dB vs. lower, and living < 100 m to the major road (upper quartile 
of the diesel vehicles density) vs. living farther away.  
Correction for BPLM intake 
As a first attempt to correct for medication effect, I included medication as a covariate. An air 
pollution-related increase in BP may lead to BPLM intake in the most susceptible individuals. 
Therefore, BPLM intake may lay in the causal pathway from air pollution to BP. Adjustment for 
the variable that mediates the effect of exposure on the outcome may lead to a biased estimate of 
the main association, which is why other methods of correction were applied as well. 
My second approach was to use binary outcomes: BPLM intake and hypertension. The latter out-
come combines BPLM and high BP values. Using these outcomes would help to diminish the 
bias in the analysis. However, dichotomizing the variable implies power loss. Additionally, it is 
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possible that in the less susceptible participants, a change in BP related to air pollution would 
likely not result in hypertension. Thus, it is possible that a null association of air pollution with 
BPLM intake and hypertension will be observed. 
The third approach was to implement some of the correction techniques recommended in the lit-
erature (Tobin et al. 2005). I chose to use the fixed addition method. With this method, a fixed 
increment (e.g., 5 or 10 mmHg) is added to BP values of medicated participants. The advantages 
of this method are that it is simple and straightforward. The limitation of this method is that an 
assumption regarding treatment effect is made. In a population-based cohort, the participants will 
vary greatly by the treatment scheme, achieved control of hypertension, and other related factors. 
Along with the fixed addition method, I implemented another recommended strategy: the normal 
censored regression. With this method, BP values in the medicated participants are right-
censored: it is assumed that the ―real‖, underlying BP (without the treatment effect) in subjects 
taking BPLM is at least as high as the measured value (Tobin et al. 2005). The model is fit into a 
linear regression equation as follows:  
𝐵𝑃∗  =  𝛽0 + 𝛽1 ∗ 𝑃𝑀 + 𝛽2 ∗ 𝐶𝑜𝑣𝑎𝑟𝑖𝑎𝑡𝑒2 + ⋯ + 𝛽𝑥 ∗ 𝐶𝑜𝑣𝑎𝑟𝑖𝑎𝑡𝑒𝑥 + 𝜀𝑖   [13], 
where BP* = censored BP (BP* = BP in participants not taking BPLM and BP* ≥ BP in partici-
pants taking BPLM); β0 = intercept; β1…βx regression coefficients; and εi = error term (Tobin et 
al. 2005). Model parameters were estimated by maximum likelihood using a Newton-Raphson 
algorithm (Jennrich and Robinson 1969). Standard errors were estimated from the inverse of the 
observed information matrix.  
In addition, I estimated the association of air pollution with blood pressure in participants taking 
BPLM (―medicated‖) and not taking BPLM (―non-medicated‖) separately. The interaction term 
exposure×BPLM intake was used to increase power. This method avoids making assumptions 
about treatment effect and BP distribution. BPLM intake was entered as a separate outcome in the 
study. 
3.2. Experimental part 
3.2.1. Experimental setting 
Study animals 
Eight-week-old C57BL/6J female mice obtained from the Charles River Company (Sulzfeld, 
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Germany) were used in the experiment. The Animal Ethics Committee of the Dutch National 
Vaccine Institute approved the experiment. Animals were housed in inhalation chambers during 
the entire experiment. The temperature was maintained at 22 ± 2 ⁰C and the relative humidity at 
30–70% with a 12-hour light/dark cycle. The animals were allowed ad libitum access to a com-
mercially available rodent diet (CRM) and tap water via an automatic drinking water system 
(Gerlofs-Nijland 2012). 
Exposure 
Diesel engine exhaust (DEE) was generated using a 100 KVA common-rail diesel generator 
(Stammis, Heerhugowaard, Netherlands) under load (38 KW) and idling conditions fueled with 
EN590 diesel. Exposure level was controlled with a proportional-integral-derivative controller. 
NO2 was generated by heating liquid nitrogen and mixing it with diluted diesel in two different 
concentrations to obtain low and high NO2 conditions. To remove the particulate fraction (filtered 
DEE), the flow was split after the addition of NO2 and partially passed through a HEPA filter 
(Gerlofs-Nijland 2012).  
Table 3. Group codes, exposure test atmospheres, and concentrations of NO2. 
Group Abbreviation Exposure 
NO2 
concentration 
1 Control Clean air – 
2 DEE DEE (~ 1 mg/m³) 2 ppm1 
3 DEE + NO2 (low) DEE + low NO2 4 ppm 
4 DEE + NO2 (high) DEE + high NO2 15 ppm 
5 DEE (filtered) + NO2 (low) Filtered DEE + low NO2 4 ppm 
6 DEE (filtered) + NO2 (high) Filtered DEE + high NO2 15 ppm 
7 NO2 (high) High NO2 15 ppm 
1ppm = parts per million 
The following test atmospheres were generated: (i) control with clean air (HEPA filtered, chemi-
cally purified with activated charcoal and purafill and conditioned to a temperature of 21 ⁰C and 
a relative humidity of 55%); (ii) DEE diluted to 1 mg/m3 with clean and conditioned air; (iii) 
DEE combined with low-concentration NO2 (volume concentration NO2/NOx approximately 
20%); (iv) DEE combined with high-concentration NO2 (NO2/NOx ~ 50% v/v of NOx); (v) fil-
tered DEE (only the gaseous fraction) combined with low-concentration NO2; (vi) filtered DEE 
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combined with high-concentration NO2; and (vii) high-concentration NO2 alone (Table 3). The 
animals (10 per exposure group) were exposed over 13 weeks (5 days per week, 6 h per day) to 
different test atmospheres in whole-body exposure units. On the day after the last exposure day, 
the animals were anesthetized with a mixture of Ketamine (100 mg/ml) and Xylazine (20 mg/ml) 
in a 10:8 ratio and sacrificed via exsanguination. Necropsy was performed on the day after the 
last exposure day. Lung tissue samples were snap-frozen in liquid nitrogen and stored at -80 °C 
(Gerlofs-Nijland 2012). 
3.2.2. Measurement of gene expression in the lung tissue 
Lung tissues were ground and homogenized in Trizol®. To extract ribonucleic acid (RNA), the 
RNeasy® mini kit was used in combination and the DNAse treatment with the QIAGEN ® 
RNAse-free DNAse set. The extraction was performed according to the manufacturer’s instruc-
tions (Qiagen 2012; 5 PRIME 2007). Next, coding DNA was synthesized from 0.5 µg of RNA 
with the iScript Advanced coding DNA Synthesis Kit for real time quantitative polymerase chain 
reaction (RT-qPCR) (BioRad, CA, USA). Coding DNA was consequently diluted 1:15 in DNA-
free water (Van Berlo et al. 2010).  
Five genes involved in oxidative, inflammatory, or vascular responses, were investigated: 
CYP1A1, iNOS, TNFα, NAD(P)H dehydrogenase quinone 1 (NQO1), and ICAM-1. Three 
housekeeping genes were also selected for this study: glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), hypoxanthine-guanine phosphoribosyltransferase (HPRT), and β-actin. The sequences 
of the RT-qPCR primers are presented in Table 4. The primers were designed using Primer Ex-
press software  Version 3.0 (Applied Biosystems). The PCR efficiencies of the primers were 90% 
or higher (data not shown). I used the SYBR© Green Supermix (BioRad), diluted coding DNA, 
and 0.3 µM primers in a total volume of 25 µL. The RT-qPCR reactions were run with the iQ5TM 
real-time PCR detection system (BioRad, CA, USA). Cycling conditions were as follows: 3 min 
denaturation at 95 °C, and then 40 cycles of 15 s at 95 °C and 45 s 60 °C (Van Berlo et al. 2010). 
Melt curves (60–95°C) were produced for product identification and purity. The threshold cycle 
(Ct), the PCR cycle at which fluorescence rises above threshold background fluorescence, indi-
cating that the amount of amplified material has reached the threshold (Livak and Schmittgen 
2001), was calculated using iQ5™ Optical System Software (BioRad, CA, USA).  
Table 4. Primer sequences used in the current study 
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Gene Sense (forward) primer Antisense (reverse) primer 
CYP1A1 5´ -CCTCATGTACCTGGTAACCA-3 5´ -AAGGATGAATGCCGGAAGGT-3 
iNOS 5´ -AACATCAGGTCGGCCATCA-3 5´ -CGTACCGGATGAGCTGTGAA-3 
TNFα 5´ -AGGCTGCCCCGACTACGT-3 5´ -ACTTTCTCCTGGTATGAGATAGCAAAT-3 
NQO1 5´ -CCATGGCGGCGAGAAG-3 5´ -CATGGCGTAGTTGAATGATGTCTT-3 
ICAM-1 5´ -GTCCGCTGTGCTTTGAGAACT-3 5´ -CGGAAACGAATACACGGTGAT-3 
GAPDH 5´ -AACCTGCCAAGTATGATGACATCA-3 5´ -GGTCCTCAGTGTTAGCCCAAGAT-3 
HPRT 5´ -AAGACTTGCTCGAGATGTCATGAA-3 5´ -AAAGAACTTATAGCCCCCCTTGA-3 
β-actin 5´ -CGTGAAAAGATGACCCAGATCA-3 5´ -CACAGCCTGGATGGCTACGT-3 
3.2.3. Relative gene expression calculations (2-ΔΔCt method) 
I calculated difference in gene expression in each exposed group compared to the control group 
using a housekeeping gene as an endogenous reference. For that, I used the 2-ΔΔCt method (Livak 
and Schmittgen 2001). I ran a linear regression model as follows: 
∆𝐶𝑡  =  𝛽0 + 𝛽1 × 𝐺𝑟𝑜𝑢𝑝2 + 𝛽3 × 𝐺𝑟𝑜𝑢𝑝3 + 𝛽4 × 𝐺𝑟𝑜𝑢𝑝4 + 𝛽5 × 𝐺𝑟𝑜𝑢𝑝5 + 𝛽6 × 𝐺𝑟𝑜𝑢𝑝6 +
𝛽7 × 𝐺𝑟𝑜𝑢𝑝7 + 𝜀          [14] 
The dependent variable ΔCt was calculated as: 
∆𝐶𝑡  =  𝐶𝑡(𝐺𝑒𝑛𝑒 𝑜𝑓 𝑖𝑛𝑡𝑒𝑟𝑒𝑠𝑡) − 𝐶𝑡(𝐻𝑜𝑢𝑠𝑒𝑘𝑒𝑒𝑝𝑖𝑛𝑔 𝑔𝑒𝑛𝑒)    [15] 
In the formula [14], ß0 is the intercept; ß1 to ß7 are linear regression coefficients for each of the 
exposure groups (independent predictors in the linear regression model); and ε is residual error. 
The fold change of gene expression for the exposed group X compared to the control group was 
calculated as 2−𝛽𝑋. The 95% confidence interval was calculated as 2−(𝛽𝑋±1.96×𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝐸𝑟𝑟𝑜𝑟𝛽𝑋). 
As a sensitivity analysis, I calculated the fold change in expression without normalizing for the 
housekeeping gene. In addition, I tested for an exposure-response relationship with NO2 concen-
tration, which was entered as a continuous predictor in the linear regression model. The data were 
prepared using Microsoft Office Excel 2010. Analyses were performed using SAS (version 9.2; 
SAS Institute Inc., Cary, NC, USA). Graphs were produced with R 2.13.1 (R Core Team 2013).  
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4. OBSERVATIONAL STUDY RESULTS 
4.1. Cross-sectional analysis with BP and hypertension at baseline 
4.1.1. Description of study population 
At baseline, 4,584 participants with no missing values for exposure, outcome, and covariates 
were included. The distribution of outcomes in the study population at baseline is summarized in 
Table 5. On average, the study participants at baseline had slightly elevated SBP: 133.2 mmHg 
(standard deviation (SD) = 20.8 mmHg), which, according to the JNC7 classification, is in the 
pre-hypertensive range (Chobanian et al. 2003). DBP was very close to normal range, with a 
mean value of 81.4 mmHg (standard deviation, SD, 10.9 mmHg). The average PP was 51.7 
mmHg (SD 14.7 mmHg). At the time of the baseline measurement, 1,628 (35.5%) participants 
took BPLM, and 2,611 (57.0%) had prevalent hypertension according to the JNC7 definition 
(Chobanian et al. 2003). During baseline examination, participants also indicated whether they 
had hypertension diagnosed by a physician (42.7%) and whether it was treated with medications 
(31.2%).  
Table 5. Average BP values and rates of hypertension and BPLM intake in the analysis sample. 
Variable (unit) Statistics Description N missing 
SBP (mmHg) Mean ± SD 133.2 ± 20.8 – 
DBP (mmHg) Mean ± SD 81.4 ± 10.9 – 
PP (mmHg) Mean ± SD 51.7 ± 14.7 – 
Hypertension n (%) 2,611 (57.0%) – 
BPLM intake n (%) 1,628 (35.5%) – 
Self-reported hypertension1 n (%) 1,955 (42.7%) 10 
Self-reported BPLM intake1 n (%) 1,432 (31.2%) 1 
N = 4,584. 
1For the complete case analysis, participants with missing values of BP or BPLM intake were 
excluded; the outcomes in the sensitivity analyses contained few additional missing values. 
The distribution of BP was quite symmetric but was slightly skewed either to the left (PP, SBP) or 
to the right (DBP) of the mean value (Figure 6). The distribution deviated from normal (p < 0.01 
with Shapiro-Wilk test of normality for SBP, DBP and PP). 
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Figure 6. Distribution of BP in the study population.  
Legend: blue line indicates normal distribution. 
I compared the distribution of hypertension and BPLM intake according to the definition used in 
this study: the JNC7 definition for hypertension (Chobanian et al. 2003) and BPLM intake ac-
cording to the ATC codes (see Methods, ―Assessment of BPLM intake‖) in Table 6.  
Table 6. Difference between hypertension and BPLM intake, included as main outcomes accord-
ing to the study definition, and self-reported hypertension and BPLM intake. 
Hypertension 
(JNC7 definition) 
Self-reported 
hypertension = No 
Self-reported 
hypertension = Yes 
Self-reported 
hypertension = Missing 
No 1,747 (88.5%) 220 (11.2%) 6 (0.3%) 
Yes  872 (33.4%) 1,735 (66.4%) 4 (0.2%) 
BPLM intake 
(ATC codes) 
Self-reported BPLM 
intake = No 
Self-reported 
BPLM intake = Yes 
Self-reported BPLM 
intake = Missing 
No 2,870 (97.1%) 85 (2.9%) 1 (0.0%) 
Yes  281 (17.3%) 1,347 (82.7%) 0 (0.0%) 
N = 4,584.    
Of 2,611 participants with hypertension according to the study definition, 66.4% reported physi-
cian-diagnosed hypertension. Of 1,973 non-hypertensive (study definition), 11.2% reported hav-
ing physician-diagnosed hypertension. The overall agreement for main definition of hypertension 
and for self-reported hypertension was 76.1%, Cohen’s kappa was 0.53, which corresponds to 
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fair to good agreement. Among 1,628 participants taking BPLM according to the study definition, 
82.7% also reported medication use. The overall agreement for the study definition of BPLM and 
self-reported BPLM intake was 92.0%. Cohen’s kappa was 0.82, which corresponds to excellent 
agreement. 
Table 7. Distribution of personal characteristics in the baseline analysis sample. 
Variable (unit), statistics Description N missing 
Age (years), Mean ± SD 59.6 ± 7.8 – 
Sex (male), n (%) 2,274 (49.6%) – 
CHD, n (%) 296 (6.5%) – 
T2DM, n (%) 623 (13.6%) – 
BMI (kg/m²), Mean ± SD 27.9 ± 4.6 – 
LDL:HDL ratio, Mean ± SD 2.7 ± 1.1 – 
Smoking, n (%) 
 
– 
 Current 1,064 (23.2%)  
 Former 1,585 (34.6%)  
 Never 1,935 (42.2%)  
Smoking pack-years1, Mean ± SD 16.1 ± 24.6 112 
ETS exposure, n (%) 1,658 (36.2%) – 
Alcohol (drinks/week)1, Mean ± SD 5.3 ± 10.2 107 
No sport, n (%) 2,100 (45.8%) – 
Education, n (%) 
 
– 
 < 10 years (low) 517 (11.3%)  
 11–17 years (middle) 2,558 (55.8%)  
 ≥ 18 years (high) 1,509 (32.9%)  
Economic activity  – 
Employed 1,847 (40.3%)  
Unemployed 290 (6.3%)  
Housewife/homemaker 642 (14.0%)  
Retired 1,805 (39.4%)  
N = 4,584. 
1For the complete case analysis, missing values in all variables in the main adjustment model 
were excluded; some variables, used only in the sensitivity analyses, may contain missing values: 
pack-years of smoking, alcohol consumption.  
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Other characteristics of the study population are presented in Table 7. On average, the study par-
ticipants were 59.6 (SD 7.8) years old. Gender distribution was equal (49.6% men). CHD was 
reported by 6.5%. T2DM was found in 13.6%. The average BMI of the participants was 27.9 
kg/m² (SD 4.6 kg/m²), which corresponds to the WHO definition of overweight, indicating the 
presence of overweight subjects in the population. Twenty-three percent (N = 1,064) were smok-
ers, and thirty-five percent (n = 1,585) were former smokers, leaving forty-two percent of the 
analysis sample (n = 1,935) with no history of smoking. This percentage is lower than the one 
estimated by the World Health Organization for the year 2000 for the European region (29.9%) 
and for Germany (34.8%; European health for all database 2014). On average, participants re-
ported 16.1 pack-years of smoking (SD 24.6 pack-years). Approximately one-third of the study 
population (36.2%) reported exposure to ETS. Forty-five percent of study participants did not 
practice sport regularly. Approximately half of all of the study population at baseline had second-
ary education (11-17 years; n = 2,558, 55.8%), thirty-three percent reported having tertiary edu-
cation (≥ 18 years; n = 1,509), and the remaining 517 (11.3%) had primary education only (≤ 10 
years). Equal proportions of the population (approximately 40%) reported being employed or 
retired at the time of the baseline measurement. 
4.1.2. Description of exposure 
Particulate matter  
The distributions of modeled long-term concentrations of PM in the analysis sample at baseline 
are given in Table 8. The mean concentration of background PM2.5 365 days prior to BP meas-
urement at baseline was 16.7 µg/m³ PM2.5 (SD 1.6 µg/m³). The grid-specific mean of the baseline 
period (2000–2003) was slightly higher than the individual 365-day mean: 17.1 µg/m³ (SD 1.4 
µg/m³). The average concentration of the individual 365-day mean PM10 was 20.7 µg/m³ PM10 
(SD 2.6 µg/m³). Equivalently to PM2.5, the grid-specific mean value of PM10 was slightly higher 
than the individual 365-day mean: 21.1 µg/m³, SD 2.6 µg/m³. For comparison, the yearly mean 
concentration of PM10 for the Rhein–Ruhr area in 2000 was 24 µg/m³, as reported by the North 
Rhine-Westphalia State Agency for Nature, Environment and Consumer Protection.  
On average, 365-day mean PMcoarse reached 4.0 µg/m³ (SD 1.5 µg/m³). The mean concentration 
of PM1 was 11.6 µg/m³ (SD 1.3 µg/m³) one year before the baseline measurement. The mean 
365-day concentration of particle number, also representing the ultrafine fraction of particles, was 
8.8×104/L (SD 1.9×104/L). The grid-specific mean values for the entire baseline period (2000–
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2003) for PMcoarse, PM1, and PN did not differ from the individual 365-day mean values. 
Table 8. Concentrations of particulate matter in the study population at baseline. 
Exposure (unit) 
 Individual 365-day mean  Mean of 2000–2003  Correlation 
 Mean ± SD
 
Min –Max IQR  Mean ± SD Min –Max IQR  Pearson’s ρ 
PM2.5 (µg/m³)  16.7 ± 1.6 13.3 – 22.4 2.4  17.1 ± 1.4 14.5 – 21.6 2.3  0.875
*1
 
PM10 (µg/m³)  20.7 ± 2.6 15.8 – 29.3 4.0  21.1 ± 2.6 17.2 – 29.1 4.1  0.933
*
 
PMcoarse (µg/m³)  4.0 ± 1.6 2.1 – 11.8 1.7  4.0 ± 1.5 2.2 – 9.2 1.9  0.895
*
 
PM1 (µg/m³)  11.6 ± 1.3 8.7 – 16.1 1.9  12.0 ± 1.1 9.9 – 15.7 1.7  0.863
*
 
PN (×10
4
/L)  8.8 ± 1.9 4.9 – 18.4 2.7  8.8 ± 1.9 5.0 – 18.1 2.7  0.987* 
N = 4,584. 
1Significance: * = p < 0.05.  
I observed a strong to very strong correlation of the individual 365-day mean concentration with 
the grid cell-specific mean concentration (Table 8): Pearson’s ρ was > 0.85 for all pollutants and 
was higher than 0.9 for PM10 and PN.  
Gaseous pollutants  
Table 9. Concentrations of gaseous pollutants in the study population at baseline. 
Exposure 
 (unit) 
 Individual 365-day mean  Mean of 2000–2003  Correlation 
 Mean ± SD
 
Min –Max IQR  Mean ± SD Min –Max IQR  Pearson’s ρ 
O3 (µg/m³)  35.4 ± 1.6 29.9 – 39.6 2.2  34.7 ± 1.4 30.1 – 38.1 1.9  0.874
*1
 
NO2 (µg/m³)  40.1 ± 4.2 27.6 – 53.3 5.7  41.3 ± 4.0 28.4 – 53.1 5.1  0.935
*
 
NO (µg/m³)  12.7 ± 4.5 4.8 – 35.7 5.5  13.2 ± 4.4 5.9 – 30.7 5.8  0.964* 
SO2 (µg/m³)  8.7 ± 1.1 5.9 – 16.3 1.5  9.1 ± 1.0 6.7 – 17.1 1.5  0.874
*
 
CO (µg/m³)  0.3 ± 0.1 0.2 – 0.6 0.1  0.3 ± 0.1 0.3 – 0.6 0.1  0.967* 
NH3 (µg/m³)  2.6 ± 0.4 1.8 – 3.7 0.5  2.7 ± 0.3 2.2 – 3.6 0.4  0.724
*
 
N = 4,584. 
1Significance: * = p < 0.05. 
The average modeled long-term concentrations of gaseous pollutants in the analysis sample at 
baseline are presented in Table 9. The average concentrations of gaseous pollutants 365 days be-
fore BP measurement were 35.4 µg/m³ O3 (SD 1.6 µg/m³), 40.1 µg/m³ NO2 (SD 4.2 µg/m³), 8.7 
µg/m³ SO2 (SD 1.1 µg/m³), 0.3 µg/m³ CO (SD 0.1 µg/m³), and 2.6 µg/m³ NH3 (SD 0.4 µg/m³). 
These values were close to the yearly mean values for 2000 in the Rhein-Ruhr area, as reported 
by the North Rhine-Westphalia State Agency for Nature, Environment and Consumer Protection 
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(LANUV 2000b): 33 µg/m³ for O3, 30 µg/m³ for NO2, 8 µg/m³ for SO2, and 0.4 µg/m³ for CO. 
The grid-specific mean concentrations for the 2000–2003 period were quite similar to the indi-
vidual 365-day mean, though the standard deviation was smaller due to the longer averaging pe-
riod. The individual 365-day mean was very collinear with the grid cell mean for 2000–2003: 
Pearson’s correlation coefficient varied from 0.724 (observed for NH3) and 0.967 (observed for 
CO; Table 9). 
Ambient noise, distance to major road, and neighborhood SES indicators (Table 10) 
The mean level of 24-hour weighted mean road traffic noise at the residence, defined as the max-
imum façade value of the 10-m buffer around the geocoded address, was 53.9 dB. Mean level of 
night-time noise was 45.1 dB. Average tram noise was 12.2 dB.  
Table 10. The average levels of ambient noise, distance to major road and neighborhood-level 
unemployment rate in the baseline analysis sample. 
Variable (unit) Mean ± SD 
Ambient noise   
Lden (traffic) (dB)
1
 53.9 ± 9.6 
Lnight (traffic) (dB)
1
 45.1 ± 9.3 
Lden (tram) (dB) 12.2 ± 13.6 
Distance to major road by vehicle type   
Diesel vehicles (km) 0.9 ± 0.8 
Area socio-economic characteristics   
Population density (×10³ residents/km²) 3.6 ± 2.1 
Proportion of residents ≥ 65 years (%) 28.3 ± 3.3 
Unemployment rate (%) 12.5 ± 3.4 
Social welfare rate (%) 4.6 ± 2.7 
N = 4,584. 
1Traffic Lden and Lnight variable contain 46 missing values. In the analyses, Lden was entered in 5-
dB categories, and the missing values were replaced with available noise isophones data. 
On average, study participants resided far away from highly trafficked roads (Table 10). The 
mean distance from participants’ residences to major roads with high densities of all-type, diesel, 
and heavy-duty vehicles was 0.9 km (shown for diesel vehicles only). The mean population den-
sity in the 106 neighborhoods in the study area was 36,000 residents per 1 km². Approximately 
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one-third of each neighborhood residents were older than 65 years of age, 12.5% were unem-
ployed, and 4.6% received social welfare support (Table 10). 
Short-term air pollution and meteorology (Table 11) 
Short-term concentrations of air pollutants were quite similar to yearly mean concentrations for 
all pollutants except NH3, for which the short-term value was substantially smaller than the long-
term one. The short-term mean all-source PM2.5 concentration was 16.8 µg/m³. The mean tem-
perature 2 days before the BP measurement was 10.3° C; the mean relative humidity was 6.5 
g/kg.  
Table 11. Description of short-term air pollution and meteorology in the study population. 
Variable Time lag (days) Unit  Mean ± SD 
PM2.5 lag 0–6  µg/m³ 16.8 ± 6.1 
PM10 lag 0–6  µg/m³ 20.9 ± 7.3 
PN lag 0–6  ×104/L 8.7 ± 2.8 
O3 lag 0–2 µg/m³ 36.4 ± 21.1 
NO2 lag 0–6 µg/m³ 40.7 ± 15.9 
SO2 lag 0–6 µg/m³ 9.1 ± 4.4 
CO lag 0–6 µg/m³ 0.3 ± 0.1 
NH3 lag 0–1 µg/m³ 0.2 ± 2.6 
Humidity lag 0–1  g/kg 6.5 ± 2.5 
Temperature  lag 0–1 °C 10.3 ± 7.6 
North-South wind  lag 0–1  m/s 1.3 ± 1.9 
East-West wind  lag 0–1  m/s 0.8 ± 2.2 
N = 4,584.    
Correlation of exposures at baseline (Table 11) 
The different metrics of PM (PM2.5, PM10, PM1, and PN) showed moderate to high correlations 
(Pearson’s ρ 0.625 to 0.990). PMcoarse was highly correlated with PM10 (ρ = 0.811) and weakly to 
moderately correlated with smaller particles (ρ 0.328 to 0.519). I observed mostly high correla-
tions between particulate and gaseous pollutants. O3 was inversely correlated with all PM metrics 
(ρ -0.752 to -0.434). NO2, SO2 and NH3 were highly positively correlated with PM10, PM2.5, PM1 
and PN. NO2, SO2 and NH3 were not or only weakly correlated with coarse particles. NO and CO 
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were weakly to moderately correlated with PM2.5 and PM1 and were highly correlated with 
PMcoarse and PN. Gaseous compounds correlated moderately to highly with each other. O3 showed 
an inverse moderate correlation with all other gaseous compounds (ρ -0.628 to -0.374).  
NO2 was highly positively correlated with SO2 (0.740) and moderately correlated with NH3 
(0.623), NO (0.443), and CO (0.405). NO, in turn, correlated highly with CO (0.901) and moder-
ately with other gases. A high correlation was also observed between NH3 and SO2 (0.734). 
Short-term concentrations of PM2.5 did not correlate with any of the exposures but weakly in-
versely correlated with short-term humidity. The 24-hour mean traffic noise was weakly correlat-
ed with PN, NO, and CO (ρ 0.234, 0.266, and 0.231). A moderate correlation of tram noise was 
observed with NO (0.451) and CO (0.582). Tram noise was also weakly correlated with PM10, 
PMcoarse, PN, and SO2 (ρ 0.235, 0.277, and 0.216). Road traffic noise and tram noise were only 
weakly collinear (ρ 0.249). Distance to major road correlated weakly and inversely with most of 
the air pollutants. Moderate correlations of distance to major road with traffic noise Lden and Lnight 
were observed (ρ = -0.382 and -0.415). The area-level unemployment rate correlated moderately 
with CO (ρ 0.421) and weakly with PMcoarse, PN, NO, SO2, and road traffic noise.  
The Shapiro-Wilk test for normality of distribution revealed deviations from normality for all en-
vironmental variables at baseline (p < 0.01). The parametric statistics were employed for the de-
scription of these variables based on the central limit theorem.  
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Table 12. Correlation matrix of exposures and environmental variables in the study population at baseline. 
Variable 
 P
M
2
.5
 
P
M
1
0
 
P
M
co
a
rs
e 
P
M
1
 
P
N
 
O
3
 
N
O
2
 
N
O
 
S
O
2
 
C
O
 
N
H
3
 
P
M
2
.5
 (
 s
h
o
rt
) 
H
u
m
id
it
y
 
L
d
en
 (
tr
a
ff
ic
) 
L
n
ig
h
t 
(t
ra
ff
ic
) 
L
d
en
 (
tr
a
m
) 
R
o
a
d
 
PM10
1  0.819*5 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PMcoarse
1
  0.328
*
 0.811* 1 
PM1
1
  0.990
*
 0.818* 0.337* 1 
PN
1
  0.625
*
 0.703* 0.519* 0.645* 1 
O3
1
  -0.572* -0.618* -0.434* -0.567* -0.752* 1 
NO2
1
  0.670* 0.506* 0.149* 0.685* 0.732* -0.628* 1 
NO
1
  0.415* 0.752* 0.814* 0.428* 0.696* -0.511* 0.443* 1 
SO2
1
  0.761* 0.588* 0.192* 0.799* 0.684* -0.558* 0.740* 0.403* 1 
CO
1
  0.262* 0.596* 0.714* 0.298* 0.599* -0.374* 0.405* 0.901* 0.431* 1 
NH3
1
  0.840* 0.728* 0.341* 0.824* 0.611* -0.529* 0.623* 0.502* 0.734* 0.377* 1 
PM2.5 (short)
2  -0.027 -0.026 -0.016 -0.046* -0.015 -0.060* -0.000 0.001 -0.026 -0.010 -0.054* 1 
Humidity  0.002 -0.018 -0.031
*
 0.026 -0.012 0.051* 0.003 -0.035* 0.004 -0.042* 0.017 -0.316* 1 
Lden (traf.)  0.085
*
 0.185* 0.218* 0.093* 0.234* -0.136* 0.140* 0.266* 0.078* 0.231* 0.094* 0.020 -0.012 1 
Lnight (traf.)  0.120
*
 0.212* 0.226* 0.125* 0.255* -0.163* 0.167* 0.275* 0.087* 0.218* 0.117* 0.021 -0.009 0.994* 1 
Lden (tram)  0.021 0.235
*
 0.366* 0.050* 0.277* -0.085* 0.074* 0.451* 0.216* 0.582* 0.123* -0.019 -0.039* 0.249* 0.208* 1 
Road
3  -0.162* -0.298* -0.325* -0.170* -0.330* 0.228* -0.277* -0.400* -0.104* -0.315* -0.144* -0.003 0.006 -0.382* -0.415* -0.077* 1 
nSES
4
  -0.054
*
 0.089* 0.201* 0.000 0.340* -0.115* 0.166* 0.327* 0.224* 0.421* 0.113* -0.014 -0.006 0.175* 0.155* 0.329* -0.165* 
N = 4,584. Pearson’s rho is presented. 
1Long-term air pollution = individual 365-day mean. ²Lag of 0–6 days, basic effect (365-day mean) subtracted. 3Distance to highly trafficked road 
(upper quartile of diesel vehicle density). 4Unemployment rate in the neighborhood. 5* = p < 0.05. 
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4.1.3. Stratified description of participants 
Stratification by hypertension status  
Table 13. Description of participants by hypertension status. 
Variable (unit)  Statistics 
 Prevalent hypertension  
pdifference
2
 
 No (n = 1,973) Yes (n = 2,611)  
PM2.5 (µg/m³)  Mean ± SD
  16.7 ± 1.6 16.7 ± 1.6   
PM10 (µg/m³)  Mean ± SD  20.7 ± 2.6 20.7 ± 2.6   
PMcoarse (µg/m³)  Mean ± SD  4.0 ± 1.5 4.1 ± 1.6   
PM1 (µg/m³)  Mean ± SD  11.6 ± 1.3 11.6 ± 1.3   
PN (×10
4
/L)  Mean ± SD  8.8 ± 1.9 8.9 ± 1.9   
O3 (µg/m³)  Mean ± SD  35.5 ± 1.6 35.4 ± 1.6   
NO2 (µg/m³)  Mean ± SD  40.0 ± 4.2 40.2 ± 4.1   
NO (µg/m³)  Mean ± SD  12.5 ± 4.4 12.8 ± 4.6  * 
SO2 (µg/m³)  Mean ± SD  8.7 ± 1.1 8.7 ± 1.1  
 
CO (µg/m³)  Mean ± SD  0.3 ± 0.1 0.3 ± 0.1  * 
NH3 (µg/m³)  Mean ± SD  2.6 ± 0.4 2.6 ± 0.4  
 
Lden traffic (dB)  Mean ± SD  53.6 ± 9.4 54.2 ± 9.8  (*) 
Lden tram (dB)  Mean ± SD  11.9 ± 13.4 12.5 ± 13.7   
Road
1
 (km)  Mean ± SD  0.9 ± 0.8 0.9 ± 0.8   
Unemployment (%)  Mean ± SD  12.4 ± 3.4 12.6 ± 3.5  ** 
SBP (mmHg)  Mean ± SD  119.8 ± 12.2 143.3 ± 20.3  *** 
DBP (mmHg)  Mean ± SD  76.1 ± 7.4 85.4 ± 11.3  *** 
PP (mmHg)  Mean ± SD  43.7 ± 8.9 57.8 ± 15.4  *** 
BPLM intake  %  0.0% 62.4%  *** 
Age (years)  Mean ± SD  57.0 ± 7.3 61.6 ± 7.5  *** 
Sex (male)  %  42.6% 54.9%  *** 
CHD    1.3% 10.4%  *** 
T2DM  %  6.2% 19.1%  *** 
BMI (kg/m²)  Mean ± SD  26.5 ± 4.0 29.0 ± 4.7  *** 
Smoking: Current  %     *** 
Former    27.9% 19.7%  
 
Never    30.4% 37.7%  
 
ETS exposure    41.7% 42.6%  
 
No sport  %  39.3% 33.8%  *** 
Education: < 10 yrs  %  40.5% 49.8%  *** 
BPLM intake  %  8.7% 13.2%  *** 
N = 4,584. 
1
Distance to road in upper quartile of diesel vehicle density. 2Student’s T test significance was 
applied with continuous variables, and χ²-test was applied with stratum-specific proportions 
with categorical variables. Test significance: (*) =  p < 0.1; * = p < 0.05; ** =  p < 0.01; 
*** = p < 0.001.
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Hypertensive and non-hypertensive participants did not differ with regard to exposure concen-
trations (although Student’s T-test revealed significant differences in concentrations of NO 
and CO between these groups, the absolute differences were quite small). I observed incre-
mentally higher values of road traffic noise and neighborhood unemployment rate in partici-
pants with hypertension (Table 13).  
Hypertensive participants differed from the non-hypertensive ones substantially with regard to 
personal characteristics. Subjects without hypertension had lower BP values, were younger 
and had lower BMIs (T-test p < 0.001 for these characteristics). The hypertensive participants 
were more frequent alcohol drinkers (not shown) and had lower physical activity and educa-
tional levels; there were more men, former smokers, diabetics and subjects with CHD among 
the hypertensive. 
The medicated subjects differed from the non-medicated in the same way as did the hyperten-
sive subjects from the non-hypertensive; in addition, they resided on average closer to major 
roads (T-test p < 0.05; Appendix Table 45). 
 Stratification by city (Table 14) 
I observed differences in exposure and environmental covariates by the city of residence. The 
highest levels of particulate matter and gaseous pollutants were found in Mülheim, whereas 
the lowest concentrations were observed in Bochum (T-test p < 0.001). In contrast, the noise 
levels were higher in Essen, especially the tram noise (T-test p < 0.01). On average, partici-
pants in Mülheim lived nearer to major roads than participants in Essen and Bochum, and the 
neighborhood-level unemployment rate was lower in Mülheim (for both, T-test p < 0.001). 
The mean values of BP and age were lower in Essen, than in Bochum (p < 0.05). Subpopula-
tions in the three cities differed slightly by sex distribution, smoking, alcohol consumption, 
and physical activity, but these differences were not statistically significant. The proportion of 
participants with lower education levels was significantly smaller in Essen, than in Bochum (p 
< 0.05). 
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Table 14. Description of study participants at baseline by city. 
Variable (unit) Statistics 
City pdifference
2 
B
o
/ 
E
s3
 
E
s/
M
h
 
B
o
/M
h
 
Bochum  
(N = 1,331) 
Essen  
(N = 1,572) 
Mülheim  
(N = 1,681) 
PM2.5 (µg/m³) Mean ± SD
 15.3 ± 0.9 16.4 ± 1.2 18.0 ± 1.3 *** *** *** 
PM10 (µg/m³) Mean ± SD 18.2 ± 1.3 21.1 ± 2.3 22.3 ± 2.0 *** *** *** 
PMcoarse (µg/m³) Mean ± SD 2.9 ± 0.7 4.7 ± 2.0 4.4 ± 1.1 *** *** *** 
PM1 (µg/m³) Mean ± SD 10.5 ± 0.9 11.5 ± 1.1 12.6 ± 1.1 *** *** *** 
PN (×10
4
/L) Mean ± SD 7.9 ± 1.7 9.1 ± 2.0 9.3 ± 1.7 *** *** *** 
O3 (µg/m³) Mean ± SD 36.5 ± 1.3 35.4 ± 1.3 34.6 ± 1.4 *** *** *** 
NO2 (µg/m³) Mean ± SD 39.0 ± 4.6 39.4 ± 3.9 41.8 ± 3.5 ** *** *** 
NO (µg/m³) Mean ± SD 9.8 ± 2.3 14.9 ± 5.6 12.9 ± 3.1 *** *** *** 
SO2 (µg/m³) Mean ± SD 8.1 ± 0.7 8.8 ± 1.3 9.1 ± 1.0 *** *** *** 
CO (µg/m³) Mean ± SD 0.3 ± 0.0 0.4 ± 0.1 0.3 ± 0.0 *** *** *** 
NH3 (µg/m³) Mean ± SD 2.3 ± 0.2 2.6 ± 0.3 2.8 ± 0.3 *** *** *** 
Lden traffic (dB) Mean ± SD 52.8 ± 10.5 55.1 ± 9.6 53.7 ± 8.7 *** *** ** 
Lden tram (dB) Mean ± SD 6.7 ± 9.8 24.6 ± 14.9 5.0 ± 0.0 *** *** *** 
Road
1
 (km) Mean ± SD 1.1 ± 1.0 0.9 ± 0.8 0.8 ± 0.5 *** *** *** 
Unemployment (%) % 13.4 ± 3.0 13.7 ± 3.9 10.7 ± 2.5 * *** *** 
SBP (mmHg) Mean ± SD 132.1 ± 20.6 133.8 ± 21.1 133.4 ± 20.8 * 
 
(*) 
DBP (mmHg) Mean ± SD 80.7 ± 10.4 81.7 ± 11.0 81.7 ± 11.0 * 
 
* 
PP (mmHg) Mean ± SD 51.3 ± 14.8 52.1 ± 15.0 51.7 ± 14.4    
Hypertension % 56.5% 58.5% 55.9%    
BPLM intake % 37.0% 35.8% 34.1%  
 
 
Age (years) Mean ± SD 59.2 ± 7.7 59.9 ± 7.8 59.7 ± 7.9 * 
 
(*) 
Sex (male) % 51.2% 47.6% 50.3%    
CHD % 5.9% 7.7% 5.7%    
T2DM % 14.0% 14.6% 12.4%    
BMI (kg/m²) Mean ± SD 28.0 ± 4.6 27.9 ± 4.6 27.9 ± 4.6    
Smoking: Current % 23.2% 22.5% 18.4%    
Former % 35.7% 36.5% 28.3%    
Never % 41.1% 41.0% 32.5%    
ETS exposure % 37.2% 36.5% 35.1%    
No sport % 46.3% 47.0% 44.3%    
Education: < 10 yrs % 11.3% 11.4% 8.9% *   
N = 4,584. 
1
Distance to road in upper quartile of diesel vehicle density. 2Student’s T test significance 
was applied with continuous variables, and χ²-test was applied with stratum-specific propor-
tions with categorical variables. Test significance: (*) =  p < 0.1; * = p < 0.05; ** =  p < 
0.01; *** = p < 0.001.
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4.1.4. Cross-sectional association of air pollution with BP and hypertension  
Particulate matter (Table 15) 
Yearly mean concentrations of PM2.5 and PM1 were positively associated with SBP and DBP 
and showed a positive relationship with PP, independent of lifestyle, personal characteristics, 
ambient noise, distance to major road, short-term PM, and time trend (Table 15). The IQR 
increase in the yearly mean PM2.5 (2.4 µg/m³) was associated with higher SBP by 1.1 mmHg 
(95% confidence interval (CI): 0.2, 2.0), higher DBP by 0.7 mmHg (95% CI: 0.2, 1.2), and 
higher PP by 0.4 mmHg (95% CI: -0.2, 1.0). Estimates with PM1 (presented per IQR) were 
almost identical. The PM10 exposure was positively associated with DBP and showed a weak-
er positive relationship with SBP. No clear associations were identified with PMcoarse and PN 
concentrations, although effect estimates were mostly positive. No association between expo-
sure to PM and prevalent hypertension was observed. The yearly mean concentrations of dif-
ferent PM metrics, but not of PN, were linked to lower odds ratios (ORs) for BPLM intake 
(Table 15). 
Gaseous pollutants (Table 15) 
The yearly mean concentration of NH3 was positively associated with BP: per IQR (0.5 
µg/m³), the estimated increase in SBP was 1.3 mmHg (95% CI: 0.4, 2.2), the increase in DBP 
was 0.7 mmHg (95% CI: 0.2, 1.2), and the increase in PP was 0.6 mmHg (95% CI: 0.0, 1.2). 
NH3 exposure was related to elevated OR for hypertension and lower OR for BPLM intake. 
Long-term NO concentration was positively associated with DBP (0.6 mmHg (95% CI: 0.1, 
1.0) per 5.5 µg/m³) and related to elevated SBP and OR for hypertension. The findings with 
other gaseous pollutants were weaker. Exposure to O3 was inversely related to BP and was 
positively related to BPLM intake. The yearly mean concentration of NO2 was weakly posi-
tively related to SBP and PP; NO2, NO and CO concentrations were weakly positively related 
to the OR for hypertension.  
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Table 15. The associations of ambient air pollution concentrations (individual 365-day means) with BP and hypertension. 
Exposure 
 
IQR 
 Change in BP, mmHg (95% CI)  Hypertension  BPLM intake 
 
 SBP
 
 DBP
1 
 PP  
Odds ratio 
(95% CI) 
 
Odds ratio 
(95% CI) 
PM2.5  (µg/m³)  2.4  1.1 (0.2, 2.0)  0.7 (0.2, 1.2)  0.4 (-0.2, 1.0)  1.00 (0.90, 1.11)  0.96 (0.86, 1.07) 
PM10  (µg/m³)  4.0  0.9 (0.0, 1.8)  0.7 (0.2, 1.2)  0.2 (-0.4, 0.9)  1.00 (0.90, 1.11)  0.95 (0.85, 1.06) 
PMcoarse  (µg/m³)  1.7  0.3 (-0.4, 1.0)  0.3 (-0.1, 0.7)  0.0 (-0.5, 0.4)  1.00 (0.92, 1.08)  0.96 (0.89, 1.04) 
PM1  (µg/m³)  1.9  1.1 (0.2, 2.1)  0.7 (0.2, 1.2)  0.5 (-0.2, 1.1)  1.01 (0.90, 1.12)  0.96 (0.86, 1.08) 
PN  (×10
4
/L)  2.7  0.5 (-0.4, 1.3)  0.3 (-0.2, 0.8)  0.2 (-0.5, 0.8)  1.00 (0.90, 1.11)  1.00 (0.90, 1.11) 
O3  (µg/m³)  2.2  -0.7 (-1.5, 0.1)  -0.3 (-0.8, 0.1)  -0.3 (-0.9, 0.2)  1.00 (0.91, 1.10)  1.04 (0.94, 1.14) 
NO2  (µg/m³)  5.7  0.7 (-0.1, 1.5)  0.3 (-0.1, 0.7)  0.4 (-0.2, 0.9)  1.06 (0.96, 1.16)  1.02 (0.93, 1.13) 
NO  (µg/m³)  5.5  0.4 (-0.4, 1.2)  0.6 (0.1, 1.0)  -0.1 (-0.7, 0.4)  1.06 (0.96, 1.17)  1.01 (0.92, 1.12) 
SO2  (µg/m³)  1.5  0.4 (-0.4, 1.2)  0.2 (-0.3, 0.6)  0.3 (-0.3, 0.8)  1.01 (0.92, 1.11)  1.01 (0.91, 1.11) 
CO  (µg/m³)  0.1  0.3 (-0.4, 1.0)  0.4 (0.0, 0.8)  -0.1 (-0.6, 0.4)  1.05 (0.96, 1.14)  0.99 (0.91, 1.08) 
NH3 (µg/m³)  0.5  1.3 (0.4, 2.2)  0.7 (0.2, 1.2)  0.6 (0.0, 1.2)  1.02 (0.91, 1.13)  0.95 (0.85, 1.06) 
N = 4,584. The results are presented per given IQRs of exposure concentrations. 
Adjusted for: time trend, short-term exposure, Lnight traffic (linear, in 5-dB categories), Lden tram (linear, in 5-dB categories), distance to major road 
(upper quartile of diesel vehicle density), age, sex, BMI (linear and squared terms, centered on mean), WHR, blood lipids (lipid ratio, HDL, triglyc-
erides), smoking status, ETS, physical activity (in categories), education (in categories), and economic activity (in categories).  
1In the analysis with DBP, age and blood triglycerides were entered as linear and squared terms, centered on the mean. 
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4.1.5. Sensitivity analyses 
Results with self-reported binary outcomes (Table 16) 
Yearly mean concentrations of PM1 to PM10 were related to lower ORs for self-reported hyper-
tension. The strongest association was observed with PM10: OR 0.86 (95% CI: 0.77, 0.95) per 
IQR of 4 µg/m³. Similarly to results with self-reported hypertension, higher long-term concentra-
tions of PM were related to lower ORs of self-reported BPLM intake, but the confidence intervals 
were generally wider. No statistically significant associations of gaseous pollutants with hyper-
tension or BPLM intake were observed. Concentration of O3 was related to an elevated OR for 
hypertension, and concentrations of NO, SO2, CO, NH3 were related to decreased ORs for self-
reported hypertension. Exposure to CO and NH3 were inversely related to ORs for BPLM intake.  
Table 16. The cross-sectional associations with self-reported hypertension and BPLM intake. 
Exposure (unit)  IQR  
Self-reported hypertension
1 
Odds ratio (95% CI) 
 
Self-reported BPLM intake
2 
Odds ratio (95% CI) 
PM2.5  (µg/m³)  2.4  0.90 (0.81, 1.00)  0.94 (0.84, 1.05) 
PM10  (µg/m³)  4.0  0.86 (0.77, 0.95)  0.91 (0.81, 1.01) 
PMcoarse  (µg/m³)  1.7  0.89 (0.83, 0.97)  0.93 (0.86, 1.01) 
PM1  (µg/m³)  1.9  0.90 (0.81, 1.00)  0.94 (0.84, 1.06) 
PN  (×10
4
/L)  2.7  0.96 (0.87, 1.07)  1.00 (0.90, 1.11) 
O3  (µg/m³)  2.2  1.06 (0.97, 1.17)  1.02 (0.92, 1.13) 
NO2  (µg/m³)  5.7  0.99 (0.90, 1.08)  1.02 (0.92, 1.12) 
NO  (µg/m³)  5.5  0.93 (0.85, 1.03)  0.98 (0.89, 1.09) 
SO2  (µg/m³)  1.5  0.95 (0.86, 1.04)  1.02 (0.92, 1.13) 
CO  (µg/m³)  0.1  0.93 (0.86, 1.01)  0.97 (0.89, 1.06) 
NH3 (µg/m³)  0.5  0.92 (0.83, 1.02)  0.95 (0.85, 1.06) 
The results are presented per given IQRs of exposure concentrations. 
Adjusted for: time trend, short-term exposure, Lnight traffic, Lden tram, distance to major road, age, 
sex, BMI, WHR, blood lipids, smoking status, ETS, physical activity, education, and economic 
activity. 
 1
Analysis subset: N = 4,574.
2
Analysis subset: N = 4,583. 
Models from crude to main (Figure 7) 
I calculated results with a range of reduced models: the covariates from the main model were 
added in steps to observe the changes in the estimate with exposure after adjustment (models 0 to 
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MAIN, Figure 7 with PM2.5 and PM10).  
 
Figure 7. Estimated associations of PM2.5 and PM10 with SBP and DBP, using different adjust-
ment models.  
Legend: N = 4,584 (if not indicated otherwise). The results are presented per given IQRs of expo-
sure concentrations. Reduced models: M0 = crude model (only exposure); M1 = added time 
trend; M2: added age, sex; M3: added BMI, WHR, blood lipids, smoking, ETS, physical activity, 
educational level, economic activity; M4: added Lnight traffic, Lden tram; MAIN = M4 with short-
term exposure; sensitivity models (MAIN with additional covariates): SM6 = MAIN with short-
term humidity, wind speed; SM7 = MAIN with alcohol, pack-years of smoking (N = 4,368); SM8 
= MAIN with CHD, T2DM; SM9 = MAIN with city, geographic area; SM10 = MAIN, influential 
observations (high residual, high leverage excluded, N = 4,581); MAIN* = MAIN model, grid-
specific mean for 2000-2003 (representing the spatial contrast only) as the exposure.  
The crude association of the yearly mean PM2.5 with BP concentration was positive and statisti-
cally significant in the presence of the time trend (models M1 to MAIN); without the time trend, 
a null effect was observed (model M0). PM10 showed a crude positive association with BP, which 
became stronger after addition of time trend to the model.  Adjustment for personal risk factors 
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resulted in decreased estimates (models M2, M3). Further adjustment for road traffic noise and 
short-term air pollution did not affect the estimates substantially (models M4 and MAIN). Ad-
justment for the variables in the main model had similar effects on the estimates with gaseous 
compounds (not shown). In addition to what was observed with PM, the precision of estimates 
further decreased, and they diminished towards null after adjustment for short-term pollutant 
concentration. Only the results with NH3 were robust across different model specifications. 
Extended adjustment sets 
Adjustment for short-term meteorology (model SM6), additional personal risk factors (alcohol 
consumption and pack-years of smoking), estimated with a reduced analysis sample due to miss-
ing values (model SM7), and co-diseases, namely, CHD and T2DM (model SM8), did not affect 
the estimates (Figure 7 with PM2.5 and PM10). Adjustment for city and geographic location (SM9) 
led to an increase in the estimate and a wider confidence interval. Exclusion of the observations 
with high residuals or leverages (SM10) did not affect the estimates substantially. 
Spatial versus spatiotemporal variations in exposure 
When grid-specific means over the entire baseline period (2000–2003) were used instead of indi-
vidual 365-day means, without adjustment for time trend, the estimated relationship with BP was 
slightly weaker than in the main model with 365-day mean. The confidence intervals were wider 
with SBP. With DBP, the association with grid-specific mean was statistically significant. 
Adjusting for neighborhood SES 
I calculated the mixed-effects models, which included a neighborhood-level SES parameter and 
random intercept for the neighborhood, in addition to the long-term air pollution exposure and 
covariates from the main model. The results for the main exposure remained unchanged after 
adjustment for various neighborhood SES variables (Figure 8). 
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Figure 8. The associations of long-term exposure to PM2.5 and PM10 with SBP and DBP, adjusted 
for neighborhood-level SES.  
Legend: N = 4,584. The results are presented per given IQRs of exposure concentrations. Adjust-
ed for time trend, short-term exposure, Lnight traffic, Lden tram, distance to major road, age, sex, 
BMI, WHR, blood lipids, smoking status, ETS, physical activity, education, and economic activity.  
4.1.6. Independence of PM effects from gaseous compounds 
Multi-pollutant models 
I computed multi-pollutant models, adding each of the gaseous compounds to the main model 
with PM2.5 or PM10 and SBP (Figure 9). In comparison to the main adjusted model (adjustment 
set MAS1), adjustment for O3, NO2, and SO2 resulted in slightly lower estimates. Adjustment for 
NO and CO had no effect on the estimates for PM2.5 and PM10 but slightly increased confidence 
intervals. I observed null association of PM with BP after adjustment for NH3. 
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Figure 9. Multipollutant models: association of the 365-day mean PM2.5 and PM10 concentra-
tions with SBP, adjusted for the 365-day mean concentration of gaseous pollutants.  
Legend: N = 4,584. The results are presented per given IQRs of exposure concentrations. Adjust-
ed for time trend, short-term exposure, Lnight traffic, Lden tram, distance to major road, age, sex, 
BMI, WHR, blood lipids, smoking status, ETS, physical activity, education, and economic activity. 
Interaction of PM with gaseous compounds 
I dichotomized each of the gaseous compounds at the 75th percentile and computed product terms 
with PM2.5 and PM10 to estimate the association of PM with BP at different concentration levels 
of the gaseous component (Figure 10). For all interactions tested, the estimates at the gas levels 
below the cut point were quite similar to the main model. At high levels of O3 and NO2, the effect 
estimate for PM was also similar to the main model, although less precise. Close to null or in-
verse association was observed at high levels of NO and CO; this interaction was statistically 
significant (p < 0.05). The results with interaction by NH3 were inconsistent for PM2.5 and PM10.  
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Figure 10. Effect modification of the associations of the 365-day mean PM2.5 and PM10 concen-
trations with SBP by 365-day mean concentrations of gaseous pollutants.  
Legend: N = 4,584. The results are presented per given IQRs of exposure concentrations. Adjust-
ed for time trend, short-term exposure, Lnight traffic, Lden tram, distance to major road, age, sex, 
BMI, WHR, blood lipids, smoking status, ETS, physical activity, education, economic activity; 
high = concentration ≥ 75th percentile; low = concentration < 75th percentile. * = pinteraction < 
0.05; (*) = pinteraction < 0.1. Adjusted for time trend, short-term exposure, Lnight traffic, Lden tram, 
distance to major road, age, sex, BMI, WHR, blood lipids, smoking status, ETS, physical activity, 
education, and economic activity. 
4.1.7. Independence of the gaseous compounds from PM  
Multi-pollutant models 
Adjustment for PM10 or PM2.5 led to changes of the effect estimate towards zero and also to loss 
of precision for all gases but NH3 (Figure 11). With NH3, the estimates remained unchanged, but 
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the confidence intervals increased. 
 
Figure 11. The multipollutant models: association of 365-day mean exposure to gaseous pollu-
tants with SBP, adjusted for the 365-day mean concentrations of PM2.5 and PM10.  
Legend: N = 4,584. The results are presented per given IQRs of exposure concentrations. Adjust-
ed for time trend, short-term exposure, Lnight traffic, Lden tram, distance to major road, age, sex, 
BMI, WHR, blood lipids, smoking status, ETS, physical activity, education, and economic activi-
ty. 
Interaction of gaseous pollutants with dichotomized PM  
At lower concentrations of PM2.5 or PM10, the estimates for O3, nitrogen oxides, SO2, CO and 
NH3 were similar to the main model, although the precision of these results was often lower than 
in the main model (Figure 12). At high levels of PM, I observed mostly null associations of the 
gaseous compounds with BP. The results with NH3 were similar to the main model at high levels 
of PM10 but diminished towards null at high levels of PM2.5.  
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Figure 12. Effect modification of the association of 365-day mean concentrations of gaseous pol-
lutants with SBP by 365-day mean concentrations of PM2.5 and PM10.  
Legend: N = 4,584. The results are presented per given IQRs of exposure concentrations. Adjust-
ed for time trend, short-term exposure, Lnight traffic, Lden tram, distance to major road, age, sex, 
BMI, WHR, blood lipids, smoking status, ETS, physical activity, education, economic activity; 
high = concentration ≥ 75th percentile; low = concentration < 75th percentile. * = pinteraction < 
0.05; (*) = pinteraction < 0.1.  
4.1.8. Linearity of exposure-outcome association 
I divided long-term grid-specific mean exposure concentrations (mean of 2000–2003) into quar-
tiles to check the linearity of the exposure-outcome relationship. A monotonic relationship was 
observed for PM with DBP; with SBP, the relationship was similarly linear, though the estimate 
for quartile 3 was slightly lower than for quartile 2 (Figure 13). Similarly to PM, monotonic in-
verse relationships with both systolic and DBP were observed with O3 (Figure 14). For the rest of 
gaseous pollutants, I found a gradual increase in estimates for quartiles 2–4 compared to quartile 
1. The estimate for quartile 3 was in some cases lower than the estimate for quartile 2, as was 
already observed with PM. The results for quartile 4 were either significantly different from 0 (p 
< 0.05) or close to significance (p < 0.1) for all pollutants. 
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Figure 13. The associations of grid-specific mean concentrations of PM (2000–2003), divided in 
quartiles, with SBP and DBP.  
Legend: N = 4,584. Adjusted for Lnight traffic, Lden tram, distance to major road, age, sex, BMI, 
WHR, blood lipids, smoking status, ETS, physical activity, education, and economic activity. 
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Figure 14. The associations of grid-specific mean concentrations of gaseous pollutants (2000–
2003), divided in quartiles, with SBP and DBP.  
Legend: N = 4,584. Adjusted for Lnight traffic, Lden tram, distance to major road, age, sex, BMI, 
WHR, blood lipids, smoking status, ETS, physical activity, education, and economic activity. 
I tested the linearity of exposure effects using penalized splines with 4 knots (Figure 15). The two 
models – a linear regression with exposure as a continuous covariate and a generalized additive 
model with a penalized spline – were compared using ANOVA. The exposure-outcome relation-
ships did not significantly deviate from linearity.  
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Figure 15. The associations of long-term grid-specific mean air pollution concentrations (2000–
2003), entered as penalized splines, with SBP.  
Legend: N = 4,584. Adjusted for Lnight traffic, Lden tram, distance to major road, age, sex, BMI, 
WHR, blood lipids, smoking status, ETS, physical activity, education, and economic activity. 
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4.1.9. Association of other environmental exposures with BP and hypertension 
Road traffic noise 
I analyzed road traffic noise both as a continuous variable (with the original modeled noise value and merged into 5-dB categories) and as a 
categorical variable (Table 17). I controlled for air pollution and distance to major road in the model.  
Table 17. The cross-sectional associations of 24-hour mean road traffic noise with BP, hypertension, and BPLM intake.  
Exposure  N  SBP (mmHg)  DBP (mmHg)  PP (mmHg)  Hypertension (OR)  BPLM (OR) 
Lden (original value, continuous)         
(per 5 dB)  4,538  0.26 (-0.06, 0.58)  0.07 (-0.10, 0.25)  0.19 (-0.03, 0.41)  1.02 (0.99, 1.06)  1.01 (0.97, 1.05) 
Lden (in 5-dB categories, as continuous)         
(per 5 dB)  4,584  0.31 (0.01, 0.61)  0.10 (-0.07, 0.26)  0.22 (0.01, 0.43)  1.03 (0.99, 1.06)  1.01 (0.98, 1.05) 
Lden (in 5-dB categories, as categorical)         
 < 40 dB  177  3.29 (0.07, 6.50)  1.28 (-0.46, 3.02)  2.05 (-0.18, 4.28)  1.17 (0.80, 1.73)  0.98 (0.67, 1.45) 
 ≥ 40 and < 45 dB  580  Reference  Reference  Reference  Reference  Reference 
 ≥ 45 and < 50 dB  1,028  2.04 (0.11, 3.98)  -0.24 (-1.29, 0.81)  2.32 (0.98, 3.66)  1.05 (0.83, 1.32)  1.02 (0.80, 1.29) 
 ≥ 50 and < 55 dB  901  2.93 (0.89, 4.96)  -0.14 (-1.24, 0.97)  3.06 (1.65, 4.48)  1.00 (0.78, 1.27)  0.95 (0.74, 1.21) 
 ≥ 55 and < 60 dB  599  2.13 (-0.11, 4.37)  -0.33 (-1.54, 0.89)  2.46 (0.91, 4.02)  1.12 (0.86, 1.47)  1.10 (0.84, 1.45) 
 ≥ 60 and < 65 dB  510  2.62 (0.31, 4.93)  0.38 (-0.87, 1.63)  2.29 (0.69, 3.89)  1.00 (0.76, 1.32)  0.99 (0.75, 1.31) 
 ≥ 65 and < 70 dB  492  3.48 (1.14, 5.82)  0.42 (-0.85, 1.69)  3.08 (1.46, 4.70)  1.26 (0.96, 1.67)  1.07 (0.80, 1.42) 
 ≥ 70 dB  251  1.62 (-1.36, 3.66)  0.79 (-0.83, 1.89)  0.87 (-1.20, 2.28)  1.20 (0.84, 1.53)  1.15 (0.80, 1.47) 
Adjusted for time trend, 365-day mean PM2.5, short-term mean PM2.5, Lden tram, distance to major road, age, sex, BMI, WHR, blood lipids, 
smoking status, ETS, physical activity, education, and economic activity.  
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Table 18. The cross-sectional associations of night-time mean road traffic noise with BP, hypertension, and BPLM intake.  
Exposure  N  SBP (mmHg)  DBP (mmHg)  PP (mmHg)  Hypertension (OR)  BPLM (OR) 
Lnight (continuous)         
(per 5 dB)  4,538  0.29 (-0.04, 0.62)  0.08 (-0.10, 0.26)  0.22 (-0.01, 0.45)  1.03 (0.99, 1.07)  1.01 (0.97, 1.05) 
Lnight (in 5-dB categories, as continuous)         
(per 5 dB)  4,584  0.23 (-0.04, 0.50)  0.11 (-0.03, 0.26)  0.12 (-0.07, 0.30)  1.02 (0.99, 1.06)  1.01 (0.98, 1.05) 
Lnight (in 5-dB categories, as categorical)         
< 30 dB  121  4.10 (0.39, 7.81)  3.26 (1.25, 5.28)  0.82 (-1.76, 3.39)  1.21 (0.77, 1.89)  0.93 (0.59, 1.45) 
≥ 30 and < 35 dB  449  -1.51 (-3.66, 0.63)  0.51 (-0.65, 1.67)  -2.05 (-3.54, -0.57)  1.18 (0.92, 1.52)  1.25 (0.97, 1.62) 
≥ 35 and < 40 dB  939  Reference  Reference  Reference  Reference  Reference 
≥ 40 and < 45 dB  953  1.62 (-0.08, 3.33)  0.35 (-0.58, 1.27)  1.26 (0.08, 2.45)  1.02 (0.84, 1.25)  1.04 (0.85, 1.28) 
≥ 45 and < 50 dB  693  1.00 (-0.87, 2.88)  0.39 (-0.62, 1.41)  0.57 (-0.73, 1.87)  1.00 (0.80, 1.25)  0.89 (0.71, 1.12) 
≥ 50 and < 55 dB  551  0.75 (-1.26, 2.75)  0.51 (-0.58, 1.59)  0.26 (-1.13, 1.65)  1.04 (0.82, 1.31)  1.12 (0.88, 1.43) 
≥ 55 and < 60 dB  541  2.02 (0.00, 4.04)  0.71 (-0.38, 1.81)  1.28 (-0.13, 2.68)  1.29 (1.01, 1.64)  1.18 (0.93, 1.51) 
≥ 60 dB  291  1.24 (-1.33, 2.94)  1.25 (-0.15, 2.17)  0.01 (-1.77, 1.19)  1.16 (0.86, 1.42)  1.04 (0.76, 1.28) 
Adjusted for time trend, 365-day mean PM2.5, short-term mean PM2.5, Lden tram, distance to major road, age, sex, BMI, WHR, blood lipids, 
smoking status, ETS, physical activity, education, and economic activity. 
Noise as a continuous variable. Road traffic noise values Lden and Lnight were weakly positively related to SBP and PP (Tables 17, 18). When 
continuous noise values were merged into 5-dB categories, the linear association was significant with SBP and PP. For example, a 5 dB in-
crease in Lden was associated with an increase in SBP by 0.31 mmHg (95% CI: 0.01, 0.61). Results with Lnight and BP were similar. I also 
detected weak positive relationships of Lden and Lnight with hypertension. 
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Noise as a categorical variable. I used category 40-45 dB as a reference with Lden and category 
30-35 dB as a reference with Lnight (both in 5-dB categories). The following Lden traffic categories 
were associated with elevated SBP and PP compared to the reference (≥ 40 and < 45 dB): ≥ 50 
and < 55 dB, ≥ 60 and < 65 dB, ≥ 65 and < 70 dB. The lowest noise level, observed in a very 
small category of participants, was associated with elevated BP compared to the reference. The 
ORs for hypertension and BPLM intake were mostly elevated but not for all categories above the 
reference. There were significant positive associations of Lnight ≥ 55 and < 60 dB with hyperten-
sion: OR 1.29 (95% CI: 1.01, 1.64), compared to the reference group (Lnight ≥35 and <40 dB). 
Tram noise 
No associations of tram noise with the study outcomes were detected: the estimates (per 5 dB) 
were 0.02 mmHg (-0.19, 0.22) with SBP, 0.02 mmHg (-0.09, 0.13) with DBP, and -0.01 mmHg  
(-0.15, 0.13) with PP. The OR for hypertension was 1.00 (0.97, 1.02), and the OR for BPLM in-
take was 1.00 (0.97, 1.02). 
Traffic indicators (Table 19) 
I estimated the associations between distance to high general traffic (continuous and in catego-
ries) and BP, hypertension and BPLM intake, independently of co-exposure to background air 
pollution, road traffic noise, and other relevant confounders. Distance to a major road (high den-
sity of all-type vehicles) was weakly inversely associated with BPLM intake: the OR was 0.99 
(95% CI: 0.98, 1.00) per 100 m. When I truncated distance to a major road at 400 m, this effect 
was stronger: the OR was 0.92 (95% CI: 0.87, 0.98) per 100 m. Results with hypertension were 
weaker. No associations with BP were detected. The findings with distance to major road with 
high heavy-duty and diesel vehicles were very similar (not shown). 
When considering distance to high heavy-duty and diesel traffic, I observed elevated BP in partic-
ipants living ≤ 50 m from the road, and in other categories ≤ 500 m, compared to the reference    
> 500 m, but these findings were not statistically significant. The ORs for BPLM intake were 
elevated for all categories compared to the reference (> 500 m); this association was statistically 
significant for the categories ≤ 50 m and > 50 and ≤ 100 m compared to > 500 m. There were 
positive, yet imprecise, relationships of distance > 100 and ≤ 200 m, > 200 and ≤ 300 m with 
ORs for hypertension.  
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Table 19. The cross-sectional associations of distance to road with high all-type traffic with BP, hypertension, and BPLM intake. 
Exposure  N  SBP (mmHg)  DBP (mmHg)  PP (mmHg)  Hypertension (OR)  BPLM (OR) 
Distance to road with high all-type traffic (continuous)       
(per 100 m)  4,584  0.00 (-0.07, 0.08)  0.00 (-0.04, 0.05)  0.00 (-0.05, 0.05)  0.99 (0.98, 1.00)  0.99 (0.98, 1.00) 
Truncated400 m (per 100 m)  4,584  0.05 (-0.48, 0.59)  0.01 (-0.28, 0.30)  0.05 (-0.32, 0.42)  0.97 (0.91, 1.04)  0.92 (0.87, 0.98) 
Distance to road with high all-type traffic (in categories)  
 
 
 
 
 
> 500 m  2,885  Reference  Reference  Reference  Reference  Reference 
≤ 50 m  137  -0.38 (-3.80, 3.04)  0.19 (-1.66, 2.04)  -0.66 (-3.04, 1.71)  1.01 (0.67, 1.50)  1.34 (0.89, 2.00) 
> 50 and ≤ 100 m  187  -0.61 (-3.47, 2.25)  -1.17 (-2.72, 0.38)  0.55 (-1.44, 2.55)  1.13 (0.81, 1.59)  1.60 (1.14, 2.23) 
> 100 and ≤ 200 m  384  0.13 (-1.92, 2.17)  0.24 (-0.86, 1.35)  -0.13 (-1.55, 1.29)  1.08 (0.84, 1.37)  1.08 (0.85, 1.38) 
> 200 and ≤ 300 m  368  -0.14 (-2.21, 1.93)  0.09 (-1.03, 1.20)  -0.16 (-1.60, 1.28)  1.16 (0.91, 1.49)  1.23 (0.96, 1.57) 
> 300 and ≤ 500 m  623  -0.34 (-1.99, 1.31)  -0.69 (-1.58, 0.20)  0.39 (-0.75, 1.54)  1.01 (0.83, 1.23)  1.11 (0.91, 1.35) 
Distance to road with high heavy-duty traffic (in categories)       
> 500 m  2,884  Reference  Reference  Reference  Reference  Reference 
≤ 50 m  118  2.28 (-1.34, 5.90)  1.22 (-0.74, 3.18)  1.01 (-1.51, 3.53)  1.52 (0.98, 2.35)  1.91 (1.26, 2.91) 
> 50 and ≤ 100 m  214  0.48 (-2.20, 3.16)  -0.68 (-2.13, 0.77)  1.10 (-0.77, 2.96)  1.00 (0.73, 1.38)  1.37 (1.00, 1.88) 
> 100 and ≤ 200 m  359  0.37 (-1.75, 2.48)  -0.06 (-1.20, 1.09)  0.41 (-1.06, 1.88)  1.10 (0.85, 1.41)  1.10 (0.85, 1.42) 
> 200 and ≤ 300 m  380  0.32 (-1.72, 2.36)  0.29 (-0.81, 1.39)  0.05 (-1.37, 1.47)  1.12 (0.88, 1.43)  1.12 (0.88, 1.44) 
> 300 and ≤ 500 m  629  0.31 (-1.33, 1.95)  -0.47 (-1.36, 0.41)  0.82 (-0.32, 1.96)  0.98 (0.81, 1.19)  1.13 (0.93, 1.37) 
Distance to road with high diesel traffic (in categories)       
> 500 m  2,920  Reference  Reference  Reference  Reference  Reference 
≤ 50 m  133  0.93 (-2.51, 4.37)  0.72 (-1.14, 2.58)  0.17 (-2.23, 2.56)  1.10 (0.73, 1.66)  1.41 (0.94, 2.11) 
> 50 and ≤ 100 m  184  -0.25 (-3.12, 2.63)  -1.07 (-2.62, 0.49)  0.81 (-1.19, 2.81)  1.17 (0.83, 1.64)  1.56 (1.12, 2.19) 
> 100 and ≤ 200 m  357  0.24 (-1.87, 2.35)  0.50 (-0.64, 1.64)  -0.25 (-1.72, 1.22)  1.05 (0.82, 1.35)  1.00 (0.78, 1.29) 
> 200 and ≤ 300 m  359  0.78 (-1.31, 2.86)  0.59 (-0.53, 1.72)  0.26 (-1.19, 1.71)  1.15 (0.90, 1.47)  1.09 (0.85, 1.41) 
> 300 and ≤ 500 m  631  -0.46 (-2.10, 1.18)  -0.67 (-1.55, 0.22)  0.26 (-0.88, 1.40)  0.96 (0.79, 1.17)  1.02 (0.84, 1.24) 
Adjusted for time trend, 365-day mean PM2.5, short-term mean PM2.5, Lnight traffic, Lden tram, age, sex, BMI, WHR, blood lipids, smoking 
status, ETS, physical activity, education, and economic activity. 
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Neighborhood-level SES (Table 20) 
I investigated the association of neighborhood-level SES with BP, adjusting for exposure to background air pollution, road traffic noise, distance to 
major road, and relevant confounders. Higher residential density and unemployment rate were associated with lower BP. In addition, unemployment 
rate in the neighborhood was weakly related to elevated OR for BPLM intake. A higher proportion of elderly residents was weakly linked to lower 
PP (Table 20).  
Table 20. The cross-sectional associations of neighborhood-level SES indicators with BP in the study population. 
Area-level factor (increment) 
 BP change, mmHg (95% CI) Hypertension 
OR (95% CI) 
 Medication 
OR (95% CI)  SBP  DBP  PP   
Unemployment rate (per 10%)  -1.6 (-3.3, 0.1)  -0.9 (-1.9,0 .1)  -0.7 (-1.9, 0.5)  1.09 (0.88, 1.33)  1.20 (0.97, 1.48) 
Social welfare rate (per 10%)  -1.7 (-3.8, 0.5)  -0.9 (-2.1, 0.4)  -0.7 (-2.2, 0.8)  1.18 (0.91, 1.53)  1.14 (0.87, 1.49) 
Percentage of elderly residents 
 (per 10%) 
 
-0.7 (-2.4, 1.0)  0.4 (-0.6, 1.3)  -1.2 (-2.3, 0.0)  0.92 (0.75, 1.12)  0.92 (0.74, 1.13) 
Population density  
 (per 1,000 residents/km²) 
 
-0.3 (-0.6, 0.0)  0.0 (-0.2, 0.2)  -0.3 (-0.5, -0.1)  1.01 (0.97, 1.04)  1.00 (0.97, 1.04) 
Residential turnover (per 10%)  -0.1 (-0.2, 0.1)  0.0 (-0.1, 0.1)  -0.1 (-0.1, 0.0)  1.00 (0.99, 1.02)  1.01 (0.99, 1.02) 
N = 4,584. Adjusted for time trend, 365-day mean PM2.5, short-term mean PM2.5, Lnight traffic, Lden tram, distance to major road, age, sex, BMI, 
WHR, blood lipids, smoking status, ETS, physical activity, education, and economic activity. 
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4.1.10. Analysis of effect modification 
The following factors modified the association of certain pollutants with BP: sex, CHD, 
T2DM, active inflammation, alcohol consumption, educational level, the city of residence, 
season, and distance to major road (Figures 16 and 17). In particular, a stronger positive asso-
ciation of PM2.5 with BP was observed in summer (pinteraction < 0.05). No effects of PM2.5 on BP 
were detected for participants living < 100 m from the major road (pinteraction < 0.05), partici-
pants with T2DM (pinteraction < 0.1), and those consuming > 6 drinks per week (pinteraction < 0.1). 
No associations of PM10 with SBP were found for participants living < 100 m from the major 
road (pinteraction < 0.1) and among participants with low education status. Positive associations 
of PN with SBP were detected in women (pinteraction < 0.1), participants with T2DM (pinteraction < 
0.05), participants in Mülheim (pinteraction < 0.1) and among participants living ≥ 100 m from a 
major road (pinteraction < 0.05). In addition, a positive association of PN with DBP was found in 
participants with higher or middle educational status (pinteraction < 0.1). 
The associations of O3 with BP were stronger in women (pinteraction < 0.05) and moderate or no 
alcohol drinkers (pinteraction < 0.05). No associations of NO2 with BP were detected in partici-
pants with T2DM (pinteraction < 0.05), heavy drinkers (pinteraction < 0.05), those with acute in-
flammation (defined as CRP > 3 mg/L, pinteraction < 0.05), and participants residing in Essen 
(pinteraction < 0.05). There were more precise positive associations of SO2 with BP in no or mod-
erate drinkers (p < 0.05) and in participants living in Bochum. Weak inverse relationships of 
CO with BP were observed in participants with T2DM and in those residing in Mülheim (pin-
teraction < 0.05 and < 0.1, respectively). The associations of NH3 with BP were more positive in 
participants with CHD, among those living in Essen and Bochum, and during summer (pinterac-
tion < 0.05, < 0.1, and < 0.05, respectively).  
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Figure 16. Effect modification analysis: the associations of PM2.5, PM10 and PN with SBP 
(mmHg change with 95% CI)  in subgroups, using product terms exposure×effect modifier.  
Legend: N = 4,584. The results are presented per given IQRs of exposure concentrations. Ad-
justed for time trend, short-term mean PM2.5, Lnight traffic, Lden tram, distance to major road, 
age, sex, BMI, WHR, blood lipids, smoking status, ETS, physical activity, education, and eco-
nomic activity. * = pinteraction < 0.05; (*) = pinteraction < 0.1. 
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Figure 17. Effect modification analysis: the associations of gaseous pollutants with SBP 
(mmHg change with 95% CI) in subgroups, using product terms exposure×effect modifi-
er.  
Legend: N = 4,584. The results are presented per given IQRs of exposure concentrations. 
Adjusted for time trend, short-term mean PM2.5, Lnight traffic, Lden tram, distance to major 
road, age, sex, BMI, WHR, blood lipids, smoking status, ETS, physical activity, education, 
and economic activity. * = pinteraction < 0.05; (*) = pinteraction < 0.1.  
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4.1.11. Correction for medication effect (Table 21) 
I employed the following methods to correct for the intake of BPLM among study partici-
pants: (i) adjusted for BPLM in a multivariable regression model; (ii) added a fixed constant 
(5, 10, 15 mmHg) to the BP values of participants taking BPLM; (iii) calculated a right-
censored regression model (censoring on BPLM intake); and (iv) estimated results in medi-
cated and non-medicated participants separately, using an interaction term, and tested for the 
significance of interaction. 
Table 21. The cross-sectional associations of PM2.5, PN, NO2, NH3 with SBP, estimated using 
strategies to correct for BPLM intake. 
Correction method 
Exposure 
PM2.5 (2.4 µg/m³) PN (2.7×10
4
/L) NO2 (5.7 µg/m³) NH3 (0.5 µg/m³) 
No correction 1.1 (0.2, 2.0) 0.4 (-0.4, 1.3) 0.7 (-0.1, 1.5) 1.3 (0.4, 2.2) 
+ BPLM (covari-
ate) 
1.1 (0.2, 2.1) 0.4 (-0.4, 1.3) 0.7 (-0.1, 1.5) 1.3 (0.4, 2.2) 
Fixed addition (only in medicated)    
+ 5 mmHg 1.1 (0.2, 2.0) 0.4 (-0.5, 1.3) 0.7 (-0.1, 1.5) 1.3 (0.4, 2.2) 
+ 10 mmHg 1.0 (0.1, 2.0) 0.4 (-0.5, 1.3) 0.7 (-0.1, 1.6) 1.2 (0.3, 2.2) 
+ 15 mmHg 1.0 (0.0, 2.0) 0.4 (-0.5, 1.4) 0.8 (-0.1, 1.6) 1.2 (0.2, 2.1) 
Censored regression 0.9 (-0.3, 2.0) 0.6 (-0.5, 1.7) 1.0 ( 0.0, 2.0) 0.9 (-0.2, 2.0) 
Estimate in subgroups by BPLM intake    
No BPLM intake 0.9 (-0.2, 2.0) 0.5 (-0.5, 1.6) 0.9 ( 0.0, 1.9) 1.1 (0.1, 2.2) 
BPLM intake 1.6 (0.2, 3.0) 0.3 (-1.1, 1.6) 0.2 (-1.1, 1.5) 1.7 (0.3, 3.1) 
pinteraction  0.373 0.737 0.358 0.507 
N = 4,584. Results are presented as mmHg change in SBP with 95% CI. Adjusted for time 
trend, short-term mean air pollution concentration, Lnight traffic, Lden tram, distance to major 
road, age, sex, BMI, WHR, blood lipids, smoking status, ETS, physical activity, education, and 
economic activity. 
The results with different pollutants and SBP are presented in Table 21. The estimates did not 
change after adding BPLM as a covariate or fixed addition. The estimates with censored re-
gression, compared to no correction, were lower and less precise with PM2.5 and NH3, higher 
with PN, and higher and more precise with NO2.With SO2 and CO, censored regression pro-
duced a higher and more precise effect estimate (not shown). I did not observe any statistical-
ly significant effect modifications with BPLM intake. The effect was stronger in medicated 
participants than in non-medicated participants (with up to 2-fold higher effect estimates) with 
PM2.5, PM10 (not shown), O3 (not shown), SO2 (not shown) and NH3 (Table 21). In contrast, 
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the association of NO2 in non-medicated participants was stronger than in medicated partici-
pants.  
4.2. Cross-sectional and longitudinal analysis with BP and hypertension at follow-up 
4.2.1. Description of the study population at follow-up (Table 22) 
Table 22. Description of the study population at follow-up. 
Variable (unit) statistics Description N missing 
Prevalent binary outcomes   
Hypertension, n (%) 2,157 (66.6%) – 
BPLM intake, n (%) 1,595 (49.2%) – 
Self-reported hypertension1, n (%) 1,434 (45.4%) 80 
Self-reported BPLM intake1, n (%) 1,391 (43.3%) 25 
Incident binary outcomes2  
Hypertension, n (%) 520 (36.2%) 1,802 
BPLM intake, n (%) 556 (26.1%) 1,108 
Self-reported hypertension, n (%) 382 (21.3%) 1,449 
Self-reported BPLM intake, n (%) 515 (23.3%) 1,028 
Personal characteristics  
Age (years), Mean ± SD 64.6 ± 7.6 – 
Sex (male), n (%) 1,630 (50.3%) – 
CHD, n (%) 263 (8.1%) – 
T2DM, n (%) 614 (19.0%) – 
BMI (kg/m²), Mean ± SD 28.3 ± 4.8 – 
LDL:HDL ratio, Mean ± SD 2.3 ± 0.8 – 
Smoking, n (%)  – 
 Current 552 (17.0%) – 
 Former 1,301 (40.2%) – 
 Never 1,387 (42.8%) – 
ETS exposure, n (%) 799 (24.7%) – 
Alcohol (drinks/week), Mean ± SD 7.1 ± 11.2 – 
No sport, n (%) 1,379 (42.6%) – 
Education, n (%)  – 
 < 10 years 289 (8.9%) – 
 11–17 years 1,817 (56.1%) – 
 ≥ 18 years 1,134 (35.0%) – 
N = 3,240. 
1Self-reported hypertension and self-reported BPLM intake were included to the sensitivity 
analyses only and therefore had missing values. 2For incident outcomes, the prevalent cases 
were set to missing and were excluded from the analysis. 
There were 520 incident cases of hypertension (36.2%) and 556 new cases of BPLM intake 
(26.1%). These values are higher than the estimated 5-year incidence of 20% for men and 
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women aged 65 years (Chobanian et al. 2003). The incidence of self-reported hypertension 
was 21.3%, and the incidence of self-reported BPLM intake was 23.3%. Mean follow-up time 
was 5.1 years (SD 0.4 years). On average, the age at follow-up examination was 5 years high-
er (mean 64.6 years, SD 7.6 years). The gender distribution remained equal to those at the 
baseline. The proportion of subjects with CHD was 8.1%, slightly higher than at baseline. The 
proportion of diabetics increased almost by half (19.1%). The mean BMI increased slightly to 
28.3 kg/m² (SD 4.8 kg/m²). The LDL : HDL ratio decreased at the follow-up (mean 2.3, SD 
0.8). The percentage of current smokers dropped to 17%, whereas the proportion of ex-
smokers increased correspondingly. The mean alcohol consumption decreased to 7.1 drinks 
per week (SD 11.2 drinks per week). The proportion of participants not practicing sport de-
creased to (42.6%). The ratio of subgroups by education level remained very similar to base-
line. 
Table 23. Difference between hypertension and BPLM intake, included as main outcomes ac-
cording to the study definition, and self-reported hypertension and BPLM intake.  
Prevalent outcomes 
Hypertension 
(JNC7 definition) 
Self-reported 
hypertension = No 
Self-reported 
hypertension = Yes 
Self-reported 
hypertension = Missing 
No 971 (89.7%) 72 (6.6%) 40 (3.7%) 
Yes  755 (35.0%) 1,362 (63.1%) 40 (1.9%) 
BPLM intake 
(ATC codes) 
Self-reported BPLM 
intake = No 
Self-reported 
BPLM intake = Yes 
Self-reported BPLM 
intake = Missing 
No 1,555 (94.5%) 86 (5.2%) 4 (0.2%) 
Yes  269 (16.9%) 1,305 (81.8%) 21 (1.3%) 
Incident outcomes 
Hypertension 
(JNC7 definition) 
Self-reported 
hypertension = No 
Self-reported 
hypertension = Yes 
Self-reported 
hypertension = Missing 
No 791 (86.2%) 26 (2.8%) 101 (11.0%) 
Yes  266 (51.2%) 138 (26.5%) 116 (22.3%%) 
BPLM intake 
(ATC codes) 
Self-reported BPLM 
intake = No 
Self-reported 
BPLM intake = Yes 
Self-reported BPLM 
intake = Missing 
No 1,505 (95.5%) 48 (3.0%) 23 (1.5%) 
Yes  114 (20.5%) 386 (69.4%) 56 (10.1%) 
Agreement of prevalent hypertension by study definition and self-report was 73.8%, Cohen’s 
kappa was 0.49, corresponding to fair to good agreement. Agreement of incident hypertension 
by the two definitions was 76.1%, Cohen’s kappa was 0.36 (poor agreement). Agreement of 
prevalent BPLM intake with study definition and self-report was 89.0%, Cohen’s kappa was 
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0.78. Agreement of incident BPLM intake with these definitions was 92.1%, Cohen’s kappa 
was 0.78 (excellent agreement). 
4.2.2. Progression of BP at follow-up 
In the follow-up analysis sample, SBP increased by 0.3 mmHg (SD 3.8 mmHg), DBP de-
creased by 0.4 mmHg (SD 2.1 mmHg), and PP increased by 0.8 mmHg (SD 2.6 mmHg) (Ta-
ble 23). The decrease in DBP could be due to the stiffening of the arteries that progresses with 
age (Chobanian et al. 2003). In the subgroup of participants taking BPLM (N = 1,595), SBP 
decreased by 0.3 mmHg (SD 4.4 mmHg), DBP decreased by 0.8 (SD 2.3 mmHg), and PP 
increased by 0.5 mmHg (SD 2.9 mmHg). Approximately half of the study subjects used 
BPLM. Among non-medicated participants (N = 1,645), SBP increased by 1.0 mmHg (SD 3.0 
mmHg) and DBP did not change (0.0 mmHg, SD 1.8 mmHg). On average, men had higher 
arterial BP at both baseline and follow-up compared to women. The increase in SBP in wom-
en was higher than that in men, and the decrease in DBP was lower in women. 
I stratified the study participants by hypertension status at baseline and follow-up according to 
the JNC7 definition (Chobanian et al. 2003). Approximately half of the analysis sample par-
ticipants were hypertensive at baseline and follow-up (1,637). The SBP and PP values were 
the highest in this group (Table 24). In the group with incident hypertension at follow-up (N = 
520), the increase from baseline to follow-up was the highest. The lowest values of BP were 
observed in the group with normal BP values at baseline and follow-up (N = 918). The small-
est group (N = 165) included subjects who had hypertension at baseline and no hypertension 
at follow-up. Their BP values at baseline were almost as high as in the group with prevalent 
hypertension and at follow-up and were similar to BP values in the normotensive group. 
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Table 24. Progression of BP from baseline to follow-up in the entire analysis sample and in subgroups. 
Group  SBP, mmHg  DBP, mmHg  PP, mmHg 
   BL FU FU-BL
5 
 BL FU FU-BL  BL FU FU-BL 
All (N = 3,240)  132.9 ± 20.2 134.6 ± 19.8 0.3 ± 3.8  81.5 ± 10.6 79.2 ± 10.5 -0.4 ± 2.1  51.4 ± 14.2 55.4 ± 14.7 0.8 ± 2.6 
By BPLM intake             
Yes (N = 1,645)  138.7 ± 20.6 137.2 ± 20.4 -0.3 ± 4.4  83.5 ± 11.0 79.2 ± 11.0 -0.8 ± 2.3  55.2 ± 14.9 58.0 ± 15.5 0.5 ± 2.9 
No (N = 1,595)  126.8 ± 17.8 131.9 ± 18.6 1.0 ± 3.0  79.4 ± 9.7 79.3 ± 9.9 0.0 ± 1.8  47.4 ± 12.3 52.7 ± 13.2 1.0 ± 2.2 
By sex             
Men (N = 1,630)  137.4 ± 19.0 138.2 ± 19.1 0.2 ± 3.8  83.8 ± 10.3 80.9 ± 10.6 -0.6 ± 2.1  53.6 ± 13.8 57.3 ± 14.7 0.7 ± 2.6 
Women (N = 1,610)  128.4 ± 20.4 131.0 ± 19.8 0.5 ± 3.9  79.2 ± 10.5 77.6 ± 10.1 -0.3 ± 2.1  49.3 ± 14.3 53.4 ± 14.5 0.8 ± 2.6 
By hypertension             
BL–, FU–1 (N = 918)  117.2 ± 12.0 120.7 ± 11.2 0.7 ± 2.3  75.0 ± 7.3 74.7 ± 7.3 -0.1 ± 1.4  42.2 ± 8.5 46.1 ± 8.4 0.8 ± 1.7 
BL+, FU+2 (N = 1,637)  143.1 ± 20.3 141.7 ± 20.6 -0.3 ± 4.3  85.5 ± 11.2 81.2 ± 11.4 -0.8 ± 2.3  57.7 ± 15.1 60.5 ± 15.8 0.5 ± 2.9 
BL–, FU+3(N = 520)  126.0 ± 9.8 139.3 ± 17.4 2.6 ± 3.3  78.9 ± 6.4 82.0 ± 10.1 0.6 ± 1.9  47.1 ± 8.6 57.3 ± 12.9 2.0 ± 2.3 
BL+, FU–4 (N = 165)  141.5 ± 15.0 127.3 ± 9.9 -2.8 ± 2.8  86.8 ± 10.4 76.3 ± 7.7 -2.0 ± 2.0  54.7 ± 13.0 51.0 ± 9.5 -0.7 ± 2.3 
N = 3,240. BL = baseline; FU = follow-up. 
 
1
No hypertension at baseline and follow-up measurement. 
2
Hypertension both at baseline and follow-up measurements.
 3
No hypertension at base-
line, incident hypertension at follow-up measurement. 
4
Hypertension at baseline, no hypertension at follow-up measurement.
 5
Progression of BP, 
calculated as BP (follow-up measurement) minus BP (baseline measurement) per year of follow-up. 
I stratified participants in 5-year age groups (age at baseline) and calculated the mean SBP and DBP at baseline and follow-up (Figure 18). In the 
entire group, SBP increased from baseline to follow-up in all age groups except for participants aged 65–69 years. Among participants not taking 
BPLM at follow-up, SBP increased in all age groups. In the non-medicated participants aged 65–69 years, this increase was smaller. Among partici-
pants taking BPLM at follow-up, mean SBP decreased in all age groups except for those aged 50–54 years.  
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Figure 18. Changes in BP from baseline to follow-up in groups by age at baseline.  
Legend: N = 3,200 (. Mean BP values per 5-year age group at baseline and follow-up meas-
urements are presented. 
The strongest decrease in BP was observed in the age groups 65–69 and 45–49 years. In 
women (regardless of medication status), SBP increased; in men, SBP increased in all age 
groups but two: 65–69 and 70–75 years. DBP decreased in all age groups in the entire cohort. 
Among participants not taking BPLM, DBP decreased in participants aged 55–59, 60–64, and 
70–75 years and increased in the other age groups. In medicated participants, I observed a 
steep decrease in DBP in all age groups. In women, DBP increased in the 50-54-year age 
group and decreased in the other age groups. In men, DBP decreased in all age groups. 
4.2.3. Description of air pollution exposure at follow-up  
The individual 365-day mean values were quite close to the grid-specific mean during 2006–
2008 (Table 25). During the 365 days before the follow-up examination, the mean concentra-
tions were as follows: PM2.5, 15.6 µg/m³; PM10, 18.1 µg/m³; O3, 37.6 µg/m³; NO2, 38.6 
µg/m³; SO2, 7.4 µg/m³; CO 0.3, µg/m³; and NH3, 2.8 µg/m³. The measured mean values of 
PM10 in 2006 (available from the background stations in Ruhr area) were as follows: BUCH 
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(Duisburg) 26 µg/m³ and STYR (Mülheim) 27 µg/m³ (LANUV 2006a). The measured mean 
concentrations of gaseous pollutants for year 2006 in the Ruhr area were as follows: 31 µg/m³ 
for NO2, 13 µg/m³ for NO, and 40 µg/m³ for O3 (LANUV 2006b). The modeled EURAD val-
ues were higher for NO2 and O3 and lower for NO. 
Table 25. Long-term concentrations of particulate air pollution in the study population at fol-
low-up. 
Exposure (unit) 
 365-day mean  Mean of 2006-2008 
 Mean ± SD Min – Max IQR  Mean ± SD Min – Max IQR 
PM2.5 (µg/m³)  15.6 ± 1.4 12.7 – 19.8 2.1  15.5 ± 1.3 13.3 – 19.1 2.0 
PM10 (µg/m³)  18.1 ± 1.8 14.7 – 23.5 2.7  19.5 ± 2.7 15.8 – 28.2 3.8 
PMcoarse (µg/m³)  2.4 ± 0.5 1.7 – 4.3 0.7  4.0 ± 2.0 1.9 – 12.4 2.0 
PM1  (µg/m³)  11.0 ± 1.1 8.6 – 14.5 1.6  10.9 ± 1.0 9.0 – 13.8 1.6 
PN  (×10
4
/L)  7.7 ± 1.7 4.5 – 15.8 2.4  7.7 ± 1.7 4.6 – 15.9 2.4 
O3 (µg/m³)  37.6 ± 2.0 31.9 – 43.5 2.7  37.0 ± 1.5 32.5 – 40.1 2.1 
NO2 (µg/m³)  38.6 ± 4.7 28.6 – 52.6 7.1  38.4 ± 4.2 26.5 – 48.7 5.4 
NO (µg/m³)  7.7 ± 2.2 3.4 – 18.0 3.2  11.5 ± 5.6 4.5 – 36.5 5.7 
SO2 (µg/m³)  7.4 ± 1.1 5.3 – 14.7 1.6  7.4 ± 1.0 5.6 – 15.5 1.5 
CO (µg/m³)  0.3 ± 0.0 0.2 – 0.4 0.0  0.3 ± 0.0 0.2 – 0.4 0.0 
NH3 (µg/m³)  2.8 ± 0.3 2.0 – 3.9 0.5  2.9 ± 0.3 2.3 – 3.8 0.5 
N = 3,240          
Correlations of exposure concentrations at follow-up 
The correlations of particulate matter of different sizes were higher at follow-up than at base-
line (Table 26). For example, the correlation of PM2.5 with PMcoarse was 0.881 (Pearson’s ρ), 
with PM10 0.993, with PM1 0.994, and with PN 0.733. The correlations between gaseous pol-
lutants were also higher than at baseline. O3 was highly inversely correlated to PM metrics 
and to other gaseous compounds. The correlations of fine particles with long-term gaseous 
pollutants were also moderate to high, except for carbon monoxide with PM1. The short-term 
concentration of PM2.5 did not correlate with long-term exposures.  
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Table 26. Correlation matrix of exposures and environmental variables in the study population at follow-up. 
Variable 
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1 0.993*6 1   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PMcoarse
1
 0.881* 0.932* 1 
PM1
1
 0.994* 0.978* 0.842* 1 
PN
1
 0.733* 0.707* 0.564* 0.770* 1 
O3
1
 -0.787* -0.786* -0.711* -0.770* -0.645* 1 
NO2
1
 0.901* 0.882* 0.744* 0.912* 0.858* -0.770* 1 
NO
1
 0.839* 0.804* 0.626* 0.853* 0.842* -0.755* 0.965* 1 
SO2
1
 0.771* 0.719* 0.498* 0.799* 0.793* -0.644* 0.828* 0.821* 1 
CO
1
 0.567* 0.496* 0.237* 0.613* 0.777* -0.485* 0.752* 0.787* 0.918* 1 
NH3
1
 0.913* 0.884* 0.717* 0.916* 0.712* -0.760* 0.883* 0.852* 0.884* 0.740* 1 
PM2.5 (sh.)
2 
-0.005 -0.008 -0.018 0.002 -0.017 0.008 -0.011 -0.016 -0.021 -0.010 -0.011 1 
Humidity -0.037* -0.049* -0.083* -0.022 0.017 0.150* 0.030 0.041* 0.035* 0.087* -0.035* -0.200* 1 
Lden (traf.) 0.103
*
 0.088* 0.035* 0.114* 0.218* -0.073* 0.165* 0.169* 0.140* 0.193* 0.126* -0.002 0.004 1 
Lnight (traf.) 0.136
*
 0.125* 0.080* 0.145* 0.241* -0.099* 0.199* 0.198* 0.145* 0.193* 0.152* -0.004 0.002 0.994* 1 
Lden (tram) 0.054
*
 0.005 -0.146* 0.085* 0.251* -0.026 0.102* 0.112* 0.378* 0.435* 0.192* -0.008 0.025 0.246* 0.209* 1 
Road
3 
-0.166* -0.154* -0.104* -0.174* -0.305* 0.147* -0.278* -0.275* -0.166* -0.250* -0.185* 0.033 -0.011 -0.382* -0.414* -0.083* 
BL365×FU365
4 0.759* 0.733* 0.309* 0.755* 0.978* 0.634* 0.697* 0.479* 0.662* 0.627* 0.400* – – – – – 
BLgrid×FUgrid
5 0.998* 0.917* 0.845* 0.998* 0.990* 0.964* 0.917* 0.759* 0.966* 0.785* 0.991* – – – – – 
N = 3,240. 1Long-term air pollution = individual 365-day mean. 2PM2.5 short-term (lag 0–6), basic effect (365-day mean) subtracted.
3Distance to 
major road (upper quartile of diesel vehicle density). 4Correlation between individual 365-day mean concentrations at baseline and follow-up. 
5Correlation of long-term grid cell means at baseline and follow-up. 6* = p < 0.05. 
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I observed collinearity in the long-term air pollutant concentrations at follow-up with baseline 
concentrations of the respective pollutants (Table 26). With 365-day mean concentrations, all 
pollutants except PMcoarse and NH3 showed moderate to high (ρ > 0.6) correlation of follow-up 
and baseline concentration. With long-term grid cell means, the correlation of follow-up con-
centration with baseline concentration was high (ρ > 0.7) to very high (ρ > 0.9) for all pollu-
tants. Neither tram nor road traffic noise correlated with PM or PN. I detected weak positive 
correlations between road traffic and tram noise and PN. Distance to major road correlated 
weakly and inversely with air pollutants. Similarly to baseline, tram and traffic noise were 
weakly correlated with each other (ρ 0.246), and road traffic noise correlated moderately and 
inversely with distance to a major road (ρ -0.382). 
Changes in exposure during the follow-up period 
Table 27. Changes in exposure during follow-up, calculated as differences in the long-term 
grid-specific mean concentrations at follow-up (2006–2008) and at baseline (2000–2003) per 
year of follow-up.  
Exposure (unit) 
 
Description 
 Correlation with long-term 
exposure
1 
 
Mean ± SD Min – Max 
 
×
B
L
3
6
5
2
 
×
F
U
3
6
5
 
×
B
L
g
ri
d
 
×
F
U
g
ri
d
 
PM2.5 (µg/m³ per year)  -0.31 ± 0.04 -0.68 – 0.03  -0.85 -0.76 -0.85 -0.82 
PM10 (µg/m³ per year)  -0.30 ± 0.21 -1.11 – 0.86  -0.07 -0.25 -0.06 0.35 
PMcoarse  (µg/m³ per year)  0.00 ± 0.04 -0.10 – 0.25  0.15 -0.22 0.20 0.68 
PM1 (µg/m³ per year)  -0.21 ± 0.03 -0.54 – 0.08  -0.83 -0.74 -0.83 -0.80 
PN  (×104/L per year)  -0.22 ± 0.07 -0.88 – 0.24  -0.72 -0.63 -0.75 -0.65 
O3 (µg/m³ per year)  0.45 ± 0.08 -0.17 – 0.85  0.18 0.28 0.11 0.36 
NO2 (µg/m³ per year)  -0.56 ± 0.33 -1.81 – 1.18  -0.14 0.15 -0.14 0.26 
NO (µg/m³ per year)  -0.31 ± 0.71 -1.70 – 3.10  -0.02 0.01 -0.02 0.64 
SO2 (µg/m³ per year)  -0.33 ± 0.06 -0.76 – 0.00  -0.50 -0.14 -0.45 -0.21 
CO (µg/m³ per year)  -0.01 ± 0.01 -0.05 – 0.00  -0.90 -0.41 -0.90 -0.45 
NH3 (µg/m³ per year)  0.03 ± 0.01 -0.04 – 0.08  0.46 0.58 0.56 0.67 
N = 3,240.  
1p < 0.05 for all correlation coefficients. 2BL = baseline measurement; FU = follow-up meas-
urement; 365 = 365-day mean exposure concentration; grid = long-term grid-specific mean 
exposure concentration (mean of 2000–2003 at baseline and of 2006–2008 at follow-up). 
I calculated the changes in long-term exposure using grid-specific means of the whole base-
line (2000–2003) and follow-up (2006–2008) periods. The average concentrations decreased 
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for all pollutants except for PMcoarse (no change), O3 and NH3 (both increased). The average 
decreases in PM2.5, PM10, NO and SO2 were 0.3 µg/m³ per year (Table 27). The decrease in 
NO2 was 0.6 µg/m³ per year. The concentration of O3 increased by 0.45 µg/m³ per year, and 
the concentration of NH3 increased by 0.03 µg/m³ per year on average. 
I calculated the correlations of change during follow-up with the follow-up and baseline ex-
posure values (Table 27). The changes in PM2.5 were highly inversely correlated with baseline 
and follow-up concentrations (Pearson’s ρ -0.85 to -0.76). In contrast, the changes in PM10 
correlated weakly with follow-up concentrations as follows: inversely with the 365-day mean 
(ρ -0.25) and positively with the long-term grid cell mean (0.35); no correlation was detected 
with the baseline value. The findings with PMcoarse were similar to PM10, except the correla-
tion with the follow-up grid cell mean was higher (ρ 0.68). The correlations of change in PM1 
and PN with their long-term concentrations were similar to PM2.5. The changes in O3 during 
the follow-up period correlated weakly and positively with the baseline and follow-up values. 
NO2 and NO were positively correlated with their follow-up grid-specific mean concentration 
(ρ 0.26 and 0.64, respectively) but not with other long-term concentrations. The changes in 
SO2 and CO were negatively correlated with baseline and follow-up concentrations. The 
change in NH3 was moderately positively correlated with baseline and follow-up concentra-
tions.  
4.2.4. Cross-sectional associations of air pollution at follow-up with the study outcomes 
Air pollution at follow-up and BP (Table 28) 
The observed cross-sectional associations  of air pollution with BP at follow-up were stronger 
and more consistent across pollutants compared to the cross-sectional analysis with baseline 
data (Table 28). The 365-day mean concentrations of PM1 to PM10 at follow-up were positive-
ly associated with SBP and DBP in the cross-sectional analysis; the same pollutants were also 
positively related to PP. When compared per IQR, the estimates were quite similar for differ-
ent PM metrics. For example, per increase in PM2.5 by 2.1 µg/m³, I detected increases in SBP 
of 1.2 mmHg (95% CI: 0.2 to 2.2), in DBP of 0.7 mmHg (95% CI: 0.2 to 1.2), and in PP of 
0.4 mmHg (95% CI: -0.3 to 1.2). The results with PN and BP were inconclusive. Analysis 
with 365-day NH3 as a main exposure yielded results quite similar to those observed with 
PM: positive associations with SBP and DBP and a positive relationship with PP. Follow-up 
concentrations of NO2, NO, SO2, and CO were positively associated with DBP and more 
weakly positively related to SBP.  
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Table 28. The cross-sectional associations of 365-day mean air pollution at follow-up with BP 
at follow-up among participants with no change in address from baseline to follow-up. 
Exposure (IQR) 
 Blood pressure change, mmHg (95% CI) 
 SBP  DBP  PP 
PM2.5 (2.1 µg/m³)  1.2 (0.2, 2.2)  0.7 (0.2, 1.2)  0.4 (-0.3, 1.2) 
PM10 (2.8 µg/m³)  1.2 (0.1, 2.2)  0.7 (0.2, 1.3)  0.4 (-0.3, 1.2) 
PMcoarse (0.7 µg/m³)  1.1 (0.0, 2.1)  0.7 (0.1, 1.3)  0.3 (-0.4, 1.1) 
PM1 (1.6 µg/m³)  1.1 (0.1, 2.0)  0.7 (0.1, 1.2)  0.4 (-0.3, 1.1) 
PN (2.4×104/L)  0.2 (-0.8, 1.2)  0.5 (-0.1, 1.0)  -0.3 (-1.0, 0.5) 
O3 (2.7 µg/m³)  -0.9 (-2.0, 0.1)  -0.8 (-1.4, -0.3)  -0.1 (-0.9, 0.6) 
NO2 (7.1 µg/m³)  1.0 (0.0, 2.1)  0.9 (0.3, 1.4)  0.1 (-0.6, 0.9) 
NO (3.2 µg/m³)  0.9 (-0.1, 2.0)  0.9 (0.3, 1.5)  0.1 (-0.7, 0.8) 
SO2  (1.6 µg/m³)  0.8 (-0.3, 1.8)  0.7 (0.1, 1.2)  0.1 (-0.6, 0.9) 
CO  (0.04 µg/m³)  0.5 (-0.6, 1.5)  0.6 (0.0, 1.2)  -0.1 (-0.9, 0.7) 
NH3  (0.5 µg/m³)  1.4 (0.4, 2.5)  0.8 (0.3, 1.4)  0.6 (-0.2, 1.3) 
N = 3,240. The results are presented per given IQRs of exposure concentrations. Adjusted for 
time trend, short-term exposure, traffic and tram noise, distance to major road, age, sex, BMI, 
WHR, blood lipids, smoking, ETS, physical activity, and educational level. 
Air pollution at follow-up and prevalent hypertension and BPLM intake (Table 29) 
The concentrations of PM10 and PMcoarse were related to lower ORs for prevalent hyperten-
sion, whereas the concentrations of PN, NO2, and CO exhibited positive relationships; how-
ever, neither of the estimates was statistically significant. PM2.5, PM10 and PMcoarse were asso-
ciated with lower ORs for BPLM intake. Weaker inverse relationships with OR for BPLM 
intake were observed for PM1, PN, NO2, NO, and NH3. I also observed inverse associations of 
PM1 to PM10 with self-reported hypertension and BPLM intake. 
Air pollution at follow-up and incident hypertension and BPLM intake (Table 30) 
I detected no significant associations with incidence of hypertension. Exposures to 365-day 
mean concentrations of PM2.5, PM10, PM1, PN, NO2, NO, SO2, and CO at follow-up were 
related to higher relative risk (RR) for incident hypertension, though these estimates were 
imprecise. Relative risk (RR) for BPLM intake was decreased at higher levels of PM, NO2 
and NH3. RRs for incident self-reported hypertension were inversely related to different PM 
metrics and were positively related to O3, NO2, NO and CO concentrations. The results with 
incident self-reported BPLM intake were almost identical to the results with incident BPLM 
intake according to the study definition.   
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Table 29. The cross-sectional associations of 365-day mean air pollution concentrations at follow-up with the prevalent outcomes hypertension and 
BPLM intake. 
Exposure (unit) 
 
IQR 
 Main study outcomes  Self-reported outcomes 
  
Hypertension 
OR (95% CI) 
 
BPLM intake 
OR (95% CI) 
 
Self-reported hyperten-
sion 
OR (95% CI) 
 
Self-reported BPLM 
intake 
OR (95% CI) 
PM2.5 (µg/m³)  2.1  0.98 (0.86, 1.11)  0.89 (0.79, 1.00)  0.88 (0.78, 0.99)  0.85 (0.76, 0.96) 
PM10 (µg/m³)  2.7  0.97 (0.85, 1.10)  0.88 (0.78, 0.99)  0.88 (0.78, 0.99)  0.85 (0.75, 0.96) 
PMcoarse (µg/m³)  0.7  0.94 (0.82, 1.07)  0.85 (0.75, 0.97)  0.88 (0.78, 1.00)  0.85 (0.75, 0.97) 
PM1 (µg/m³)  1.6  0.98 (0.87, 1.11)  0.90 (0.80, 1.01)  0.89 (0.79, 1.00)  0.86 (0.77, 0.97) 
PN (×10
4
/L)  2.4  1.03 (0.91, 1.17)  0.97 (0.86, 1.09)  1.00 (0.89, 1.12)  1.01 (0.90, 1.14) 
O3 (µg/m³)  2.7  1.00 (0.88, 1.14)  1.13 (1.00, 1.27)  1.09 (0.96, 1.23)  1.13 (1.00, 1.28) 
NO2 (µg/m³)  7.1  1.01 (0.89, 1.15)  0.92 (0.82, 1.04)  0.96 (0.85, 1.09)  0.94 (0.83, 1.07) 
NO (µg/m³)  3.2  1.05 (0.92, 1.20)  0.95 (0.84, 1.08)  0.99 (0.88, 1.12)  0.98 (0.86, 1.11) 
SO2 (µg/m³)  1.6  1.02 (0.90, 1.17)  0.98 (0.87, 1.11)  1.00 (0.88, 1.13)  0.99 (0.87, 1.12) 
CO (µg/m³)  0.0  1.04 (0.91, 1.19)  1.01 (0.89, 1.15)  1.03 (0.91, 1.17)  1.05 (0.92, 1.19) 
NH3 (µg/m³)  0.5  1.00 (0.87, 1.14)  0.90 (0.79, 1.02)  0.90 (0.80, 1.02)  0.86 (0.76, 0.97) 
N = 3,240. The results are presented per given IQRs of exposure concentrations. Adjusted for time trend, short-term exposure, traffic and tram noise, 
distance to major road, age, sex, BMI, WHR, blood lipids, smoking, ETS, physical activity, and educational level. 
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Table 30. The cross-sectional associations of 365-day mean air pollution concentrations at follow-up with the incident outcomes hypertension and 
BPLM intake. 
Exposure (unit) 
 
IQR 
 Main study outcomes  Self-reported outcomes 
 
 
Hypertension1 
RR (95% CI) 
 
BPLM intake2 
RR (95% CI) 
 
Hypertension3 
RR (95% CI) 
 
BPLM intake4 
RR (95% CI) 
PM2.5 (µg/m³)  2.1  1.04 (0.91, 1.19)  0.92 (0.81, 1.05)  0.95 (0.81, 1.11)  0.89 (0.77, 1.02) 
PM10 (µg/m³)  2.7  1.03 (0.89, 1.18)  0.91 (0.79, 1.04)  0.94 (0.79, 1.10)  0.88 (0.76, 1.01) 
PMcoarse  (µg/m³)  0.7  0.99 (0.86, 1.14)  0.86 (0.75, 1.00)  0.91 (0.77, 1.08)  0.86 (0.74, 0.99) 
PM1 (µg/m³)  1.6  1.04 (0.91, 1.19)  0.93 (0.82, 1.06)  0.96 (0.82, 1.12)  0.90 (0.78, 1.03) 
PN (×10
4
/L)  2.4  1.07 (0.93, 1.22)  0.99 (0.87, 1.14)  1.08 (0.92, 1.27)  1.04 (0.91, 1.20) 
O3 (µg/m³)  2.7  0.94 (0.82, 1.08)  1.07 (0.93, 1.24)  1.02 (0.87, 1.21)  1.09 (0.94, 1.25) 
NO2 (µg/m³)  7.1  1.07 (0.93, 1.23)  0.96 (0.83, 1.10)  1.03 (0.87, 1.21)  0.97 (0.84, 1.12) 
NO (µg/m³)  3.2  1.11 (0.96, 1.28)  0.99 (0.86, 1.14)  1.06 (0.89, 1.26)  1.02 (0.88, 1.18) 
SO2 (µg/m³)  1.6  1.06 (0.92, 1.21)  1.02 (0.89, 1.17)  1.12 (0.95, 1.32)  1.01 (0.88, 1.17) 
CO (µg/m³)  0.0  1.09 (0.94, 1.26)  1.06 (0.92, 1.22)  1.16 (0.98, 1.38)  1.07 (0.92, 1.23) 
NH3 (µg/m³)  0.5  1.06 (0.92, 1.23)  0.96 (0.84, 1.11)  0.98 (0.83, 1.16)  0.91 (0.79, 1.05) 
The results are presented per given IQRs of exposure concentrations. Adjusted for time trend, short-term exposure, traffic and tram noise, distance to 
major road, age, sex, BMI, WHR, blood lipids, smoking, ETS, physical activity, and educational level. 
1Analysis subset (prevalent cases and missing values excluded): N = 1,438. 2Analysis subset: N = 2,132. 3Analysis subset: N = 1,791. 4Analysis subset: 
N = 2,212. 
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Sensitivity analyses 
I adjusted for baseline BP values in the analyses. This resulted in attenuated effect size and 
precision, which was expected because adjustment for such a major predictor as a baseline BP 
value removes most of the outcome variability. In another sensitivity analysis, I used the as-
similated (corrected with measured value) PM10 concentration. Assimilation was not uniform-
ly performed for the air pollutants at follow-up, which is why this value was not included in 
the main analysis. In contrast to a non-assimilated value, the assimilated PM10 concentration 
was not clearly associated with BP, although the effect estimates were generally positive. For 
example, the change in SBP per increase in PM10 by an IQR of 4.1 µg/m³ was 0.5 mmHg 
(95% CI: -0.5, 1.5). 
 
Figure 19. The cross-sectional associations of 365-day mean PM2.5 concentration with BP 
among participants with no change in address since baseline, stratified by BPLM intake at 
follow-up and by hypertension status at baseline and follow-up. 
Legend: N = 3,320. Results are presented per given IQR and are adjusted for time trend, 
short-term exposure, traffic and tram noise, distance to major road, age, sex, BMI, WHR, 
blood lipids, smoking, ETS, physical activity, and educational level. 
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I performed a stratified analysis by BPLM intake at follow-up (Figure 19 with PM2.5; not 
shown with other pollutants). The results in medicated and non-medicated participants were 
very similar for PM2.5, PM10, PN (DBP only) and NH3. The results in medicated participants 
were closer to null or inverse compared to non-medicated participants for PN (SBP only), O3, 
NOx, SO2, and CO. The estimates in medicated and non-medicated participants differed less 
for DBP than for SBP. 
I also stratified participants by hypertension status at baseline and follow-up (results with 
PM2.5 in Figure 19). Among the four groups considered, the most consistent findings were 
among participants with prevalent hypertension at baseline and follow-up. The estimated as-
sociations in this group were higher than in the main model, with higher statistical signifi-
cance. In the group with incident hypertension, the results were similar to the estimate in the 
entire analysis sample but not statistically significant (most likely due to small number of par-
ticipants in this group). In the groups with no hypertension at baseline and follow-up and with 
hypertension only at baseline, the estimates were closer to a null effect compared to the entire 
analysis sample and were less precise. 
4.2.5. Longitudinal associations of air pollution with study outcomes 
BP as outcome 
I investigated the association of exposure at baseline with the progression of hypertension at 
follow-up. To eliminate temporary contrasts, I investigated this association using the long-
term grid-specific mean exposure (2000–2003 at baseline and 2006–2008 at follow-up). I 
used 2 outcomes, the BP at follow-up measurement (2006–2008) and the change in BP (ΔBP) 
during the follow-up period, calculated as: 
∆𝐵𝑃 =
(𝐵𝑃𝑓𝑜𝑙𝑙𝑜𝑤−𝑢𝑝− 𝐵𝑃𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒)
𝐷𝑢𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑓𝑜𝑙𝑙𝑜𝑤−𝑢𝑝 𝑖𝑛 𝑦𝑒𝑎𝑟𝑠
        [16]  
Concentrations of PM2.5, PM10, PM1, NO, and NH3 at baseline were positively associated with 
BP at follow-up. These results were very similar to those obtained with the cross-sectional 
analysis at follow-up (Table 28). For example, an increase in PM2.5 by 1 µg/m³ was associated 
with an increase in SBP by 0.6 mmHg (95% CI: 0.2, 1.1). The baseline concentration of O3 
was inversely associated with BP; per increase in O3 by 1 µg/m³, SBP decreased by 0.4 
mmHg (95% CI: -0.9, 0.0). When I excluded participants who used BPLM at follow-up (leav-
ing 1,645 participants in the analysis), the associations observed in the remaining group did 
not change. In addition, borderline positive associations with SBP were observed with CO and 
NO2. 
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Table 31. The longitudinal associations of long-term grid-specific mean exposures at baseline 
(2000-2003) with progression of BP during follow up in participants not taking BPLM. 
Exposure (unit) 
 
IQR 
 Progression of BP
1
, mmHg per year (95% CI) 
  ΔSBP  ΔDBP  ΔPP 
PM2.5 (µg/m³)  2.5  0.2 (0.0, 0.4)  0.1 (0.0, 0.2)  0.2 (0.0, 0.4) 
PM10 (µg/m³)  4.0  0.1 (-0.1, 0.4)  0.0 (-0.1, 0.2)  0.1 (-0.1, 0.4) 
PMcoarse  (µg/m³)  2.0  0.2 (-0.1, 0.4)  0.1 ( 0.0, 0.2)  0.2 (-0.1, 0.4) 
PM1 (µg/m³)  1.7  -0.1 (-0.2, 0.1)  -0.1 (-0.2, 0.0)  -0.1 (-0.2, 0.1) 
PN (×10
4
/L)  2.8  0.1 (-0.2, 0.3)  0.0 (-0.2, 0.1)  0.1 (-0.2, 0.3) 
O3 (µg/m³)  2.2  0.1 (-0.1, 0.3)  0.1 ( 0.0, 0.2)  0.1 (-0.1, 0.3) 
NO2 (µg/m³)  5.9  0.1 (-0.1, 0.3)  0.1 ( 0.0, 0.2)  0.1 (-0.1, 0.3) 
NO (µg/m³)  5.4  0.1 (-0.1, 0.3)  0.0 (-0.1, 0.1)  0.1 (-0.1, 0.3) 
SO2 (µg/m³)  1.5  0.1 (-0.1, 0.3)  0.1 ( 0.0, 0.2)  0.1 (-0.1, 0.3) 
CO (µg/m³)  0.1  0.1 (-0.1, 0.3)  0.0 (-0.1, 0.1)  0.1 (-0.1, 0.3) 
NH3 (µg/m³)  0.5  0.1 (-0.1, 0.3)  0.1 (-0.1, 0.2)  0.1 (-0.1, 0.3) 
N = 1,625. The results are presented per given IQRs of exposure concentrations. Adjusted for 
Lnight, Lden, distance to major road, age, sex, BMI, WHR, blood lipids, smoking, ETS, physical 
activity, and educational level. For personal risk factors (BMI, blood lipids, smoking, physical 
activity), changes in follow-up were included as separate variables. 
1
Calculated according to the formula [16]. 
I analyzed the longitudinal associations of the long-term grid-specific mean exposures at 
baseline (2000–2003) with progression of BP at follow-up (Table 31) in participants not tak-
ing BPLM at follow-up (N = 1,645). The concentration of PM2.5 at baseline was imprecisely 
positively related to BP: an increase of the mean baseline PM2.5 concentration by 2.5 µg/m³ 
(the IQR of this sample) was associated with an increase in SBP by 0.2 mmHg per year of 
follow-up (95% CI: 0.0, 0.4). A slightly weaker positive relationship was detected with the 
PMcoarse concentration at baseline. Exposures to NO2 and SO2 at baseline were positively re-
lated to DBP. For the rest of the pollutants, no conclusive associations with changes in BP in 
the follow-up period were detected.  
I also calculated the longitudinal associations of changes in exposure with progression of BP 
during the follow-up period (Table 32). Increases in PM2.5, PM10, PN and NH3 were associat-
ed with decreases in BP. For example, per increase in PM2.5 by 0.27 µg/m³ per year, SBP de-
creased by 0.2 mmHg per year (95% CI: -0.4, 0.0). The results with O3 were similar, but not 
statistically significant. The inverse associations of change in PM with change in BP may be 
because air pollution concentrations decreased over the follow-up period. I also detected a 
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strong negative correlation of the changes in PM2.5, PM1, PN concentration during follow-up 
with the concentrations at either baseline or follow-up. Although such a correlation was not 
observed with NH3, the inverse association of changes in NH3 concentration with changes in 
BP may be due to high correlations of NH3 with PM. An increase in SO2 concentration, which 
did not correlate with baseline or follow-up values substantially, was associated with in-
creased DBP: a change of 0.1 mmHg per year (95% CI: 0.0, 0.2) occurred per 0.10 µg/m³ per 
year.  
Table 32. The longitudinal associations of change in long-term grid-specific mean exposures 
during follow-up with change in BP during follow-up among participants no taking BPLM at 
follow-up. 
Exposure (unit) 
 
IQR 
 Progression of BP
1
, mmHg per year (95% CI) 
  ΔSBP  ΔDBP  ΔPP 
PM2.5 (µg/m³ per year)  0.27  -0.2 (-0.4, 0.0)  -0.2 (-0.3, -0.1)  -0.2 (-0.4, 0.0) 
PM10 (µg/m³ per year)  0.49  -0.2 (-0.4, 0.0)  -0.2 (-0.3, -0.1)  -0.2 (-0.4, 0.0) 
PMcoarse  (µg/m³ per year)  0.04  -0.1 (-0.1, 0.0)  0.0 (-0.1, 0.0)  -0.1 (-0.1, 0.0) 
PM1 (µg/m³ per year)  0.05  -0.1 (-0.3, 0.1)  -0.1 (-0.2, 0.0)  -0.1 (-0.3, 0.1) 
PN (×10
4
/L per year)  0.14  -0.1 (-0.2, 0.0)  0.0 (-0.1, 0.0)  -0.1 (-0.2, 0.0) 
O3 (µg/m³ per year)  0.02  -0.1 (-0.1, 0.0)  0.0 (-0.1, 0.0)  -0.1 (-0.1, 0.0) 
NO2 (µg/m³ per year)  0.04  -0.1 (-0.3, 0.1)  -0.1 (-0.2, 0.1)  -0.1 (-0.3, 0.1) 
NO (µg/m³ per year)  0.08  0.0 (-0.2, 0.2)  0.0 (-0.2, 0.1)  0.0 (-0.2, 0.2) 
SO2 (µg/m³ per year)  0.10  0.1 (-0.1, 0.3)  0.1 (0.0, 0.2)  0.1 (-0.1, 0.3) 
CO (µg/m³ per year)  0.35  -0.1 (-0.2, 0.1)  -0.1 (-0.2, 0.0)  -0.1 (-0.2, 0.1) 
NH3 (µg/m³ per year)  0.43  -0.1 (-0.2, 0.0)  0.0 (-0.1, 0.0)  -0.1 (-0.2, 0.0) 
N = 1,625. The results are presented per given IQRs of exposure concentrations. Adjusted for 
Lnight, Lden, distance to major road, age, sex, BMI, WHR, blood lipids, smoking, ETS, physical 
activity, and educational level. For personal risk factors (BMI, blood lipids, smoking, and 
physical activity), changes in follow-up were included as separate variables.
 
1
Calculated according to the formula [16]. 
Incident hypertension and BPLM intake as outcomes 
Using Poisson regression with robust variance estimation, I analyzed the association of air 
pollution exposure at baseline and incident hypertension or BPLM intake (Table 33). PM2.5, 
PN, NO2, NO and CO concentrations were positively related to RR for incident hypertension. 
Concentrations of SO2 and CO at baseline were associated with increased RR for incident 
BPLM intake; for example, per increase in baseline concentration of SO2 by 1.5 µg/m³, the 
estimated RR of incident BPLM intake was 1.13 (95% CI: 1.01, 1.27). PMcoarse, PN, NO2 and 
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NO had imprecise positive relationships with incident BPLM intake. Findings for self-
reported incidence of hypertension were discordant from those with the main outcome, hyper-
tension, though not statistically significant; RR was below 1 with PM and above 1 with gase-
ous pollutants. Findings with incident self-reported BPLM intake were very similar to those 
with the main study outcome, BPLM intake; NO2, SO2 and CO were positively associated 
with incident BPLM intake (RRs 1.10, 1.13 and 1.13, respectively), and positive, though not 
statistically significant, effect estimates were observed with most exposures.  
Association of change in exposure from baseline to follow-up with incident outcomes is pre-
sented in Table 34. The change in NO from baseline to follow-up was related to a lower risk 
of incident hypertension: RR 0.88 (95% CI 0.82, 0.95) per 0.08 µg/m³ NO per year. Similar, 
though not precise, inverse relationships were detected with PM10, PM1 and NO2. Incident 
intake of BPLM was inversely associated with NO: RR 0.82 (95% CI: 0.75, 0.90) per 0.08 
µg/m³ per year; a similar inverse relationship was detected with PM2.5. Changes in PN, O3, 
SO2 and NH3 concentrations were associated with elevated RR for BPLM intake. For exam-
ple, a yearly increase in O3 by 0.02 µg/m³ per year was associated with RR for BPLM intake 
1.04 (95% CI: 1.01, 1.08) after 5 years of follow-up. The results with self-reported incidence 
of hypertension and BPLM intake were quite similar to the ones with the main outcome, 
BPLM intake.  
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Table 33. The longitudinal associations of long-term air pollution concentrations at baseline (grid-specific means of 2000-2003) with incident bina-
ry outcomes at follow-up.  
Exposure 
 
IQR 
 Main study outcomes  Self-reported outcomes 
 
 
Hypertension1 
RR (95% CI) 
 
BPLM intake2 
RR (95% CI) 
 
Hypertension3 
RR (95% CI) 
 
BPLM intake4 
RR (95% CI) 
PM2.5 (µg/m³)  2.5  1.03 (0.93, 1.14)  1.01 (0.88, 1.16)  0.91 (0.82, 1.02)  1.02 (0.91, 1.15) 
PM10 (µg/m³)  4.0  1.02 (0.91, 1.15)  1.02 (0.88, 1.18)  0.91 (0.80, 1.02)  0.98 (0.86, 1.11) 
PMcoarse (µg/m³)  2.0  1.02 (0.92, 1.14)  1.04 (0.90, 1.19)  0.93 (0.83, 1.04)  1.05 (0.93, 1.17) 
PM1 (µg/m³)  1.7  1.00 (0.92, 1.09)  1.01 (0.92, 1.12)  0.96 (0.88, 1.05)  0.95 (0.87, 1.04) 
PN (×10
4
/L)  2.8  1.10 (0.99, 1.22)  1.12 (0.97, 1.28)  1.01 (0.90, 1.14)  1.07 (0.95, 1.21) 
O3 (µg/m³)  2.2  0.98 (0.89, 1.07)  0.99 (0.87, 1.12)  1.05 (0.95, 1.16)  1.06 (0.96, 1.19) 
NO2 (µg/m³)  5.9  1.06 (0.97, 1.17)  1.10 (0.97, 1.25)  1.00 (0.90, 1.11)  1.11 (0.99, 1.23) 
NO (µg/m³)  5.4  1.08 (0.98, 1.19)  1.12 (0.99, 1.27)  1.02 (0.92, 1.14)  1.09 (0.97, 1.21) 
SO2 (µg/m³)  1.5  1.02 (0.93, 1.11)  1.13 (1.01, 1.27)  1.01 (0.92, 1.11)  1.12 (1.01, 1.23) 
CO (µg/m³)  0.1  1.03 (0.94, 1.12)  1.13 (1.02, 1.25)  1.04 (0.95, 1.13)  1.08 (0.99, 1.19) 
NH3 (µg/m³)  0.5  1.02 (0.92, 1.13)  1.02 (0.89, 1.16)  0.93 (0.83, 1.03)  1.06 (0.95, 1.19) 
The results are presented per given IQRs of exposure concentrations. Adjusted for Lnight, Lden, distance to major road, age, sex, BMI, WHR, blood 
lipids, smoking, ETS, physical activity, and educational level. For personal risk factors (BMI, blood lipids, smoking, and physical activity), change 
in follow-up was included as a separate variable.  
1
Analysis subset (prevalent cases and missing values excluded): N = 1,438. 
2
Analysis subset: N = 2,132. 
3
Analysis subset: N = 1,791. 
4
Analysis sub-
set: N = 2,212. 
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Table 34. The longitudinal associations of changes in exposure from baseline to follow-up with incident binary outcomes at follow-up.  
Exposure (unit) 
 
IQR 
 Main study outcomes  Self-reported outcomes 
  Hypertension1 
RR (95% CI) 
 BPLM intake2 
RR (95% CI) 
 Hypertension3 
RR (95% CI) 
 BPLM intake4 
RR (95% CI) 
PM2.5 (µg/m³ per year)  0.27  0.99 (0.91, 1.08)  0.91 (0.82, 1.02)  1.02 (0.94, 1.11)  0.83 (0.76, 0.91) 
PM10 (µg/m³ per year)  0.49  0.96 (0.88, 1.05)  1.01 (0.91, 1.12)  1.03 (0.95, 1.12)  0.93 (0.85, 1.02) 
PMcoarse (µg/m³ per year)  0.04  0.98 (0.94, 1.02)  1.03 (0.99, 1.07)  1.01 (0.97, 1.05)  1.01 (0.97, 1.05) 
PM1 (µg/m³ per year)  0.05  0.95 (0.87, 1.05)  0.96 (0.84, 1.08)  1.06 (0.95, 1.18)  0.99 (0.90, 1.09) 
PN (×10
4
/L per year)  0.14  1.00 (0.95, 1.04)  1.06 (1.01, 1.12)  1.05 (1.01, 1.09)  1.05 (1.00, 1.10) 
O3 (µg/m³ per year)  0.02  1.00 (0.97, 1.03)  1.04 (1.01, 1.08)  1.03 (1.00, 1.06)  1.03 (1.00, 1.07) 
NO2 (µg/m³ per year)  0.04  0.94 (0.86, 1.04)  0.92 (0.81, 1.05)  1.03 (0.92, 1.15)  0.96 (0.87, 1.06) 
NO (µg/m³ per year)  0.08  0.88 (0.82, 0.95)  0.82 (0.75, 0.90)  0.87 (0.80, 0.94)  0.84 (0.77, 0.91) 
SO2 (µg/m³ per year)  0.10  1.04 (0.95, 1.13)  1.20 (1.08, 1.33)  1.12 (1.03, 1.22)  1.17 (1.07, 1.28) 
CO (µg/m³ per year)  0.35  1.00 (0.93, 1.08)  1.02 (0.92, 1.12)  0.97 (0.89, 1.05)  0.98 (0.90, 1.06) 
NH3 (µg/m³ per year)  0.43  1.01 (0.97, 1.05)  1.06 (1.01, 1.11)  1.03 (0.99, 1.08)  1.05 (1.01, 1.09) 
The results are presented per given IQRs of exposure concentrations. Adjusted for Lnight, Lden, distance to major road, age, sex, BMI, WHR, blood 
lipids, smoking, ETS, physical activity, and educational level. For personal risk factors (BMI, blood lipids, smoking, and physical activity), change 
in follow-up was included as a separate variable. 
 1
Analysis subset (prevalent cases and missing values excluded): N = 1,438. 
2
Analysis subset: N = 2,132. 
3
Analysis subset: N = 1,791. 
4
Analysis 
subset: N = 2,212. 
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5. EXPERIMENTAL STUDY RESULTS 
5.1. Expression of housekeeping genes 
 
 
 
Figure 20. The expression of beta-actin, measured at three time points.  
Legend: results are presented as Tukey box plots. Solid horizontal line represents a group-
specific mean. Ends of the whiskers are within 1.5 IQR of the lower and upper quartile. 
Beta-actin. I performed 3 PCR runs with beta-actin (17.02.2012, 08.05.2012, 15.05.2012). 
Results are presented in Figure 20. Ct stands for threshold cycle, a relative measure of beta-
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actin concentration: higher Ct indicates lower concentration. The run from 08.05 demonstrat-
ed much lower expression and much higher variability than other two runs and was not used 
in the analyses.  
 
Figure 21. The measured expression of GAPDH.  
Legend: results are presented as Tukey box plots. Solid horizontal line represents a group-
specific mean. Ends of the whiskers are within 1.5 IQR of the lower and upper quartile. N= 
number of samples included. 
GAPDH (Figure 21). Measured expression of GAPDH demonstrated high variability in dif-
ferent groups. I observed much lower expression in the group DEE + NO2 (high), compared to 
other groups. Therefore it was decided that the results would not be normalized for GAPDH.  
 
Figure 22. The measured expression of HPRT.  
Legend: results are presented as Tukey box plots. Solid horizontal line represents a group-
specific mean. Ends of the whiskers are within 1.5 IQR of the lower and upper quartile. N= 
number of samples included. 
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HPRT. Expression of HPRT is depicted at Figure 22. I observed more homogeneity between 
exposed groups and control, than with expression of GAPDH. However, I found slightly low-
er expression levels in groups DEE (filtered) + NO2 (low) and NO2 (high), than in other 
groups. 
5.2. The relative expression levels of the studied genes 
I measured the expression levels of the following genes in lung tissue: CYP1A1, iNOS, 
ICAM1, NQO1, and TNFα. Expression in exposed groups was compared with control group. 
Results were expressed as fold change in expression compared to control. I presented results 
with measured expression, not normalizing for housekeeping genes, and also normalized for 
beta-actin and HPRT concentration.  
 
Figure 23. The relative expression of CYP1A1, presented as fold change in an average ex-
pression per group, compared to the average expression in control group.  
Legend: Corrected = gene expression normalized for the given housekeeping gene; N = num-
ber of animals in the group, included to the analysis.  
The relative expression of CYP1A1 is presented at Figure 23. I observed significantly lower 
expression levels in the group NO2 (high). Fold change was about 0.5 in this group, which 
corresponds to an expression lower by 50% compared to the control group. In addition to this 
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finding, CYP1A1 expression in all groups with NO2 tended to be lower, than in the control 
group. Expression in the DEE group was higher than in the control group. However, these 
results were not statistically significant.  
 
Figure 24. The relative expression of ICAM, presented as fold change in an average expres-
sion per group, compared to the average expression in control group..  
Legend: Corrected = gene expression normalized for the given housekeeping gene; N = num-
ber of animals in the group, included to the analysis. 
Measured The relative expression of ICAM1 is shown at Figure 24. In all exposed groups, 
gene expression was 2- to 7-fold higher than in the control group. In groups with higher NO2 
concentrations, the expression levels tended to be elevated as well. The estimated fold change 
did not differ substantially, when calculated with or without correction for housekeeping 
genes. However, statistical significance of results in some groups (e.g., DEE + NO2 (low), 
NO2 (high) differed by correction method or housekeeping gene choice. 
Measured The relative expression of iNOS (Figure 25). I observed lower iNOS expression 
levels in the following groups: DEE (filtered) + NO2 (high) and NO2 (high). In the group DEE 
(filtered) + NO2 (high) expression was about twice lower than in the control group. In the 
group NO2 (high) iNOS expression was close to null, with low variation in results, possibly 
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indicating a measurement error (although no obvious problem was detected). In the group 
DEE + NO2 (high) crude expression of iNOS was about two times higher, than in the control 
group. However, after correction for a housekeeping gene the expression attenuated towards 
one. In other exposure groups, iNOS expression of iNOS was not different from the control 
group. 
 
Figure 25. The relative expression of iNOS, presented as fold change in an average expres-
sion per group, compared to the average expression in control group. 
Legend: Corrected = gene expression normalized for the given housekeeping gene; N = num-
ber of animals in the group, included to the analysis. 
Measured The relative expression of NQO1 is presented at Figure 26. Groups with higher 
concentrations of NO2 (with or without DEE and filtered DEE) showed 2- to 3-fold higher 
expression levels than the control group. The estimated expression in these groups was higher 
when presented as crude or corrected for beta-actin as housekeeping gene, than when correct-
ed for HPRT. Expression of NQO1 in the groups DEE and DEE + NO2 (low) was 1.5 to 2 
times higher than in the control group.   
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Figure 26. The relative expression of NQO1, presented as fold change in an average expres-
sion per group, compared to the average expression in control group. 
Legend: Corrected = gene expression normalized for the given housekeeping gene; N = num-
ber of animals in the group, included to the analysis. 
Measured The relative expression of TNFα (Figure 27). The width of CIs, including 1, did not 
allow to reject the null hypothesis of no difference with the control group. However, expres-
sion of TNFα in the group DEE (filtered)+NO2 (low), as well as in groups with higher concen-
trations of NO2 was lower than the control group. Estimated The relative expression of TNFα 
was mostly homogenous when corrected for housekeeping genes and crude, except for one 
group (DEE + NO2 (low)), where the estimates differed. 
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Figure 27. The relative expression of TNFα, presented as fold change in an average expres-
sion per group, compared to the average expression in control group. 
Legend: Corrected = gene expression normalized for the given housekeeping gene; N = num-
ber of animals in the group, included to the analysis. 
5.3. Sensitivity analyses 
Dose-response analysis with NO2 concentration 
Table 35. The association of NO2 concentration with gene expression in all exposure groups 
combined, normalized for beta-actin. 
Gene Fold increase per 1 ppm NO2 (95% CI) 
CYP1A1 0.94 (0.92, 0.98) 
ICAM-1 1.09 (1.04, 1.14) 
iNOS 0.91 (0.87, 0.96) 
NQO1 1.05 (1.03, 1.07) 
TNF 0.97 (0.95, 1.00) 
I included the concentration of NO2 in the exposure group as a continuous predictor to check 
whether a linear exposure-response relationship could be detected (Table 35). Linear trends 
Experimental Study Results 
134 
were significant for CYP1A, ICAM-1, iNOS and NQO1. The expression levels of CYP1A1 
and iNOS were inversely associated with NO2 concentration, and the expression levels of 
ICAM-1 and NQO1 were positively associated with NO2 concentration. 
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6. DISCUSSION 
6.1. Summary of findings 
This study was conducted to investigate the effects of long-term air pollution and its specific 
components on BP and hypertension in humans and to investigate possible pathophysiologic 
mechanisms in an animal model. Using an observational study setting, I investigated the long-
term effects of fine particulate matter urban background air pollution on arterial BP in a popu-
lation-based cohort. I also studied the effects of different components of an air pollution mix-
ture – e.g., smaller and bigger particles, and gases – and tested the independence of the effects 
in multi-pollutant models. I detected consistent positive associations of long-term urban resi-
dential concentrations of PM2.5 and PM1 with BP in a cross-sectional analysis with baseline 
and follow-up data, independent of co-exposures and relevant confounders. The associations 
with other PM sizes were positive, but less consistent compared to PM2.5 and PM1. Among 
gaseous compounds, long-term NH3 concentration was positively associated with BP, inde-
pendent of co-exposure PM and relevant confounders. The results with binary outcomes were 
less conclusive than with BP. I observed no associations with prevalent or incident hyperten-
sion (defined with BP value and BPLM intake). BPLM intake was inversely associated with 
PM2.5–10 in the cross-sectional analysis with follow-up data. In the longitudinal analysis, inci-
dent BPLM intake was positively associated with traffic-related gaseous pollutants (O3, NO, 
CO). Self-reported hypertension and BPLM intake were inversely related to PM exposure 
levels at baseline in cross-sectional analysis and in longitudinal analysis, though less consist-
ently.  
Under the experimental conditions, long-term (13 weeks) exposure to traffic-related particles 
and nitrogen oxides modulated the activity levels of five genes, the products of which are in-
volved in xenobiotic metabolism, inflammation, oxidative stress and vascular tone regulation: 
CYP1A1, NQO1, iCAM, iNOS, and TNFα. I observed dose-response relationships between 
NO2 concentration and expression of CYP1A1, NQO1, iCAM, and iNOS. 
In summary, with the observational study results I was able to confirm the first part of hy-
pothesis 1: that long-term residential exposure to fine PM is linearly associated with an in-
crease in arterial BP, independently of co-exposures and potential confounders. However, I 
could not confirm the second part: that long-term exposure to fine PM is positively associated 
with the risk of hypertension in the general population. Using the experimental data, I provid-
ed some supportive evidence for hypothesis 2: that traffic-related air pollution can alter ex-
pression of genes related to elevated BP and hypertension. 
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6.2. PM2.5 as a responsible pollutant 
The observed positive association between urban background air pollution and arterial BP in 
the population-based cohort should likely be attributed to PM2.5. Findings with PM2.5 were 
more consistent than with other PM fractions (PM10, PMcoarse, PM1 and PN, representing ul-
trafine particles). These findings were robust to adjustment for co-exposure to noise, short-
term exposure and various confounders. Additionally, the association of PM2.5 with BP was 
independent of long-term exposure to other traffic- and industry-related emissions, represent-
ed with NO2, NO, SO2, CO, and O3. As expected, in the experimental study design, DEE 
(both particulate and gaseous components) with NO2 was associated with increased expres-
sion of NQO1, an enzyme involved in the production of ROS.  
There are certain parameters of PM2.5 toxicity that support these findings. Particles in PM2.5 
belong to the inhalable fraction and can be deposited in the lungs after inhalation. PM2.5 con-
sists of primary combustion particles and secondary particles (Kelly and Fussell 2012). The 
fine and ultrafine primary particles, directly emitted from combustion processes (such as traf-
fic), can trigger redox reactions, leading to oxidative stress and inflammation (Li et al. 2002, 
2009). I found that at high levels of NO or CO, no association of PM2.5 with BP was observed 
(and vice versa – no association with the gas was found at high levels of PM2.5). These results 
indicate that at high concentrations of PM2.5 or traffic-related gases (NO and CO), which like-
ly represent traffic ―hot spots‖ with direct emissions of fresh combustion particles, the effects 
of the background air pollution mixture cannot be disentangled from the local ―hot spot‖. The 
results of this study indicate a major role of the secondary particles in the PM mixture. No 
consistent association with PN, representing primary ultrafine particles, was detected in the 
observational study part; thus, it is likely that the larger particles in the PM2.5 mixture were 
associated with BP. The secondary particles within PM2.5 may be more toxic due their longer 
life span compared to primary particles (Kelly and Fussell 2012). The chemical composition 
of air pollution is also important. The major sources of PM in the study area were traffic and 
industry; therefore, the particles can contain many redox-active compounds, such as PAH, 
transition metals, and others.  
The presented results with PM2.5 are well in line with the existing evidence (Tables 36, 37). 
The association of long-term exposure to PM2.5 with SBP was investigated in two studies 
(Auchincloss et al. 2008; Chuang et al. 2011). The 365-day mean concentration of PM2.5 in 
this study was identical to the 60-day mean concentration reported by Auchincloss et al. 
(2008) and was 2-fold lower than the 365-day mean in the study by Chuang et al. (2011). 
When presented per 1 µg/m³, the estimate in the study by Chuang et al. (2011) was the high-
Discussion 
137 
est: a 1.57 mmHg increase in SBP, compared to the estimated changes of 0.31 mmHg in the 
study by Auchincloss et al., and 0.47 mmHg in the current study. The association of PM10 
with SBP was also investigated in two other studies (Chuang et al. 2011; Dong et al. 2013). 
The levels of PM10 were the highest in the study by Dong et al. (2013), approximately 6 times 
higher than in the current study. The estimated changes of SBP per 1 µg/m³ of PM10 were 0.23 
In this study 0.34 in the study by Chuang et al., and 0.05 in the study by Dong et al. Similarly 
to DBP, the highest changes of DBP to PM2.5 or PM10 were observed in the study by Chuang 
et al. (2011) and the lowest in the study by Dong et al. (2013). In addition, a relatively high 
increase in BP per 1 µg/m³ increase in black carbon (a marker of traffic-related air pollution) 
was reported in a U.S. cohort of 853 elderly men (Schwartz et al. 2012). 
I detected no association of PM2.5 or PM10 with the prevalence of hypertension (OR = 1.000 
per 1 µg/m³) and a weak positive relationship with the incidence of hypertension (RR = 1.012 
per 1 µg/m³). The prevalence of self-reported hypertension was positively associated with 
annual PM2.5 exposure in a study with 132,224 participants: OR 1.005 per 1 µg/m³ (Johnson 
and Parker 2009). Thus far, the only two studies that used incidence of hypertension as an 
outcome reported elevated risk. In one of those studies, the estimate was larger than in the 
current study (RR = 1.040 per 1 µg/m³), but it was also imprecise (Coogan et al. 2012). In 
another study, the risk estimate was similar (hazard ratio (HR) = 1.014) but was much more 
precise than in the current study, reaching statistical significance (Chen et al. 2013). Both 
studies reporting significant associations of PM2.5 with prevalent or incident hypertension ana-
lyzed much larger populations than the one used in this observational study: 132,224 and 
35,303 compared to 4,584 participants in the analysis with prevalent hypertension and 1,471 
participants in the analysis with incident hypertension. 
6.3. Findings with gaseous compounds (except ammonia) 
With the observational study design, I did not find any independent associations of long-term 
exposure to gaseous compounds (O3, NO2, NO, SO2, and CO) with BP; the weak associations 
observed in one-pollutant models became null after adjustment for PM2.5 or PM10.  
With the experimental design, the expression of the studied genes was most affected by the 
animals’ exposure to NO2, with or without diesel exhaust; in addition, linear relationships of 
NO2 concentration with gene expression were detected for most of the studied genes.  
I compared the results of one-pollutant models with gaseous compounds of this study with the 
existing evidence (Tables 36, 37). Three other studies from Taiwan, China and Denmark have 
investigated the effects of long-term exposure to gaseous compounds on BP or hypertension 
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(Chuang et al. 2011; Dong et al. 2013; Sørensen et al. 2012). In the Danish study, nitrogen 
oxides were assessed as NOx; their concentration was much lower than the concentrations of 
NO2 and NO in the current observational study. The concentrations of all gaseous pollutants 
were higher in the Asian studies. In the Chinese cohort, the concentration of SO2 was more 
than 4 times higher than in the Taiwanese study and was approximately 7 times higher than in 
the current study. Results with gaseous pollutants were more divergent across studies than the 
results with PM. For example, O3 was inversely related to BP in my study (a change of -0.30 
mmHg SBP per 1 µg/m³), whereas in the Taiwanese cohort, O3 showed a strong positive asso-
ciation with BP (1.57 mmHg SBP); a similar, but weaker, positive association was observed 
in the Chinese cohort (0.03 mmHg SBP). NO2 was positively associated with BP in the Tai-
wanese study (0.55 mmHg SBP per 1 µg/m³) and was weakly related to BP in the current 
study (0.12 mmHg SBP); however, it was not associated with BP in the Chinese cohort (0.03 
mmHg). In the Danish study, the NOx concentration was inversely associated with BP. The 
results with SO2 indicated weak positive relationships in this study and in the Taiwanese co-
hort, but not in the Chinese study.  
 
Discussion 
139 
Table 36. The associations of long-term air pollution with systolic and DBP in the current study and in published studies, presented per increase in 
a pollutant concentration by 1 µg/m³. 
Results 
Current study Auchincloss et al. 
2008 
Chuang et al. 
2011 
Dong et al. 2013 Sørensen et al. 
2012 
Schwartz et al. 
2012 
N = 4,584 N = 5,112 N = 1,023 N = 24,845 N = 44,436 N = 853 
Exposure characteristics       
Averaging period (days) 365 days 60 days 365 days 3 years 365 days 365 days 
Daily mean (hours) 24-hour 24-hour 8–24 hours1 8-hour 24-hour 24-hour 
Mean exposure levels (µg/m³)      
BC – – – – – 0.61 
PM10 20.70 – 67.84 123.06 – – 
PM2.5 16.70 16.70 35.31 – – – 
O3 35.40 – 48.50 49.40 – – 
NOx – – – – 19.60 – 
NO2 40.10 – 49.69 35.28 – – 
SO2 8.70 – 13.90 54.42 – – 
Association with SBP: change, mmHg (95% CI) (per 1 µg/m³)     
BC – – – – – 8.25 (4.59, 11.88) 
PM10 0.23 (0.00, 0.46) – 0.34 (0.26, 0.43) 0.05 (0.03, 0.07) – – 
PM2.5 0.47 (0.09, 0.86) 0.31 (-0.05, 0.22) 1.57 (1.06, 2.09) – – – 
O3 -0.30 (-0.67, 0.07) – 1.14 (0.89, 1.38) 0.03 (0.02, 0.05) – – 
NOx
1 – – – – -0.50 (-0.84, -0.16) – 
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Results 
Current study Auchincloss et al. 
2008 
Chuang et al. 
2011 
Dong et al. 2013 Sørensen et al. 
2012 
Schwartz et al. 
2012 
N = 4,584 N = 5,112 N = 1,023 N = 24,845 N = 44,436 N = 853 
NO2 0.12 (-0.02, 0.26) – 0.55 (0.42, 0.69) 0.03 (-0.02, 0.08) – – 
SO2 0.28 (-0.27, 0.84) – 0.11 (-0.58, 0.80) 0.02 (0.01, 0.03) –  
Association with DBP: change, mmHg (95% CI) (per 1 µg/m³)     
BC – – – – – 7.53 (5.53, 9.53) 
PM10 0.18 (0.05, 0.30) – 0.31 (0.27, 0.35) 0.02 (0.00, 0.03) – – 
PM2.5 0.31 (0.10, 0.52) – 1.53 (1.25, 1.82) – – – 
O3 -0.16 (-0.36, 0.04) – 1.09 (0.96, 1.22) 0.02 (0.01, 0.03) – – 
NOx
1
 – – – – -0.24 (-0.42, -0.07) – 
NO2 0.05 (-0.02, 0.13) – 0.48 (0.41, 0.55) 0.02 (-0.01, 0.05) – – 
SO2 0.13 (-0.17, 0.43) – 0.06 (-0.30, 0.43) 0.02 (0.01, 0.03) – – 
1Estimate is calculated per doubling of exposure concentration. 
Table 37. The associations of long-term air pollution with prevalent and incident hypertension in the current study and in published studies, pre-
sented per increase in a pollutant concentration by 1 µg/m³. 
Exposure 
Current study Current study Dong et al. 
2013 
Johnson and 
Parker 2009 
Coogan et al. 
2012 
Sørensen et al. 2012 Chen et al. 
2013 
N = 4,584 N = 1,471 N = 24,845 N = 132,224 N = 3,236 N = 50,721 N = 33,275 N = 35,303 
Mean exposure levels (µg/m³)   
PM10 20.70 19.80 123.06 – – – –  
PM2.5 16.70 15.60 – Not presented 20.70 – – 10.70 
O3 35.40 37.60 49.40 – – – –  
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Exposure 
Current study Current study Dong et al. 
2013 
Johnson and 
Parker 2009 
Coogan et al. 
2012 
Sørensen et al. 2012 Chen et al. 
2013 
N = 4,584 N = 1,471 N = 24,845 N = 132,224 N = 3,236 N = 50,721 N = 33,275 N = 35,303 
NOx – – – – 43.30 19.60 19.60  
NO2 40.10 38.60 35.28 – – – –  
SO2 8.70 7.40 54.42 – – – –  
Outcome 
(%) 
Prevalence 
57.0% 
Incidence 
36.2% 
Prevalence 
40.6% 
Prevalence 
25.0% 
Incidence 
16.4% 
Prevalence 
16.2% 
Incidence 
9.6% 
Incidence 
24.5% 
Estimated association      
PM10 
OR 1.000 
(0.900, 1.123) 
RR 1.005 
(0.912, 1.166) 
1.006 
(1.004, 1.008) 
– –    
PM2.5 
OR 1.000 
(0.900, 1.123) 
RR 1.012 
(0.932, 1.151) 
– 
OR 1.005 
(1.000, 1.010) 
RR 1.040 
(0.995, 1.087) 
  
HR 1.014 
(1.007, 1.022) 
O3 
OR 1.000 
(0.910, 1.110) 
RR 0.991 
(0.888, 1.079) 
1.006 
(1.003, 1.008) 
– –    
NOx
1 – – – – 
RR 1.005 
(1.001, 1.009) 
OR 0.96 
(0.91, 1.00) 
RR 1.01 
(0.95, 1.08) 
 
NO2 
OR 1.010 
(0.962, 1.167) 
RR 1.006 
(0.990, 1.022) 
1.010 
(1.000, 1.020) 
– –    
SO2 
OR 1.007 
(0.921, 1.120) 
RR1.013 
(0.931, 1.119) 
1.005 
(1.002, 1.008) 
– –    
1Estimate is calculated per doubling of exposure concentration. 
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6.4. Findings with ammonia 
In the current study the long-term exposure to NH3 was positively associated with BP and 
positively related to hypertension. PM and NH3 were highly correlated, which is why it was 
not possible to completely disentangle their effects. The results with NH3 were robust to ad-
justment with PM, whereas the association of PM with BP diminished to null after adjustment 
with NH3. Ammonia is an important component of secondary particles in PM2.5 (such as am-
monium nitrate or sulfate). Therefore, the positive association of ammonia with BP may be 
indicative of the health effect of secondary particles.  
Ammonia is a toxic component of air pollution. The acute health effects of NH4 in animals 
include respiratory and eye irritation, deeper and slower breathing, lung inflammation, re-
duced smelling capacity, lethargy, immune response, and increased bacterial susceptibility in 
the respiratory tract (WBK and Associates Inc. 2004). Chronic exposure to NH3 results in af-
fected lung function, coughing, phlegm, wheezing, and dyspnea (WBK and Associates Inc. 
2004).  
However, it is not clear whether NH3 can increase BP or whether the observed association is 
due to collinearity of exposures. To date, there are no studies on the association of NH3 with 
BP. Nevertheless, it is biologically not implausible that NH3 can increase BP. Atmospheric 
NH3 is an odorant chemical. Malodors such as NH3, hydrogen sulfide (H2S), and VOC, can 
potentially affect BP through a stress-related mechanism (Wing et al. 2013). In a panel study 
with healthy nonsmoking adults, self-perceived and measured (as H2S) malodor from the in-
dustrial swine operations was strongly and positively associated with SBP and DBP (Wing et 
al. 2013). More studies on the biological plausibility of the association of ammonia with BP 
are needed. 
6.5. Potential biological mechanisms: analyzing experimental results  
I found some indication that long-term exposure to diesel exhaust and NO2 affects the activity 
levels of genes involved in inflammatory and immune responses, cell signaling, and cardio-
vascular pathology in mouse lung tissue. The results with these genes were summarized and 
compared with other studies.  
CYP1A1 
In the controlled exposure study, I observed decreased expression of CYP1A1 in the murine 
lung at higher levels of NO2. The effect of diesel exhaust was inconclusive. The product of 
CYP1A1, cytochrome P450, takes part in the metabolism of xenobiotics and in the synthesis 
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of cholesterol, steroids and other lipids (National Center for Biotechnology Information 
2014a). CYP1A1 takes part in the production of arachidonic acid-derived vasoactive sub-
stances. Some of these substances influence renal function, peripheral vascular tone and BP 
(Newton-Cheh et al. 2009). The products of the metabolism of omega-3 polyunsaturated fatty 
acids with cytochrome P450, such as 17,18-epoxyeicosatetraenoic acid and 19,20-
epoxydocosapentaenoic acid, are strong vasodilators, and the loss of these vasodilators result-
ed in increased BP in CYP1A1 knockout mice (Agbor et al. 2012). The decreased activity of 
CYP1A1 may also result in increased BP.  
Some studies link CYP1A1 activity to BP. In a genome-wide association study with up to 
84,114 individuals of European and Indian Asian ancestry, few loci were associated with SBP 
and DBP, including genes coding the cytochrome P450 proteins (Newton-Cheh et al. 2009). 
Another study showed that CYP1A1 mediates endothelial dysfunction and hypertension after 
exposure to xenobiotics, such as dioxin-like halogenated aromatic hydrocarbons (Kopf et al. 
2010). Therefore, the alteration of CYP1A1 activity may change cardiovascular risk. In a 
case-control study with Turkish participants, different genetic variants of CYP1A1 contribut-
ed to inter-individual variability in smoking- and hypertension-induced ischemic stroke risk 
(Demirdöğen et al. 2013). CYP1A1 activity was positively associated with the incidence of 
stroke in patients with essential hypertension (Lança et al. 2004).  
The organic component in the diesel exhaust and the PM mixture can activate CYP1A1 
(Dieme et al. 2012; Ma and Ma 2002). Other studies showed that combustion-derived parti-
cles stimulated the expression of CYP1A1 through the activation of the aryl hydrocarbon re-
ceptor and increased binding to xenobiotic response elements (Chan et al. 2013; Matsumoto et 
al. 2007; Rouse et al. 2008; Wenger et al. 2009). In an in vitro model with human cells, short-
term exposure to PM2.5 from a highly industrialized area induced significant increases in the 
mRNA expression levels of CYP1A1 and other related enzymes (Billet et al. 2007). Chan et 
al. showed that combustion-derived ultrafine particles were capable of a rather weak increase 
in AhR activity and altered CYP1A1 expression differently according to age, lung compart-
ment, and recovery time after exposure (Chan et al. 2013). Expression of CYP1A1 in rat lung 
rapidly increased after exposure to diesel exhaust particles (Van Berlo et al. 2010). 
The downregulation of CYP1A1 may be a result of the activation of host defense mecha-
nisms. The administration of inflammatory cytokines, such as TNFα, inhibited CYP1A1 ac-
tivity in vitro (Gharavi and El-Kadi 2007; Paton and Renton 1998). Another possible explana-
tion of the reduced activity of CYP1A1 following NO2 inhalation may be that NO (assuming 
that NO2 also contains some quantity of NO), also a potent vasodilator, competes with 
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CYP1A1 metabolites, the vasoactive substances, and downregulates its activity. The inhibi-
tion of CYP1A1 by NO was demonstrated in vitro (Gharavi and El-Kadi 2007; Stadler et al. 
1994; Vuppugalla and Mehvar 2004).  
The potential health impact of cytochrome P450 activity inhibition is not clear. The process of 
metabolizing the foreign chemical, CYP1A1, may lead to the formation of highly toxic me-
tabolites, such as dihydroxyl epoxide, a potential carcinogen emerging during the transfor-
mation of VOCs, in particular, benzo(a)pyrene. The finding that NO2 decreased CYP1A1 ex-
pression could indirectly also mean that the capacity of the lung to address the metabolism of 
such xenobiotics could be affected during co-exposure to NO2 in addition to diesel exhaust. 
This finding might be specific to long-term exposure because short-term exposure with diesel 
exhaust upregulated CYP1A1 in a rat lung (Van Berlo et al. 2010) 
ICAM-1 
I observed elevated expression of ICAM-1 with diesel engine exhaust and NO2. The product 
of this gene is involved in leukocyte adhesion and trans-migration to the endothelium; it is 
also involved in vascular inflammation and signal transduction. Expression of this gene corre-
lates with systemic inflammation and cardiovascular risk, rheumatoid arthritis, hypertension, 
and growth of atherosclerotic lesions (Lawson and Wolf 2009; Witkowska and Borawska 
2004). Immune cell recruitment, activated by ICAM-1, is an important event in atherosclero-
sis development (Wang et al. 2013). 
The activity of ICAM-1 is related to both the inflammatory process and endothelial function. 
It has been suggested that hydrogen peroxide (H2O2) can activate ICAM-1 gene transcription 
(Zadeh et al. 2000). H2O2 is produced by leukocytes during vascular response to injury; its 
production is increased by cytokines such as TNFα (Zadeh et al. 2000). Correspondingly, 
TNFα upregulates ICAM-1 expression (Wang et al. 2013). At the same time, induction of  
iNOS expression can inhibit ICAM-1 expression to protect the vascular endothelium (Zadeh 
et al. 2000).  
ICAM-1 activity is affected by smoking, antioxidant intake and vasoconstriction agents, such 
as angiotensin (Witkowska and Borawska 2004). Air pollution exposure can increase ICAM-1 
production. For example, in a cohort study with 704 elderly men, traffic and secondary parti-
cles were associated with ICAM-1 and vascular cellular adhesion molecule (VCAM-1) con-
centrations (Bind et al. 2012b). In the same cohort, exposures to O3 and sulfate were associat-
ed with changes in ICAM-1 gene methylation (Bind et al. 2014). In diabetic patients, outdoor 
exposures to PM2.5, black carbon and sulfate were positively related to ICAM-1 expression; 
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stronger associations were observed for PM2.5 and black carbon with VCAM-1 (O’Neill et al. 
2007).  
Similar findings have been reported in animal and in vitro studies. In an ischemic stroke mod-
el in rats, the inhalation of SO2 activated gene expression in a dose-dependent manner com-
pared to the control for ICAM-1 and other genes, such as iNOS, cyclooxygenase 2, and ET-1 
(Sang et al. 2010). In an animal model with hyperlipidemic rats, exposure to PM10 induced 
ICAM-1 and VCAM-1 expression in the aorta endothelium and caused the progression of 
atherosclerosis (Yatera et al. 2008). Elevated ICAM-1 levels were reported in lung tissue in 
rats exposed to O3 (Bhalla and Gupta 2000). NO2 was positively associated with ICAM-1 
expression in human bronchial cells in vitro (Ayyagari et al. 2007; Pathmanathan et al. 2003). 
Diesel exhaust particles increased the production of inflammatory mediators, including 
ICAM-1, in human respiratory epithelial cells in vitro (Bayram et al. 1998; Yang et al. 2009).  
INOS 
INOS expression was somewhat increased in the DEE+NO2(high) group, but this increase was 
not statistically significant. I detected strong decreases of iNOS activity in two groups: 
DEE(filtered) + NO2(high) and NO2(high). In the latter group, the gene expression was almost 
null, and the variances were very low compared to other groups. Therefore, these observations 
might be a chance finding and should await confirmation in further studies. There was a linear 
trend in the association of NO2 concentration with gene activity: higher concentration of NO2 
was associated with lower expression of iNOS.  
iNOS is involved in the immune defense response but also plays a role in vascular pathology, 
such as hypertension (Lee and Yen 2008). This dual role is provided by NO: a potent oxidant 
on the one hand, protecting against infectious organisms, and a vasodilatory agent on the oth-
er hand, triggering smooth muscle relaxation (Wang et al. 2013). Under normal conditions, 
iNOS is not expressed or is expressed at a minimal level. Inflammatory cytokines can activate 
iNOS expression in vascular cells (Lee and Yen 2008). INOS upregulation might play a role 
in vascular dysfunction and atherogenesis (Bai et al. 2011). 
Thus far, two studies have investigated the effect of nitrogen oxides (only NO) on iNOS activ-
ity, with different results. In one study, NO downregulated iNOS gene transcription in vitro; 
the authors hypothesized that this inhibition might be a regulatory mechanism to limit NO 
overproduction during the inflammatory response (Taylor et al. 1997). In another study, gase-
ous NO activated iNOS in a mouse model of lung cancer and promoted lung cancer develop-
ment (Chen et al. 2008). It is possible that duration of exposure additionally modifies iNOS 
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activity: acute exposure results in an inflammatory response, characterized by iNOS upregula-
tion, similar to the study by Chen et al. (2008), whereas during long-term exposure, a com-
pensatory protective mechanism is activated, and iNOS activity is inhibited, as suggested by 
Taylor et al. (1997). 
Other air pollutants have also shown heterogeneous effects on iNOS activity. In a controlled 
exposure study with healthy volunteers, exposure to fine and coarse concentrated ambient 
particles (CAPs) was related to the decreased methylation of Alu, TLR4, and iNOS (for the 
latter, not statistically significant) (Bellavia et al. 2013). Increased iNOS expression after ex-
posure to CAPs and O3 was observed in an animal study (Sun et al. 2013). In an ApoE knock-
out mouse model, exposure to diesel exhaust increased iNOS expression (Bai et al. 2011). In 
an animal study in which murine lung tissues were investigated after long-term exposure to 
diesel exhaust, the expression levels of iNOS in the lung and of TNFα and some interleukins 
in lung macrophages were suppressed after low- and high-dose diesel exhaust exposure; be-
cause iNOS, TNFα and IL play important roles in defense against infections, the authors hy-
pothesized that exposure to diesel exhaust may cause increased infectivity (Saito et al. 2002). 
In a rat model of with O3-induced lung inflammation, short-term exposure to particles resulted 
in increased iNOS expression; the authors hypothesized that the free radical NO may have 
caused the observed endothelial damage (Ulrich et al. 2002). Chauhan et al. (2004) detected in 
vitro modulation of iNOS activity according to differences in the PM mixture: urban particles 
(SRM-1648, SRM-1649, EHC-93) downregulated iNOS activity, whereas PM2.5 or cristobal-
ite (SRM-1879) were associated with higher iNOS activity levels. 
NQO1 
In the experimental part of the current study, high NO2 concentrations (alone or combined 
with DEE) were associated with elevated NQO1 expression compared to the control. The re-
lationship of NO2 concentration to gene expression was linear. NQO is involved in redox re-
actions: it catalyzes the reduction of endogenous (vitamin E) or environmental (benzene) qui-
nones (Nebert et al. 2002). Polymorphisms in NQO1 and other genes involved in oxidative 
stress genes increase respiratory symptoms, which affects lung function (Yang et al. 2009).  
Elevations of NQO-1 expression may work to both protect and exacerbate vascular injury. 
The inhibition of NQO1 activity increases the risk of toxicity or cancer (Nebert et al. 2002). 
At the same time, NQO1 is a potent protecting factor against adverse cardiovascular condi-
tions, such as cardiovascular injury, atherogenesis, and others. (Zhu and Li 2012). The gene 
NQO1 is under control of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) transcription 
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factor pathway, and this transcription factor is emerging as a potentially important player in 
particle-induced lung diseases (Araujo and Nel 2009). 
To date, there are no studies on the association of ambient NO2 with NQO1 expression. How-
ever, it is possible that NO2 increases NQO1 activity, similarly to other air pollutants. For ex-
ample, organic chemicals in the PM2.5 mixture (such as PAH) induced the expression of 
CYP1A11 and NQO1 in vitro (Dergham et al. 2012). The organic component of the PM2.5 
mixture activated NQO1 expression and, to a greater extent, the cytochrome P450 genes in 
vitro (Dieme et al. 2012). The activity of the NQO-1 gene may be mediated through antioxi-
dant responses (Li 1992) and can interact with smoking status and benzene exposure (Kim et 
al. 2007). 
TNFα 
TNFα encodes an acute-phase cytokine that regulates multiple processes: apoptosis, inflam-
mation, proliferation, lipid metabolism, and coagulation (National Center for Biotechnology 
Information 2014b). Similarly to NQO1, it has a dual role; both adverse and protective effects 
have been reported for its activity (Tracey and Cerami 1993). I did not detect statistically sig-
nificant differences in TNFα activity in exposed groups compared to the control. However, 
the expression of TNFα tended to be inhibited in some groups with NO2. This is in line with 
at least one study, where PM2.5 and PMcoarse inhibited TNFα activity, whereas diesel exhaust 
did not alter it in vitro (Becker et al. 2005). 
However, most studies report activation of TNFα induced by air pollution exposure. For ex-
ample, in a panel study with healthy individuals, TNFα activity was positively associated with 
zinc in urban air pollution (Wu et al. 2012). In a case-control study on myocardial infarction, 
Panasevich et al. (2013) found that different genetic variants of TNFα modified the effects of 
short-and long-term exposure of air pollution on inflammatory marker levels and the risk of 
infarction. In an in vitro model with human cells, short-term exposure to PM2.5 induced apop-
tosis, which involved TNFα activation and cytochrome c release from the mitochondria 
(Dagher et al. 2006); these results were preceded by an inflammatory response involving 
changes in iNOS activity and NO release (Garçon et al. 2006). In another in vitro model, traf-
fic-related particles induced IL-6, TNFα and NO (Lindbom et al. 2007). Future research could 
shed more light on the role of TNFα in adverse cardiovascular effects of air pollution. 
6.6. Clinical relevance of the observed BP change 
The estimated change in BP following exposure to air pollution is rather small. However, 
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even small changes of arterial BP are of high public health importance. The increase of BP by 
only a few mmHg is not substantial at the individual level; however, it implies that larger pro-
portions of individuals in the population are hypertensive. The rates of hypertension are in-
creasing worldwide in all countries where economic growth is accompanied by epidemiologi-
cal transition (with non-communicable diseases becoming a more urgent issue than communi-
cable), increasing life expectancy, and population aging. Unhealthy diet, low physical activity 
level, overweight and psychosocial stress also contribute to the increasing prevalence of hy-
pertension worldwide (WHO 2013). Hypertension is a major risk factor for CVD, stroke, kid-
ney failure, premature mortality and disability (WHO 2013). According to the Global Burden 
of Disease Study in 2010, high BP was the leading risk factor for mortality (Lim et al. 2013).  
The prevention of hypertension is a crucially important issue for public health. A reduction in 
SBP of only 2 mm leads to reductions in stroke mortality by 5%, in CHD mortality by 4%, 
and in total mortality by 3% (Whelton et al. 2002). A reduction of DBP of 2 mmHg has been 
linked to a 6% lower risk of CHD and a 15% lower risk of stroke and transient ischemic at-
tack (Cook et al. 1995). It has been estimated that a 2.2 mm Hg lower SBP (resulting from, 
e.g., a lower habitual population sodium intake of 100 mmol/day) corresponds to a 4% lower 
risk of coronary death and a 6% lower risk of stroke death among the middle aged in the US 
and UK populations (Stamler et al. 1989). 
The current levels of urban background air pollution can be seen, with regards to the results of 
this study, as a target for population-based preventive strategies (Rose 1985). Since a mono-
tonic linear relationship of PM with BP was observed, reduction of PM at any levels is im-
portant. Prevention of air pollution-related increases in BP is especially important because 
hypertension may be a linking mechanism between air pollution exposure and cardiovascular 
events. Exposure to air pollution may affect vasomotor tone and cause a pro-hypertensive 
response, which, in turn, could trigger ischemic cardiac events and, thus, could increase the 
risk for heart failure and stroke (Brook et al. 2009; Tofler and Muller 2006). High BP and hy-
pertension are important intermediates in atherosclerosis progression, an underlying condition 
for many cardiac events. Air pollution-related increase in BP could be one of the mechanisms 
by which PM air pollution may lead to atherosclerosis, as shown in recent studies (Bauer et al. 
2010; Hoffmann et al. 2007; Künzli et al. 2010). 
6.7. The impact of different definitions of hypertension 
Availability of measured BP data defines the definitions of hypertension, used in different 
studies: if no BP data are not accessible, self-reported hypertension status or hospital records 
Discussion 
149 
could be used. However, using different definitions limits the studies’ comparability. Of 5 
studies on air pollution and hypertension, the JNC7 definition, based on both BP values and 
medication (used as the main outcome definition in this work), was used in one study (Dong 
et al. 2013). One study used the hospital registry with physician-defined hypertension (Chen 
et al. 2013). Three studies used self-reported diagnosis of hypertension (Coogan et al. 2012; 
Johnson and Parker 2009; Sørensen et al. 2012). Coogan et al., who used a self-report of doc-
tor-diagnosed hypertension and the concurrent use of BPLM as an outcome definition, ascer-
tained this definition in the subset of hypertensive participants (139 cases) with the help of 
medical records or physician checklists; 99% of the cases were confirmed (Coogan et al. 
2012). 
I compared two outcomes in this study: the ―measured‖ hypertension (included as main study 
outcome and defined with BP values and BPLM intake status) and the self-reported hyperten-
sion. Both outcomes were obtained in most of HNR participants, which provided a unique 
possibility of comparison. The definitions overlapped quite well: 73% to 76% of participants 
with information on both outcomes were characterized equally. However, Cohen’s kappa, a 
measure of agreement, was somewhat worse for the incident hypertension, than for prevalent 
hypertension at baseline or follow-up. Results of the analysis with air pollution were some-
what different with ―measured‖, than with self-reported hypertension. Although not statistical-
ly significant, the relationship of exposures with ―measured‖ hypertension was mostly posi-
tive, similar to the observed associations with BP, whereas the relationship of exposures with 
self-reported hypertension was null to slightly negative, similar to the results observed with 
BPLM intake as an outcome. 
The observed difference between results with ―measured‖ and self-reported hypertension 
might indicate a group of subjects with variable BP, which increased during the measurement 
and, correspondingly, the overestimation of hypertension prevalence when using the JNC7 
definition in the current study. Indeed, there were 5% of participants classified as hyperten-
sive at baseline and as normotensive at follow-up. Benetos et al. (2003) have shown that a 
single BP measurement could overestimate the proportion of subjects receiving BPLM and 
yet having high BP values. Possibly, the definition of hypertension based on a single meas-
urement (although standardized and repeated 3 subsequent times) is insensitive towards short-
term elevation of BP, which does not indicate an underlying vascular pathology. Indeed, in the 
group of participants with prevalent hypertension at baseline and follow-up, which constituted 
approximately half of the follow-up sample, the association of air pollution with BP was 
stronger than in the entire sample.  
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An alternative explanation to the observed phenomenon would be a relatively low overlap of 
known and ―measured‖ hypertension may imply inadequate coverage of hypertensive patients 
by medical services. Therefore, it is not recommended to favor self-reported hypertension 
over the information provided by BP values and medication. However, it is advisable to repeat 
measurements of BP over some period of time for more validity of the ―measured‖ hyperten-
sion definition, and to check the ―measured‖ outcome using the self-reported information. 
6.8. The role of BPLM intake 
I employed a few strategies to assess the potential bias because of the BPLM intake. No cor-
rection and adjustment for BPLM intake as a covariate, labeled as ―fundamentally flawed‖ in 
a methods article on correction for medication (Tobin et al. 2005), delivered very similar re-
sults. Moreover, the results remained unchanged when one of the methods recommended by 
Tobin et al. (Tobin et al. 2005) was employed, namely the addition of a fixed value to the BP 
of medicated subjects. Right-censored regression, another recommended strategy, yielded 
slightly different results: some estimates were higher, others were lower, and the precision of 
the estimates differed somewhat. Estimates with right-censored regression mimicked the ef-
fect in non-medicated participants. 
In addition to the aforementioned methods, I assessed the association with BP separately in 
medicated and non-medicated individuals. To avoid power loss, I calculated the effects in the 
model with interaction terms. In addition, BPLM intake was also included as an outcome. 
This method has the advantage of implying no assumptions regarding, for example, the treat-
ment effect. Despite the BP-lowering effect of medication, the BP values in medicated indi-
viduals were substantially higher than in non-medicated individuals. This observation, togeth-
er with the finding that known hypertension status has only a 66.4% overlap with the JNC7 
definition, possibly hints at the fact that the medication was not effective in some participants. 
With regard to this finding, it is advisable to assess the effectiveness of medication when mak-
ing the decision on the strategy to correct for the BPLM intake in the analysis of BP.  
I observed the most consistent association of PM with BP in the group of medicated individu-
als, at both baseline and follow-up. In non-medicated individuals, the effect estimate was 
slightly lower and less precise than in medicated individuals. The results with NH3 were very 
similar, with the only difference being that the association with BP was statistically significant 
in medicated and non-medicated individuals. The concentrations of PM and NH3 were also 
related to lower risk for BPLM intake in the study participants (the estimated associations 
were statistically significant with the follow-up subcohort only). The hypothesis that air pollu-
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tion-induced BP increase leads to BPLM intake and that one would see a positive association 
of PM with BPLM intake and a negative association of PM with BP was not confirmed with 
the results with PM and NH3. Therefore, the mediation of the effect of background PM2.5 by 
BPLM is less likely than confounding with noise. More likely, BPLM intake could be seen as 
a susceptibility factor in these subjects. 
The situation with traffic-related pollutants, such as NO2, CO, was slightly different. In con-
trast, the association of NO2 with BP was robust only in non-medicated individuals. NO2, O3 
and CO were imprecisely positively related to an elevated risk for BPLM intake. In agreement 
with this finding, I also observed a positive association of living close to traffic and in disad-
vantaged neighborhoods with BPLM intake. Traffic noise was imprecisely positively linked to 
BPLM intake. All exposures associated with higher BPLM intake are traffic-related. There-
fore, it is possible that noise annoyance and low socio-economic status (personal or neighbor-
hood-level) contribute to this association and confound the association of air pollution with 
BP. In this case, one should use BPLM as a covariate in the adjustment set. The exposure to 
noise, different from air pollution, can be perceived personally and can lead to elevated BP 
through the stressor response mechanism (Babisch et al. 2014). 
Self-reported BPLM intake had a very good overlap with the BPLM intake according to the 
study definition, and showed similar relationship with the studied exposures. This gives the 
reason to consider that self-report is quite valid source of information regarding BPLM intake. 
It is, however, not to forget, that some drugs, prescribed for conditions other than hyperten-
sion, may decrease BP was well (diuretics, for example). Therefore, if BPLM intake is used in 
the analysis to correct for BP values in medicated subjects, self-report may not be sufficient.  
6.9. Confounding of long-term associations with temporal variation 
Both the exposure and the outcome in the observational study are subject to temporal varia-
tion. The individual 365-day mean was used as a main exposure definition, representing long-
term air pollution concentration. Over the three years of baseline or follow-up, the 365-day 
mean demonstrated temporal variation in addition to spatial variation. For example, the 365-
day mean concentrations of two participants who lived close to each other but were scheduled 
for BP measurements on different dates would most likely differ. Such temporal changes 
might bias the analysis of long-term spatial differences in exposure, which was the primary 
interest in this study. Therefore, to overcome this problem, the time trend (a count of days 
from the first baseline or follow-up measurement date to the last, entered as a linear and 
squared term) was used in this analysis to adjust for confounding from temporal variation. 
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The results of this analysis, with and without adjustment for time trend, differed dramatically; 
without time trend, no association of exposure with outcome was observed. Therefore, time 
trend was always included as a covariate. In addition, season was an effect modifier: the asso-
ciation of PM2.5 with BP was stronger in the summer than in other seasons. BP values are also 
variable over time: BP tends to be higher in cold periods and lower in warm periods (Alpé-
rovitch et al. 2009; Rose 1961). In our data, seasonality was also observed and was more 
prominent for SBP than for DBP (Appendix Figure 29). 
To verify whether temporal variation biased the analysis, an additional exposure definition 
was used: the grid-specific mean over the entire baseline or follow-up period. This definition 
did not contain the temporal variation component and did not require adjustment for time 
trend. The concentrations of grid-specific mean exposure were similar, but not identical, to the 
individual 365-day mean (for example, there was a correlation of 0.875 for PM2.5 at baseline). 
I also observed a positive relationship of PM2.5 with SBP that was close to, though slightly 
less precise than, the estimate with the 365-day mean, adjusted for time trend. A weaker asso-
ciation may be detected because the grid-specific mean is averaged over a longer time period; 
therefore, the variation in exposure concentration is smaller. The association of the grid-
specific mean was more precise with DBP, possibly because DBP did not vary much over 
time and, in contrast to SBP, was not confounded by time trend.  
6.10. Application of the longitudinal analysis in the study setting 
I performed longitudinal analysis with BP in addition to cross-sectional one to test the causal 
inference. This analysis was done with three different strategies: analysis with baseline expo-
sure and BP at the follow-up measurement, analysis with baseline exposure and change in BP 
from baseline to follow-up, and analysis with change in exposure and change in BP from 
baseline to follow-up.  
It is shown that SBP increases with life span (Whelton 1994). I observed different rates of 
increase or even a decrease in certain subgroups of the study population. For example, SBP 
increased most rapidly among participants not taking BPLM, especially in the older age 
groups. I observed mostly a decrease in SBP from baseline to follow-up among participants 
taking BPLM. To take the different rates of progression into account, I performed the longitu-
dinal analysis in the group of participants not taking BPLM.  
DBP, opposite to SBP, decreases after certain age due to growing arterial stiffness (Whelton 
1994). I observed a decrease in DBP in the study population, regardless of medication status. 
Therefore, the analysis with change in DBP might be particularly challenging in this study: 
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the decrease in air pollution from baseline to follow-up, possibly resulting in better cardiovas-
cular health and lower BP, coincides with age-related decrease in DBP, also observed in the 
follow-up period.  
Considering this, I used PP as an additional outcome. It reflects increase in SBP and decrease 
in DBP simultaneously, and have been shown an independent risk factor for cardiovascular 
disease, possibly more important than SBP or DBP, in older subjects (Franklin et al. 2001). 
Results with PP were generally very similar to the results with SBP and are in line with a re-
ported positive association of long-term residential traffic exposure with PP (Rioux et al. 
2010). 
Longitudinal analysis with exposure at baseline and BP at follow-up has shown quite similar 
results to the cross-sectional analysis. This finding strengthens the hypothesis of causal asso-
ciation of air pollution with hypertension and BP related cardiovascular system pathology. 
However, it is necessary to consider an alternative explanation for this finding. I observed a 
high positive correlation between air pollution concentrations at baseline and after 5 years of 
follow-up, especially with grid cell means, representing the spatial contrasts in exposure. BP 
at follow-up is expectedly positively correlated with BP at baseline, especially among partici-
pants who underwent no intervention, such as BPLM intake or weight loss. It is therefore to 
expect that the analysis with baseline exposure and follow-up BP would produce results quite 
similar to cross-sectional analyses with baseline or follow-up data, which was observed in this 
study. 
I have employed two other strategies, both of which included change in BP from baseline to 
follow-up as an outcome. I observed different results with these strategies: whereas exposure 
at baseline was mostly positively related to change in BP at follow-up, change in exposure 
from baseline to follow-up was negatively associated with change in BP. I also observed a 
high negative correlation of exposure at baseline with change in exposure during follow-up 
period for PM2.5, PM1, PN, and CO. Taken together, these results may reflect decreases in 
exposure, possibly a result of focused actions in the zones with especially high concentra-
tions. The contra-intuitive findings of negative associations may also point out the fact that 
under these specific study conditions – when air quality improved but cardiovascular health of 
population with aging worsened – analysis of change with blood pressure is not an optimal 
analysis method. 
It is recommended to use categorical outcomes, such as hypertension (possibly also divided to 
stages 1, 2, and isolated systolic hypertension) in the longitudinal analysis with BP. These 
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outcomes would possibly better reflect chronic deterioration in cardiovascular health, than 
change in BP as outcome. However, using categorical outcomes implies less power to detect 
significant associations, which was also observed in the current analysis as wider confidence 
intervals, not allowing to reject the null hypothesis of no association. 
6.11. Different BP measures as outcomes 
Apart from different progression with aging, discussed in 7.10, SBP and DBP also differ in 
terms of clinical meaning. SBP represents the heart function, whereas DBP can be seen a 
marker of arterial aging. For almost three quarters of the twentieth century – starting from the 
first measurements in early 1900s and until 1970s – DBP was considered a more important 
measure of risk then SBP (Franklin et al. 2001). In 1971, results of Framingham Heart Study 
follow-up assessment showed the ―declining relative importance of diastolic and a corre-
sponding increase in the importance of systolic pressure with advancing age‖ (Kannel et al. 
1971). It has been shown that SBP better predicts cardiovascular risk in elderly, and DBP – in 
younger individuals (Franklin et al. 2001). PP has been shown an independent risk predictor 
for CHD, especially in subjects aged 60 and older (Franklin et al. 2001). 
Systolic BP is increased if cardiac output increases (Pal and Pal 2005) or if early pulse wave 
reflections during systole affect left ventricular contraction, ejecting blood into the aorta and 
creating a pressure pulse (Benetos et al. 2003). Increasing arterial stiffness results in elevated 
SBP and decreased DBP (Benetos et al. 2003). As a result, PP will also increase with arterial 
aging. In addition, DBP levels can increase with increasing peripheral vascular resistance 
(Benetos et al. 2003). Therefore, depending on the mechanism of influence of air pollution on 
BP, long-term exposure to air pollution can theoretically result in increased SBP and PP and 
decreased DBP, or in increased DBP. 
In the current study, I observed a similar direction of association – mostly positive – of air 
pollution with SBP, DBP, and PP. This finding is coherent with the current evidence. Some 
studies have reported a positive long-term association of air pollution with SBP only (e.g., 
Foraster et al. 2014), but most with both SBP and DBP (e.g., Chuang et al. 2011; Dong et al. 
2013; Schwartz et al. 2012). Sørensen et al. (2012), who showed an inverse association of 
long-term exposure to NOx with BP, reported similar results with SBP and DBP. A positive 
association of air pollution with both SBP and DBP could indirectly prove that two physiolog-
ical pathways, namely, increasing peripheral vascular resistance and increasing arterial stiff-
ness could be involved. This finding should be confirmed in further studies, 
6.12. Association of road traffic noise with BP 
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The observational cohort allowed an analysis with air pollution and noise as simultaneous 
exposures in order to test for the independence of effects. In the results presented in this work, 
road traffic noise was associated with SBP and PP, independent of air pollution, but did not 
show associations with hypertension or BPLM intake. The association of PM2.5 with BP was 
robust to adjustment for road traffic and tram noise. Therefore, the effects of noise and air 
pollution in the study population are likely independent of each other. 
To date, there are only a few studies investigating noise and air pollution simultaneously. 
Most studies report a similar finding: the independence of air pollution and noise effects. For 
example, a positive association of road traffic noise with BP, independent of air pollution, was 
observed in a large Danish cohort (Sørensen et al. 2011); in the same cohort, the inverse asso-
ciation of NO2 with BP was independent of road traffic noise (Sørensen et al. 2012). In a 
Dutch study, road traffic noise ≥ 55 dB was positively associated with hypertension in sub-
jects aged 45 to 55 years, though not in the entire cohort; this association was independent of 
PM10 levels (de Kluizenaar et al. 2007). In a Swiss cohort, railway noise was positively asso-
ciated with BP, independent of NO2, whereas road traffic noise was associated with BP only 
in a subgroup of diabetic subjects (Dratva et al. 2012). In a part of the German KORA cohort 
(city of Augsburg), road traffic noise was positively associated with isolated systolic hyper-
tension, whereas in the other part of the same cohort (greater Augsburg), noise was inversely 
related to hypertension; both findings were independent of PM2.5 (Babisch et al. 2014). In the 
same cohort, PM2.5 was positively linked to hypertension, independent of road traffic noise, 
although this relationship was not statistically significant (Babisch et al. 2014). The evidence 
of the association of road traffic noise as a single exposure with BP is inconsistent (Babisch 
2010), although a positive association with hypertension has been reported in a recent meta-
analysis of 24 studies (van Kempen and Babisch 2012).  
It is possible that air pollution and noise affect different pathophysiologic pathways, or at least 
not completely overlapping ones. Whereas the adverse effect of air pollution on BP is likely 
dominated by an oxidative stress downstream cascade, road traffic noise is a stressor affecting 
the endocrine system and the ANS (Babisch et al. 2014).  
6.13. Lessons learned from the analysis with different housekeeping genes 
I found some variability in the expression of housekeeping genes in different exposure 
groups, especially noticeable for GAPDH. The activity levels of GAPDH (the product of this 
gene takes part in energy metabolism) were lower in groups with high concentrations of NO2. 
GAPDH is a multifunctional protein that is involved in microtubule bundling modification, 
Discussion 
156 
membrane fusion, calcium flux modification, gene transcription, DNA repair and replication, 
nuclear RNA export, and cell death (Hara et al. 2006). It is highly speculative whether this 
could be a real and not a chance finding. However, at least one study has showed that 
GAPDH can react with peroxynitrite, a product of NO2 (Mohr al. 1994). NO can also trigger 
posttranslational modification of GAPDH, which may mediate neuronal cell death (Hara et al. 
2006). 
It is recommended to check the expression of housekeeping genes in the study groups, which 
will allow detecting any inconsistencies. It is also necessary to present the crude expression of 
the genes that are studied, in addition to the one corrected for the housekeeping genes activity, 
and study the differences thoroughly. A careful consideration for the choice of the housekeep-
ing gene for the measurement is advisable. 
6.14. Strengths and limitations of the analysis 
There are some limitations of the observational study. First, measurement of BP was per-
formed once at baseline and at follow-up, which has implications for the analysis with both 
BP and hypertension. BP is highly variable parameter, and individual variation may conceal 
relatively small changes caused by air pollution. Defining hypertension based on a single 
measurement may also lead to misclassification in those individuals whose BPs get unexpect-
edly low or high at the time of measurement (for example, ―white coat hypertension‖ or cold-
induced hypertension). Few repeated measurements, preferably in different seasons, are desir-
able for the correct identification of hypertension. Second, a longitudinal analysis of the air 
pollution effect in the HNR cohort is challenging: the exposure concentrations decreased over 
the follow-up time whereas the outcome naturally increased with age. At the same time, the 
cross-sectional analysis precludes a causal interpretation of the complex interplay between 
environmental factors, related confounders and individual susceptibility. Third, no infor-
mation on actual exposure dose (e.g., how many hours the participant spends at home each 
day) was included in the air pollution assessment. Finally, despite the significant effort made 
to produce unbiased estimations, there is always a chance for residual confounding due to 
some unmeasured factors in the observational study. 
At the same time, the observational study had multiple strengths. A well-characterized, large 
population-based cohort was used. The measurements were performed by certified personnel 
using standardized protocols. All data were checked for plausibility. The outcome measure-
ments were performed according to the WHO recommendations three times with each partici-
pant, and the mean of the second and the third measurements was used in the analysis, mini-
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mizing the white coat effect. BPLM intake was assessed with WHO Anatomical Therapeutic 
Chemical classification categories, checking the working substance and the dose for each 
medication. Hypertension was defined according to the JNC7 definition (Chobanian et al. 
2003). Self-reported hypertension and medication use were used as additional outcomes. The 
thorough and integrative exposure assessment employed and an assessment that accounted for 
different components of the air pollution mixture along with other residence-related environ-
mental and social factors is the strength of this study. It was possible to investigate multiple 
environmental factors at once and their possible interactions. The availability of two time 
points in the HNR study allowed for the analysis to be repeated and for the baseline findings 
to be compared and confirmed at follow-up. Careful model specification and model checks 
enhanced the validity of the regression findings. As an additional strength for the data analy-
sis, the effect of BPLM was investigated using multiple correction strategies.  
The major limitation of the experimental study was the low number of animals (5 per group), 
which limits the power to identify the significant effects. To overcome this limitation, I aimed 
to increase the data quality using a standardized procedure for gene expression measurement. 
Using various analysis methods (correction with at least two housekeeping genes, sensitivity 
analyses, etc.), I attempted to test the robustness of the findings. Another limitation is that the 
results of an animal study may not be extrapolated to humans. However, only genes with 
identical functions in mice and men were chosen; therefore, this limitation is a minor one in 
this study. Finally, the experimental study is limited because only two exposures – diesel and 
NO2 – were investigated. An additional difficulty was that, according to a predefined experi-
mental design, exposure to diesel was only investigated in combination with NO2; thus, it was 
not possible to assess the effect of DEE alone. Further studies with more exposure variants in 
groups could shed more light on the biologic pathways underlying the cardiovascular effects 
of air pollution. 
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7. SUMMARY AND OUTLOOK 
The results of this study on the effect of long-term air pollution and its specific components 
on blood pressure and hypertension and on possible underlying pathophysiologic mechanisms 
can be summarized as follows:  
 Long-term exposure to ambient urban background PM2.5 was associated with elevated 
BP in a population-based cohort, independent of relevant confounders and co-
exposure to gaseous O3, NO2, NO, and CO in addition to other residential exposures 
(e.g., traffic volume, ambient noise, and neighborhood social deprivation). 
 The association of PM2.5 with BP was linear (i.e., dose-dependent) without a threshold. 
 Subjects medicated with BPLM showed a higher increase in BP related to air pollu-
tion. It is necessary to account for BPLM intake in the analyses with population-based 
cohorts, where a large proportion of individuals are taking BPLM. 
 No statistically significant association of air pollution with hypertension was ob-
served, which is possibly due to a relatively small effect size and insufficient power. 
Further studies, employing longitudinal analysis techniques, could provide more clear 
results. 
 An unexpected and thus far not investigated association between atmospheric ammo-
nia and BP was identified. It is a goal of future studies to clarify whether this associa-
tion is real and what the underlying biological pathways are. 
 In the experimental study I found some confirmations that long-term exposure to traf-
fic-related air pollution affects the activities of the genes involved in the immune re-
sponse, the oxidative stress response and xenobiotic metabolism; at the same time, the 
activity of these genes is relevant for vascular pathology and elevated BP.  
Blood pressure is a major modifiable risk factor for morbidity and mortality in the developed 
world. The proportion of hypertensive subjects in the population continues to grow. Small but 
persistent elevation in blood pressure due to exposure to air pollution could, on a population 
level, result in a substantially higher burden of CVD. Reductions of air pollution concentra-
tions will therefore result in a noticeable decrease of rates of cardiovascular events and mor-
tality in the population. 
The findings on air-pollution–induced chronic BP elevation in this study were based on rela-
tively low air pollution concentrations, quite common for Germany and other European coun-
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tries, and below the current regulatory standards. Therefore, results of this study provide sup-
portive evidence that efforts aimed at reducing air pollution levels below the current regulato-
ry standards will result in substantial population health benefits. 
The findings of this study show, on one hand, a consistent association of fine particulate mat-
ter with elevated BP in a population-based cohort, and, on the other hand, supportive evidence 
that traffic-related air pollution can induce inflammation, oxidative stress and vascular reac-
tions, which might favor hypertension in the long run. These findings support the hypothesis 
that air-pollution–induced increases in BP could be one possible biological pathway of how 
long-term PM exposure may promote atherosclerosis, a common underlying pathology for 
cardiovascular morbidity and mortality. 
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Table 38. Estimates for the covariates in the main model with SBP at baseline. 
Variable (increment) Change, mmHg (95%-CI) p-value 
Intercept 53.008 (40.382, 65.633) 0.000 
PM2.5 (365-day mean) (1 µg/m³) 0.471 ( 0.087, 0.855) 0.016 
Time trend (centered) (100 days) -0.367 (-0.603, -0.132) 0.002 
Time trend squared (centered) (100 days²) 0.003 (0.002, 0.004) 0.000 
PM2.5 (7-day mean) (1 µg/m³) 0.083 (-0.009, 0.175) 0.076 
Lnight (traffic) (5 dB) 0.327 (-0.008, 0.662) 0.056 
Lden (tram) (5 dB) 0.002 (-0.039, 0.043) 0.928 
Distance to road (1 km) 0.048 (-0.741, 0.837) 0.905 
Age (1 year) 0.618 ( 0.517, 0.719) 0.000 
Sex (male) 8.182 ( 6.405, 9.958) 0.000 
BMI (centered) (1 kg/m²) 0.617 ( 0.459, 0.774) 0.000 
BMI squared (centered) (1 (kg/m²)²) -0.022 (-0.037, -0.007) 0.004 
WHR 13.915 ( 4.411, 23.420) 0.004 
LDL/HDL ratio 1.097 ( 0.438, 1.756) 0.001 
HDL (mg/dL) 0.134 ( 0.086, 0.182) 0.000 
Triglycerides (mg/dL) 0.024 ( 0.018, 0.030) 0.000 
Smoking (current) (reference)  
Smoking (former) 2.528 ( 0.913, 4.143) 0.002 
Smoking (never) 2.946 ( 1.337, 4.555) 0.000 
ETS 0.894 (-0.419, 2.206) 0.182 
Physical activity (<1 time/week) (reference)  
Physical activity (1 time/week) -2.309 (-4.129, -0.489) 0.013 
Physical activity (2-3 times/week) -1.597 (-3.260, 0.066) 0.060 
Physical activity (>3 times/week) -2.463 (-3.857, -1.069) 0.001 
Education (low) (reference)  
Education (medium) -0.053 (-1.877, 1.771) 0.954 
Education (high) -0.943 (-3.001, 1.115) 0.369 
Economic activity (employed) (reference)  
Economic activity (unemployed) -1.095 (-3.450, 1.261) 0.362 
Economic activity (homemaker) 1.409 (-0.550, 3.368) 0.159 
Economic activity (retired) 0.721 (-1.011, 2.452) 0.415 
N=4,584.   
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Table 39. Estimates for the covariates in the main model with DBP at baseline. 
Variable (increment) Change, mmHg (95%-CI) p-value 
Intercept 59.785 (53.360, 66.209) 0.000 
PM2.5 (365-day mean) (1 µg/m³) 0.313 ( 0.105, 0.521) 0.003 
Time trend (centered) (100 days) -0.409 (-0.536, -0.281) 0.000 
Time trend squared (centered) (100 days²) 0.001 (0.000, 0.001) 0.000 
PM2.5 (7-day mean) (1 µg/m³) 0.022 (-0.028, 0.071) 0.392 
Lnight (traffic) (5 dB) 0.098 (-0.084, 0.279) 0.291 
Lden (tram) (5 dB) 0.003 (-0.019, 0.026) 0.760 
Distance to road (1 km) -0.013 (-0.440, 0.414) 0.953 
Age (centered) (1 year) -0.104 (-0.159, -0.049) 0.000 
Age squared (centered) (1 year²) -0.011 (-0.016, -0.006) 0.000 
Sex (male) 4.189 ( 3.227, 5.150) 0.000 
BMI (centered) (1 kg/m²) 0.400 ( 0.315, 0.486) 0.000 
BMI squared (centered) (1 (kg/m²)²) -0.020 (-0.028, -0.012) 0.000 
WHR 7.157 ( 2.003, 12.311) 0.007 
LDL/HDL ratio 0.682 ( 0.322, 1.042) 0.000 
HDL (mg/dL) 0.080 ( 0.054, 0.106) 0.000 
Triglycerides (centered) (mg/dL) 0.017 ( 0.013, 0.022) 0.000 
Triglycerides squared (centered) ((mg/dL)²) 0.000 ( 0.000, 0.000) 0.037 
Smoking (current) (reference)  
Smoking (former) 1.499 ( 0.625, 2.372) 0.001 
Smoking (never) 2.165 ( 1.294, 3.037) 0.000 
ETS 0.474 (-0.235, 1.184) 0.190 
Physical activity (<1 time/week) (reference)  
Physical activity (1 time/week) -0.555 (-1.540, 0.429) 0.269 
Physical activity (2-3 times/week) -0.587 (-1.488, 0.313) 0.201 
Physical activity (>3 times/week) -0.892 (-1.647, -0.138) 0.020 
Education (low) (reference)  
Education (medium) 0.146 (-0.842, 1.134) 0.772 
Education (high) -0.200 (-1.315, 0.914) 0.725 
Economic activity (employed) (reference)  
Economic activity (unemployed) -0.352 (-1.631, 0.926) 0.589 
Economic activity (homemaker) 0.712 (-0.352, 1.776) 0.190 
Economic activity (retired) 0.324 (-0.613, 1.261) 0.498 
N=4,584.   
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Table 40. Estimates for the covariates in the main model with PP at baseline. 
Variable (increment) Change, mmHg (95%-CI) p-value 
Intercept -9.277 (-18.061, -0.494) 0.038 
PM2.5 (365-day mean) (1 µg/m³) 0.172 ( -0.096, 0.439) 0.208 
Time trend (centered) (100 days) 0.039 (-0.125, 0.203) 0.638 
Time trend squared (centered) (100 days²) 0.002 (0.002, 0.003) 0.000 
PM2.5 (7-day mean) (1 µg/m³) 0.060 ( -0.004, 0.124) 0.065 
Lnight (traffic) (5 dB) 0.231 ( -0.002, 0.465) 0.052 
Lden (tram) (5 dB) -0.003 ( -0.031, 0.026) 0.850 
Distance to road (1 km) 0.050 (-0.499, 0.599) 0.859 
Age (1 year) 0.724 ( 0.653, 0.794) 0.000 
Sex (male) 4.026 ( 2.790, 5.261) 0.000 
BMI (centered) (1 kg/m²) 0.211 ( 0.101, 0.321) 0.000 
BMI squared (centered) (1 (kg/m²)²) -0.002 ( -0.012, 0.009) 0.745 
WHR 5.893 ( -0.719, 12.506) 0.081 
LDL/HDL ratio 0.357 ( -0.102, 0.815) 0.128 
HDL (mg/dL) 0.053 ( 0.020, 0.087) 0.002 
Triglycerides (mg/dL) 0.010 ( 0.006, 0.014) 0.000 
Smoking (current) (reference)  
Smoking (former) 0.987 ( -0.137, 2.111) 0.085 
Smoking (never) 0.711 ( -0.409, 1.830) 0.214 
ETS 0.398 ( -0.515, 1.311) 0.393 
Physical activity (<1 time/week) (reference)  
Physical activity (1 time/week) -1.759 ( -3.025, -0.493) 0.007 
Physical activity (2-3 times/week) -1.041 ( -2.198, 0.116) 0.078 
Physical activity (>3 times/week) -1.559 ( -2.529, -0.589) 0.002 
Education (low) (reference)  
Education (medium) -0.300 ( -1.569, 0.970) 0.644 
Education (high) -0.835 ( -2.267, 0.597) 0.253 
Economic activity (employed) (reference)  
Economic activity (unemployed) -0.997 ( -2.636, 0.642) 0.233 
Economic activity (homemaker) 0.457 ( -0.906, 1.820) 0.511 
Economic activity (retired) 0.365 ( -0.840, 1.569) 0.553 
N=4,584.   
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Table 41. Estimates for the covariates in the main model with prevalent hypertension at base-
line. 
Variable (increment) OR (95%-CI) p-value 
Intercept 0.003 (0.001, 0.012) 0.000 
PM2.5 (365-day mean) (1 µg/m³) 1.000 (0.955, 1.046) 0.994 
Time trend (centered) (100 days) 0.989 (0.962, 1.018) 0.454 
Time trend squared (centered) (100 days²) 1.000 (1.000, 1.000) 0.009 
PM2.5 (7-day mean) (1 µg/m³) 1.006 (0.995, 1.017) 0.312 
Lnight (traffic) (5 dB) 1.021 (0.981, 1.063) 0.307 
Lden (tram) (5 dB) 0.999 (0.994, 1.004) 0.749 
Distance to road (1 km) 0.978 (0.890, 1.074) 0.637 
Age (1 year) 1.072 (1.059, 1.085) 0.000 
Sex (male) 1.249 (1.012, 1.541) 0.038 
BMI (centered) (1 kg/m²) 1.096 (1.076, 1.117) 0.000 
BMI squared (centered) (1 (kg/m²)²) 1.001 (0.999, 1.004) 0.318 
WHR 5.830 (1.872, 18.157) 0.002 
LDL/HDL ratio 0.946 (0.869, 1.030) 0.203 
HDL (mg/dL) 0.999 (0.993, 1.005) 0.699 
Triglycerides (mg/dL) 1.003 (1.002, 1.004) 0.000 
Smoking (current) (reference)  
Smoking (former) 1.378 (1.139, 1.668) 0.001 
Smoking (never) 1.252 (1.036, 1.512) 0.020 
ETS 1.108 (0.949, 1.295) 0.195 
Physical activity (<1 time/week) (reference)  
Physical activity (1 time/week) 0.886 (0.715, 1.098) 0.268 
Physical activity (2-3 times/week) 0.788 (0.649, 0.957) 0.016 
Physical activity (>3 times/week) 0.750 (0.636, 0.884) 0.001 
Education (low) (reference)  
Education (medium) 0.850 (0.682, 1.060) 0.149 
Education (high) 0.854 (0.667, 1.095) 0.213 
Economic activity (employed) (reference)  
Economic activity (unemployed) 1.024 (0.779, 1.345) 0.866 
Economic activity (homemaker) 1.083 (0.861, 1.362) 0.497 
Economic activity (retired) 1.167 (0.953, 1.430) 0.136 
N=4,584.   
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Table 42. Estimates for the covariates in the main model with BPLM use at baseline. 
Variable (increment) OR (95%-CI) p-value 
Intercept 0.013 (0.003, 0.063) 0.000 
PM2.5 (365-day mean) (1 µg/m³) 0.982 (0.937, 1.028) 0.434 
Time trend (centered) (100 days) 1.031 (1.003, 1.061) 0.032 
Time trend squared (centered) (100 days²) 1.000 (1.000, 1.000) 0.612 
PM2.5 (7-day mean) (1 µg/m³) 1.001 (0.990, 1.012) 0.866 
Lnight (traffic) (5 dB) 1.007 (0.968, 1.049) 0.719 
Lden (tram) (5 dB) 0.999 (0.994, 1.004) 0.759 
Distance to road (1 km) 0.952 (0.866, 1.048) 0.316 
Age (1 year) 1.065 (1.052, 1.078) 0.000 
Sex (male) 0.700 (0.564, 0.868) 0.001 
BMI (centered) (1 kg/m²) 1.075 (1.054, 1.096) 0.000 
BMI squared (centered) (1 (kg/m²)²) 1.002 (0.999, 1.004) 0.146 
WHR 7.261 (2.294, 22.983) 0.001 
LDL/HDL ratio 0.789 (0.720, 0.866) 0.000 
HDL (mg/dL) 0.980 (0.974, 0.986) 0.000 
Triglycerides (mg/dL) 1.001 (1.001, 1.002) 0.000 
Smoking (current) (reference)  
Smoking (former) 1.336 (1.095, 1.631) 0.004 
Smoking (never) 1.281 (1.050, 1.563) 0.015 
ETS 1.095 (0.933, 1.284) 0.266 
Physical activity (<1 time/week) (reference)  
Physical activity (1 time/week) 0.866 (0.696, 1.078) 0.198 
Physical activity (2-3 times/week) 0.841 (0.688, 1.028) 0.091 
Physical activity (>3 times/week) 0.755 (0.637, 0.895) 0.001 
Education (low) (reference)  
Education (medium) 0.911 (0.736, 1.128) 0.393 
Education (high) 1.030 (0.807, 1.313) 0.814 
Economic activity (employed) (reference)  
Economic activity (unemployed) 1.023 (0.759, 1.378) 0.882 
Economic activity (homemaker) 1.161 (0.912, 1.477) 0.226 
Economic activity (retired) 1.204 (0.980, 1.478) 0.076 
N=4,584.   
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Table 43. The distribution of exposure, outcome and most characteristics in the baseline anal-
ysis subset and among participants excluded from the analyses at baseline. 
Variable (unit), statistics 
Analysis subset (N=4,584) Excluded (N=230) 
Description N missing Description N missing 
PM2.5 (µg/m³), Mean ± SD 16.7 ± 1.6 0 16.4 ± 1.6 5 
PM10 (µg/m³), Mean ± SD 20.7 ± 2.6 0 20.5 ± 2.6 5 
PMcoarse (µg/m³), Mean ± SD 4.0 ± 1.6 0 4.2 ± 1.8 5 
PM1 (µg/m³), Mean ± SD 11.6 ± 1.3 0 11.4 ± 1.3 5 
PN (×10^4/L), Mean ± SD 8.8 ± 1.9 0 8.7 ± 1.9 5 
O3 (µg/m³), Mean ± SD 35.4 ± 1.6 0 35.4 ± 1.6 5 
NO2 (µg/m³), Mean ± SD 40.1 ± 4.2 0 39.5 ± 4.3 5 
NO (µg/m³), Mean ± SD 12.7 ± 4.5 0 12.2 ± 4.2 5 
SO2 (µg/m³), Mean ± SD 8.7 ± 1.1 0 8.6 ± 1.1 5 
CO (µg/m³), Mean ± SD 0.3 ± 0.1 0 0.3 ± 0.1 5 
NH3 (µg/m³), Mean ± SD 2.6 ± 0.4 0 2.5 ± 0.3 5 
SBP (mmHg), Mean ± SD 133.2 ± 20.8 0 132.8 ± 21.6 15 
DBP (mmHg), Mean ± SD 81.4 ± 10.9 0 81.5 ± 11.0 14 
PP (mmHg), Mean ± SD 51.7 ± 14.7 0 51.4 ± 15.6 15 
Hypertension, n (%) 2611 (57.0%) 0 151 (65.7%) 31 
BPLM use, n (%) 1628 (35.5%) 0 87 (37.8%) 16 
Self-reported hypertension, n (%) 1955 (42.7%) 10 100 (43.7%) 1 
Self-reported BPLM use, n (%) 1432 (31.2%) 1 65 (28.5%) 2 
Age (years), Mean ± SD 59.6 ± 7.8 0 59.9 ± 8.1 0 
Sex (male), n (%) 2274 (49.6%) 0 121 (52.6%) 0 
CHD, n (%) 296 (6.5%) 0 46 (20.0%) 15 
T2DM, n (%) 623 (13.6%) 0 29 (12.6%) 0 
BMI (kg/m²), Mean ± SD 27.9 ± 4.6 0 28.1 ± 5.5 29 
LDL:HDL ratio, Mean ± SD 2.7 ± 1.1 0 2.8 ± 1.1 38 
Smoking, n (%) 
 
0 
 
10 
  Current 1064 (23.2%) 
 
74 (32.2%) 
 
  Former 1585 (34.6%) 
 
87 (37.8%) 
 
  Never 1935 (42.2%) 
 
89 (38.7%) 
 
  Pack-years, Mean ± SD 16.1 ± 24.6 112 17.8 ± 25.8 19 
ETS exposure, n (%) 1658 (36.2%) 0 104 (45.2%) 17 
Alcohol (drinks/week), Mean ± SD 5.3 ± 10.2 107 5.1 ± 10.7 16 
No sport, n (%) 2100 (45.8%) 0 127 (55.2%) 1 
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Variable (unit), statistics 
Analysis subset (N=4,584) Excluded (N=230) 
Description N missing Description N missing 
Education, n (%) 
 
0 
 
16 
  <10 years 517 (11.3%) 
 
46 (20.0%) 
 
  11–17 years 2558 (55.8%) 
 
134 (58.3%) 
 
  >=18 years 1509 (32.9%) 
 
82 (35.7%) 
 
Economic activity, n (%) 
 
0 
 
15 
Employed 1847 (40.3%) 
 
96 (41.7%) 
 
Unemployed 290 (6.3%) 
 
30 (13.0%) 
 
Homemakers 642 (14.0%) 
 
36 (15.7%) 
 
Retired 1805 (39.4%) 
 
113 (49.1%) 
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Table 44. The distribution of exposure, outcome and most characteristics in the follow-up 
analysis subset and among participants excluded from the analyses at follow-up. 
Variable (unit), statistics 
Analysis subset (N=3,240) Excluded (N=232) 
Description N missing Description N missing 
PM2.5 (µg/m³), Mean ± SD 15.6 ± 1.4 0 15.7 ± 1.3 0 
PM10 (µg/m³), Mean ± SD 19.8 ± 3.1 0 20.2 ± 3.3 0 
PMcoarse (µg/m³), Mean ± SD 4.2 ± 2.4 0 4.5 ± 2.7 0 
PM1 (µg/m³), Mean ± SD 11.0 ± 1.1 0 11.1 ± 1.1 24 
PN (×10^4/L), Mean ± SD 7.7 ± 1.7 0 7.7 ± 1.5 24 
O3 (µg/m³), Mean ± SD 37.6 ± 2.0 0 37.4 ± 2.0 24 
NO2 (µg/m³), Mean ± SD 38.6 ± 4.7 0 39.3 ± 4.8 24 
NO (µg/m³), Mean ± SD 7.7 ± 2.2 0 8.1 ± 2.3 24 
SO2 (µg/m³), Mean ± SD 7.4 ± 1.1 0 7.6 ± 1.1 24 
CO (µg/m³), Mean ± SD 0.3 ± 0.0 0 0.3 ± 0.0 24 
NH3 (µg/m³), Mean ± SD 2.8 ± 0.3 0 2.8 ± 0.3 24 
SBP (mmHg), Mean ± SD 134.6 ± 19.8 0 132.6 ± 19.5 11 
DBP (mmHg), Mean ± SD 79.2 ± 10.5 0 77.3 ± 10.3 11 
PP (mmHg), Mean ± SD 55.4 ± 14.7 0 55.3 ± 14.8 11 
Hypertension, n (%) 2157 (66.6%) 0 158 (68.1%) 11 
BPLM use, n (%) 1595 (49.2%) 0 117 (50.4%) 0 
Self-reported hypertension, n (%) 1434 (45.4%) 80 107 (48.0%) 9 
Self-reported BPLM use, n (%) 1391 (43.3%) 25 102 (44.5%) 3 
Age (years), Mean ± SD 64.6 ± 7.6 0 66.3 ± 7.8 0 
Sex (male), n (%) 1630 (50.3%) 0 101 (43.5%) 0 
CHD, n (%) 263 (8.1%) 0 38 (16.4%) 7 
T2DM, n (%) 614 (19.0%) 0 49 (21.1%) 0 
BMI (kg/m²), Mean ± SD 28.3 ± 4.8 0 29.1 ± 5.9 11 
LDL:HDL ratio, Mean ± SD 2.3 ± 0.8 0 2.3 ± 0.9 25 
Smoking, n (%) 
 
0 
 
7 
Current 552 (17.0%) 
 
35 (15.1%) 
 
Former 1301 (40.2%) 
 
88 (37.9%) 
 
Never 1387 (42.8%) 
 
123 (53.0%) 
 
ETS exposure, n (%) 799 (24.7%) 0 49 (21.1%) 8 
Alcohol (drinks/week), Mean ± SD 7.1 ± 11.2 0 5.6 ± 10.5 61 
No sport, n (%) 1379 (42.6%) 0 123 (53.0%) 6 
Education, n (%) 
 
0 
 
4 
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Variable (unit), statistics 
Analysis subset (N=3,240) Excluded (N=232) 
Description N missing Description N missing 
<10 years 289 (8.9%) 
 
55 (23.7%) 
 
11–17 years 1817 (56.1%) 
 
122 (52.6%) 
 
>=18 years 1134 (35.0%) 
 
63 (27.2%) 
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Table 45. Stratified description of study population at baseline by BPLM intake.  
Variable No BPLM intake 
(N=2,956) 
BPLM intake 
(N=1,628) 
p 
(T-test,χ²-test) 
PM2.5 [µg/m³], Mean ± SD 16.6 ± 1.6 16.7 ± 1.6 0.243 
PM10 [µg/m³], Mean ± SD 20.7 ± 2.6 20.7 ± 2.7 0.467 
PMcoarse [µg/m³], Mean ± SD 4.0 ± 1.6 4.0 ± 1.6 0.994 
PM1 [µg/m³], Mean ± SD 11.6 ± 1.3 11.6 ± 1.3 0.138 
PN [×10^4/L], Mean ± SD 8.8 ± 1.9 8.9 ± 1.9 0.202 
O3 [µg/m³], Mean ± SD 35.4 ± 1.6 35.5 ± 1.6 0.554 
NO2 [µg/m³], Mean ± SD 40.1 ± 4.2 40.3 ± 4.1 0.069 
NO [µg/m³], Mean ± SD 12.6 ± 4.5 12.8 ± 4.5 0.130 
SO2 [µg/m³], Mean ± SD 8.7 ± 1.1 8.8 ± 1.1 0.033 
CO [µg/m³], Mean ± SD 0.3 ± 0.1 0.3 ± 0.1 0.226 
NH3 [µg/m³], Mean ± SD 2.6 ± 0.4 2.6 ± 0.4 0.530 
Lden (traffic) [dB], Mean ± SD 53.8 ± 9.6 54.2 ± 9.7 0.253 
Lden (tram) [dB], Mean ± SD 12.1 ± 13.6 12.4 ± 13.6 0.433 
Proximity to road [km], Mean ± SD 920.1 ± 781.9 868.3 ± 780.7 0.032 
Area-level unemployment rate [%], 
Mean ± SD 
12.4 ± 3.4 12.7 ± 3.5 0.003 
SBP [mmHg], Mean ± SD 130.6 ± 20.3 137.8 ± 21.0 0.000 
DBP [mmHg], Mean ± SD 81.1 ± 10.7 82.1 ± 11.1 0.002 
PP [mmHg], Mean ± SD 49.5 ± 13.8 55.7 ± 15.6 0.000 
Hypertension , % 33.3% 100.0% 0.000 
Age [years] 58.1 ± 7.5 62.4 ± 7.5 0.000 
Sex [male], % 48.8% 51.1% 0.140 
CHD, % 1.5% 15.4% 0.000 
T2DM, % 8.5% 22.9% 0.000 
BMI [kg/m²] 27.1 ± 4.1 29.4 ± 5.0 0.000 
Current smoker, % 26.1% 18.0% 0.000 
Former smoker, % 33.1% 37.3% 
 
Never smoker, % 40.8% 44.7% 
 
ETS exposure, % 38.5% 31.9% 0.000 
No sport, % 42.6% 51.7% 0.000 
Education <10 years, % 9.6% 14.3% 0.000 
N=4,584.    
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Figure 28. The mean BP values at baseline by the month of measurement. 
Legend: N=4,584. 
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